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Abstract 
The process of angiogenesis in which new blood vessels form from pre-existing 
vessels, can be intensively studied through the use of in vitro and in vivo models. The 
in vitro co-culture tube formation assay is used to assess the ability of endothelial 
cells to develop into three dimensional tubular structures which mimics the growth of 
capillaries. Different fluorescent labelling techniques were developed and utilised 
alongside confocal microscopy to visualise endothelial tubulogenesis and investigate 
the mechanisms of lumenogenesis. Imaging the actin cytoskeletal organisation by 
expressing the lifeact peptide conjugated to fluorescent proteins revealed that F-actin 
fibres outline lumens within endothelial tubules and enabled clear visualisation of 
filopodia formation.  
Further studies presented in this thesis aimed to develop, test and evaluate 
computational tools for analysing endothelial sprouting from fluorescently labelled 
spheroids generated using the in vitro hanging drop spheroid assay and quantify 
blood vessel formation in the in vivo zebrafish model. The results confirmed that both 
analysis tools were able to rapidly quantify a wide range of angiogenic images and 
generated comparable results to frequently used manual methods. The developed 
computational analysis tools are user friendly and can be used to assess the effects 
of inhibitor compounds and silencing vascular related genes.  
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Chapter One 
Introduction  
2 
 
1.1. Project aims 
The main focus of this PhD project was to monitor, manipulate and analyse in detail 
the process of angiogenesis through the development of high resolution fluorescence 
imaging techniques and the generation of useful analysis tools to quantify angiogenic 
images.  
The following aims are presented in the three results chapters in this thesis: 
To utilise and develop fluorescent imaging techniques to study the process of 
endothelial lumen formation within tubules formed in the in vitro co-culture 
tube formation assay  
Confocal imaging was used alongside various fluorescent labelling techniques to 
study and monitor the extension of endothelial cells into three dimensional tubules 
using the co-culture tube formation assay. The intracellular process of lumen 
formation within endothelial tubules was imaged by fluorescently labelling the 
cytoplasm of endothelial cells, staining for apical and basal cell surface markers as 
well as visualising the organisation of the actin cytoskeleton. The endothelial 
lumenogenesis mechanisms were visualised, assessed and quantified in endothelial 
tubules formed using this tube formation assay. 
To design, test and evaluate a computer based analysis tool for quantifying 
endothelial sprouting from fluorescently labelled spheroids produced using the 
in vitro hanging drop spheroid angiogenesis assay 
A computer based analysis tool was specifically designed to permit rapid and 
automated analysis of endothelial sprouting from spheroids generated from the 
3 
 
hanging drop spheroid angiogenesis assay. The Spheroid Analysis ImageJ plugin 
was tested and evaluated by applying the analysis method to a wide range of 
endothelial sprouting images generated through a kinase screen using a library of 80 
small molecule kinase inhibitors in the assay. Alongside the hanging drop spheroid 
angiogenesis assay, the scratch wound in vitro angiogenesis assay and the matrigel 
tube formation assay were used to screen and identify important kinases with roles in 
endothelial sprouting, migration and tube formation. The data generated from the 
kinase screen has been represented in analysis heat map tables which enabled easy 
and rapid identification of kinase inhibitors that affected these endothelial processes.  
To generate a computer based analysis method to assess and quantify the 
development of the intersegmental blood vessels in embryonic zebrafish  
Two computer assisted analysis methods using IMARIS and ImageJ software were 
generated which permitted quantification of numerous vascular parameters from 
fluorescent zebrafish images. Normal vascular development was studied by 
monitoring and imaging the formation of the intersegmental blood vessels in fli1-GFP 
zebrafish embryos with time-course confocal imaging. Abnormal vascular 
development was studied by knocking down vascular related genes and the effects 
of inhibitor compounds on vessel development were observed. Both normal and 
abnormal vascular development was assessed and quantified using the computer 
based analysis methods and comparative studies were performed by performing 
manual analysis on the vascular images. 
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1.2. Endothelial cells and their role in vascular development 
1.2.1. Introduction 
The endothelium consists of a single layer of endothelial cells which line the internal 
walls of blood and lymphatic vessels1.  Blood vessels transport oxygen, nutrients and 
hormones to tissues and the lymphatic vessels return interstitial fluid consisting of 
blood plasma and leukocytes from the interstitial space back to the blood vessels2. 
The vascular network contributes to the important physiological processes of tissue 
growth and repair, cell delivery and immunity3. Endothelial cells are highly 
metabolically active cells and disregulation of these cells can cause malignant, 
ischemic, immune and inflammatory disorders3-5. 
1.2.2. The formation of blood vessels 
The de novo formation of blood vessels is initiated from blood islands in the 
developing organism, these are formed from mesodermal derived hemangioblasts 
which either undergo differentiation to produce angioblasts, which are the endothelial 
precursor cells or hematopoietic stem cells6. Upon stimulation from vascular 
endothelial growth factor A (VEGF) signalling through the transmembrane receptor 
tyrosine kinase VEGFR2, the blood islands fuse together to form the first primitive 
plexus of blood vessels in the embryonic organism6,7. The process which generates 
this primitive vascular network is known as vasculogenesis8.  
The primary capillary plexus then undergoes remodelling and stabilisation by the 
attachment of mural cells to the ablumenal endothelial surface, for smaller blood 
vessels such as capillaries this involves the attachment of pericytes and for larger 
vessels it involves the attachment of vascular smooth muscle cells. Once the vessel 
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has been stabilised, the vascular network is expanded through endothelial sprouting, 
intussusception and collateral growth4,9. The process in which new blood vessels 
form from the pre-existing vascular network is known as angiogenesis, a process 
which is predominantly driven by endothelial proliferation8,10.  
The process of angiogenesis is not only critical for supporting embryonic 
development; it also has crucial roles within adult organisms such as aiding the 
multistep process of wound repair. During the proliferative phase of wound healing, 
the normally quiescent endothelial cells are recruited to the site of vascular damage 
and angiogenesis is initiated to sustain the growth of newly formed replacement 
tissue11. Angiogenesis is also a highly active process in female adult organisms, 
since there is a requirement for rapid vessel growth in uterine and placental tissues 
during pregnancy as well as during the female menstrual cycle5,12.  
However, disregulation of endothelial cells can support the progression of 
pathological diseases. Pathological conditions associated with vessel regression or 
reduced vessel growth include ischemia, hypertension and neurodegeneration4. 
Enhanced activation of the angiogenic pathway is associated with atherosclerosis, 
obesity, asthma and inflammatory associated diseases such as arthritis4. 
Angiogenesis also supports tumour growth and metastasis, as tumours are limited to 
1-2 mm in diameter which is equivalent to approximately 1 million cells without the 
infiltration of blood vessels into the hypoxic tumour environment to supply oxygen to 
the tumour cells13.  
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1.2.3. Angiogenic mechanisms 
1.2.3.1. Sprouting angiogenesis 
The process of sprouting angiogenesis is controlled through signalling pathways from 
critical regulatory factors, the pathway can be stimulated by an enhancement of pro-
angiogenic signalling molecules such as VEGF, angiopoietin-2 (ANG-2) and 
chemokines which are released by tumour or inflammatory cells1,14. In response to 
angiogenic stimulation, pericytes detach from the basement membrane and the 
vessel is destabilised through the action of matrix metalloproteinases (MMPs)14. 
There are strong intercellular adhesions between endothelial cells to ensure vessel 
integrity, the cells are connected by junctional proteins of VE-cadherin and claudins, 
however MMP degradation weakens the endothelial contacts causing increased 
vascular permeability and enables endothelial migration14. Particular endothelial cells 
within the vessel become activated and initiate endothelial sprouting which expands 
the vascular network, these endothelial cells are known as tip cells and they direct 
the growth of the newly formed blood vessel1. These dynamic and motile tip cells 
function by extending cytoplasmic projections known as filopodia into the local micro-
environment and respond to chemotropic signals from ephrins and semaphorins 
through receptors on their cell surface thereby sensing gradients of angiogenic 
factors15. The cells located behind the endothelial tip cell in the developing sprout are 
known as endothelial stalk cells and these cells are responsible for elongating the 
sprout via cellular proliferation1. The process of sprouting angiogenesis is outlined in 
figure 1.1. 
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Figure 1.1 Sprouting and intussusception angiogenesis 
In sprouting angiogenesis, 1) two neighbouring blood vessels exist as quiescent 
vessels, 2) a tip cell emerges upon activation of an endothelial cell in one vessel and 
destabilisation of the basement membrane, 3) stalk cells located behind the tip cell 
proliferate to elongate the endothelial sprout, 4) the endothelial sprout forms a 
junction with the neighbouring vessel, forming a complex and interconnecting 
vascular network. 
In intussusception angiogenesis, 1) a blood vessel exists, 2) protrusion of opposing 
sides of the vessel wall come into contact, which is stabilised by basement 
membrane components, collagen and pericytes, 3) the formation of a mature 
translumenal pillar within the vessel, increases the complexity of the vasculature.  
1 2
3 4 
Sprouting Angiogenesis 
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Signalling from the delta-like-4 (Dll4) and notch pathway determines tip and stalk cell 
fate and determines endothelial behaviour. Dll4 is a membrane bound endothelial 
specific notch ligand which is upregulated on tip cells and binds to the heterodimeric 
notch receptor on adjacent endothelial cells to promote the stalk cell phenotype1,16. 
The stalk cells continue to proliferate and elongate the sprout until the tip cell 
connects with a nearby vessel generating vascular junctions, contributing to vascular 
complexity. Endothelial stalk cells then establish a lumen via the process of 
lumenogenesis, a critical step in angiogenesis which creates a continuous open 
channel encapsulated by endothelial cells which enables blood flow15.  
Tubular lumens are generated either through the rearrangement and morphological 
changes of endothelial cells in which an extracellular space develops into a lumen or 
by the process of pinocytosis and vacuole fusion, in which intracellular vacuoles of 
adjacent cells fuse together to form a continuous lumen17,18. Lumenogenesis allows 
establishment of blood flow which increases the amount of oxygen to the tissue 
thereby causing a reduction in pro-angiogenic signalling and subsequently results in 
quiescent behaviour of the vessel1. Additionally, the integration of the newly formed 
vessel as well as the release of platelet derived growth factor B (PDGFB) from 
endothelial tip cells during this process triggers the attachment of mural cells to the 
endothelial cells thereby stabilising the new vessel1.  
1.2.3.2. Intussusception angiogenesis 
 Another angiogenic mechanism which functions to expand the vascular network in 
organisms is intussusception or splitting angiogenesis. This angiogenic mechanism 
involves the generation of translumenal tissue pillars within mature vessels leading to 
vessel separation, as shown in figure 1.119. The process of intussusception is 
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initiated by protruding endothelial cell walls on opposing sides of the vessel. The 
vascular protrusion leads to intercellular contact within the vessel which is stabilised 
by the formation of basement membrane and the diameter of the vascular pillar 
increases due to the formation of collagen and attachment of pericytes20. The 
establishment of a translumenal vascular pillar increases the complexity of the 
vascular network and occurs comparatively faster than sprouting angiogenesis which 
depends on endothelial proliferation19. 
Both angiogenic mechanisms of sprouting and intussusception are essential post 
vasculogenesis to enhance the complexity and connectivity of the primary vascular 
network to provide an efficient circulatory system. Sprouting angiogenesis is the 
dominant mechanism required to establish newly formed vessels, whereas 
intussusception angiogenesis is crucial for remodelling the vasculature20. Once blood 
flow in the vessels has been established, vascular remodelling is achieved through 
vessel regression and pruning to ensure there is efficient blood transport. Vessels 
which participate in limited blood transport regress through the retraction of 
endothelial cells, in which the endothelial cells either relocate to another vessel or 
undergo apoptosis21.  
1.2.4. Mechanisms of lumen formation 
All developing vessels must undergo the process of lumenogenesis to establish a 
lumen to transport blood and prior to lumen formation the endothelial cells exist as a 
cord of cells tightly connected by cellular junctions. The cellular and molecular 
mechanisms of endothelial lumenogenesis have been widely debated, due to the 
complex morphology of the tubules, the lack of specific apical and basolateral cell 
surface markers as well as the difficulty posed by imaging intracellular structures, 
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many researchers have had difficulty identifying the exact mechanisms behind the 
formation of tubular lumens17. However, there is evidence to support two models of 
endothelial lumen formation; the endothelial cell rearrangement mechanism and the 
vacuole fusion mechanism, these mechanisms may occur under different 
environmental conditions in vivo and in vitro22. 
1.2.4.1. Endothelial cell rearrangement mechanism 
In the first stage of the endothelial cell rearrangement or cord hollowing 
lumenogenesis mechanism, the apical and basolateral endothelial cell surfaces are 
established by cellular polarisation17,23. The apical cell surface is that which interacts 
with the lumen, whereas the basal cell surface is on the ablumenal side24. Following 
the establishment of the apicobasal polarity, junctional proteins are redistributed 
along the endothelial cell surfaces with negatively charged CD34-sialomucins, 
dextran sulphate and glycoprotein podocalyxin redirected to the apical cell 
membrane, a process regulated by VE-cadherin and β1 integrin23. Electrostatic 
repulsion between two apical endothelial surfaces of adjacent cells from the 
negatively charged proteins on these cell membranes drives the initial formation of a 
small extracellular space at the cell-cell contact region25, as shown in figure 1.2. 
Successive expansion of the extracellular space is achieved through repositioning of 
podocalyxin, which recruits F-actin and moesin to the apical cell membrane where 
actomyosin contractility causes cytoskeletal reorganisation and morphological 
rearrangement of the endothelial cells23. Signalling by the Rac1 guanine nucleotide 
exchange factor (GEF) dedicator of cytokinesis 4 (DOCK4) has been identified to be 
necessary for lumen formation through the rearrangement of the endothelial 
cytoskeleton in the cell rearrangement mechanism26. 
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Figure 1.2 Endothelial cell rearrangement mechanism of lumen formation 
In the endothelial cell rearrangement mechanism of endothelial tubular lumen 
formation, 1) VE-cadherin establishes apical and basolateral polarity and there is 
expression of the negatively charged CD34-sialomucins on the cell surfaces of 
neighbouring endothelial cells, 2) the negatively charged apical cell surfaces repel 
each other through electrostatic repulsion and an extracellular space forms between 
the cells, 3) morphological changes driven by cytoskeletal rearrangement between 
the endothelial cells forms the lumen in the extracellular space. 
1 
2 
3 
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The endothelial cell rearrangement mechanism of lumenogenesis has been observed 
in the formation of aortic lumens in mouse embryos, with the diffusion of interstitial 
fluid into the extracellular space causing lumenal expansion25. Similarly Xu et al. 
found evidence which supported this model in murine aortic endothelial cells and 
identified that RAS interacting protein 1 (RASIP1) plays a critical regulatory role 
during this process. Upon silencing of this protein endothelial lumens failed to form27. 
Jin et al. also identified that angioblasts undergo morphological changes from a 
cuboidal shape into an elongated shape to aid lumengenesis in the dorsal aorta (DA) 
in zebrafish embryos at 18 hours post- fertilisation (hpf)28. Additionally, Blum et al. 
imaged the presence and organisation of endothelial junctional proteins within the 
intersegmental blood vessels (ISVs) in developing zebrafish embryos and observed 
that lumens within ISV develop via the endothelial cell rearrangement mechanism29.  
1.2.4.2. Vacuole fusion mechanism 
The alternative endothelial tubular lumen formation mechanism is known as the 
vacuole fusion or cell hollowing mechanism. This process is initiated by integrin 
mediated pinocytosis, in which invaginations of the cell membrane containing 
surrounding fluid enters the endothelial tubule30. Subsequent fusion of small 
intracellular pinocytosed vesicles forms large intracellular vacuoles, these adjacent 
cell vacuoles fuse together causing lumenal expansion30, as shown in figure 1.3. The 
extracellular space is further enlarged by the proteolysis action of membrane type I 
matrix metalloproteinases (MT1-MMP) and there is removal of endothelial junctions 
which causes the extracellular space to become an established tubular lumen 
encapsulated by several endothelial cells31.  
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Figure 1.3 Vacuole fusion mechanism of lumen formation  
In the vacuole fusion mechanism of endothelial tubular lumen formation,1) pinocytotic 
vesicles bringing in surrounding media into the endothelial cells, 2) vesicles fuse to 
create vacuoles, 3) adjacent cell vacuoles fuse creating a lumen as a channel 
throughout the cells. 
1 
2 
3 
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The vacuole fusion mechanism of lumen formation has been the predominant 
mechanism observed within endothelial tubules developed in vitro, particularly within 
tubules formed on extracellular matrices of collagen and fibrin30,32-36. Yang et al. 
identified that the vacuole fusion mechanism was responsible for lumen formation 
within tubules formed in collagen gels by visualising the uptake of the fluorescent dye 
6-carboxyfluorescein into lumenal spaces of tubules35. These reports have identified 
the importance of the Rho family GTPases particularly RhoA, Cdc42 and Rac1 in 
regulating pinocytosis and vacuole fusion, as well as outlining the importance of 
integrin α2β1 for endothelial cell binding to collagen which leads to successive lumen 
formation. Specifically, this lumenogenesis mechanism has been found to be 
dependent on Rac1 and Cdc42 recruitment to the intracellular vacuole surfaces 
within endothelial cells30,34.  
The vacuole fusion mechanism has also been identified to occur in vivo by Kamei et 
al. as high resolution time-lapse two-photon imaging was used to visualise 
intracellular as well as intercellular fusion of vacuoles during the development of the 
ISVs in zebrafish18. ISV development and lumen formation has also been studied by 
Blum et al. as single cell imaging was used to visualise the localisation of junctional 
proteins within developing ISVs29. In this way, Blum et al. observed lateral adhesions 
within these blood vessels which corresponded to overlapping endothelial cells and 
lumen formation via the endothelial cell rearrangement mechanism29. Recent work by 
Gebala et al. also supports the endothelial cell rearrangement mechanism as the 
prevailing mechanism of lumen formation within the ISVs and identified the 
importance of blood flow to drive lumenal expansion through both unicellular and 
multicellular regions of these vessels37. Gebala et al. visualised the formation of 
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inverse blebs at the apical membrane of endothelial cells during the process of 
lumenal expansion within the ISVs and concluded that blood flow is required to form 
these spherical deformations, this mechanism of lumen expansion has been termed 
inverse membrane blebbing37. 
1.2.5. Importance of kinases in angiogenesis 
Protein phosphorylation mediates important eukaryotic signal transduction pathways 
and regulates essential cellular processes including proliferation, differentiation, 
motility and apoptosis38-41. Phosphorylation is a reversible, covalent modification 
which involves the transfer of the γ-phosphate from a purine nucleotide triphosphate 
such as adenosine triphosphate (ATP) to a hydroxyl group on a target protein by the 
action of a kinase; and the removal of the phosphate group from the protein is 
catalysed by a phosphatase41. 
Eukaryotic protein kinases are classified into tyrosine-specific protein kinases, 
serine/threonine-specific protein kinases and dual specificity protein kinases based 
on which specific amino acid residue is targeted for the addition of the γ-phosphate 
group42. Phosphorylation events cause a conformational change in the target protein 
which subsequently results in altered function or localisation of the protein. 
Disregulation or disfunctional kinases contribute to pathological diseases such as 
cancer, cardiovascular disease, diabetes and inflammation and as a result, protein 
kinases have been widely studied as potential targets for therapeutic drugs42-46. 
Currently, the Food and Drug Administration (FDA) has approved thirty inhibitors for 
clinical usage which target and inhibit the action of protein kinases45,47. Most protein 
kinase inhibitors are ATP-competitors therefore they prevent action of the kinase by 
targeting the ATP binding site and blocking the conversion of ATP to adenosine 
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diphosphate (ADP), preventing the release of the γ-phosphate group for the 
phosphorylation reaction. Once bound the inhibitor is surrounded by a hydrophobic 
pocket which inactivates the kinase molecule46,48,49.  
Kinases play important mediatory roles within signalling pathways including 
regulating the angiogenic pathway. Binding of VEGF to the extracellular domain of 
the tyrosine kinase receptors VEGFR1 and VEGFR2 causes auto-phosphorylation of 
the intracellular portion of the receptor50. Auto-phosphorylation of VEGFR2 activates 
the phospholipase C (PLC)- protein kinase C (PKC)- mitogen activated protein 
kinase (MAPK) pathway as well as stimulating other tyrosine and serine/threonine 
kinases which leads to an enhancement of endothelial migration and proliferation and 
promotes new blood vessel growth50,51. Since VEGF signalling is a mediator for the 
‘angiogenic switch’, the receptor tyrosine kinases have been targeted by therapeutic 
inhibitors to prevent tumour angiogenesis, for example sunitinib, sorafenib and 
pazopanib have all been approved as anti-angiogenic therapeutic agents for the 
treatment of kidney cancer51-54. Bevacizumab is a monoclonal antibody that targets 
VEGF to prevent VEGFR2 activation55.  
Another family of receptor tyrosine kinases are the platelet derived growth factor 
receptors α and β (PDGFR). PDGFR is activated through binding of the PDGF ligand 
causing an auto-phosphorylation event of the receptor, enhancing endothelial 
proliferation through binding to SH2 domain containing proteins from 10 different 
protein families50,56. Signalling via PDGFRβ induces VEGF transcription leading to 
activation of the angiogenic pathway, this response is stimulated in sarcomas57. 
Many therapeutic agents which target VEGFR are also known to target PDGFR; 
these include sorafenib, sunitinib, PKC412, SU666857-59. Additionally, PDGFR is 
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highly expressed by pericytes, therapies which block this receptor tyrosine kinase 
have been found to cause detachment of pericytes in tumour vasculature leading to 
vessel destabilisation and prevention of tumour growth45,60-62. Combined therapeutic 
strategies inhibiting both VEGF and PDGF signalling has been identified to further 
disrupt tumour angiogenesis compared with inhibition of VEGF alone62,63. 
Other important kinases which mediate and regulate the angiogenic pathway through 
the control of cellular migration, proliferation and differentiation, include the tyrosine 
kinase epidermal growth factor receptor (EGFR) and serine/threonine kinases 
including mitogen activated protein kinases (MAPK), myosin light chain kinase 
(MLCK), protein kinase A (PKA), protein kinase G (PKG) and protein kinase C 
(PKC)64-66. The different isoforms of PKC become activated through signalling of 
intracellular calcium ions, diacylglycerol (DAG) and phospholipids such as 
phosphatidylserine, this activation event causes PKC to modulate nuclear 
transcriptional events67. Furthermore, PKCα activation has been shown to induce 
VEGF signalling and promote angiogenic activity in endothelial cells68.  
1.3. Actin cytoskeleton organisation 
1.3.1.  Cytoskeleton overview 
The eukaryotic cytoskeleton is a highly dynamic complex network of proteins 
consisting of interconnecting filaments and molecular motors. The three primary 
polymeric filaments of the cytoskeleton are the microtubules, intermediate filaments 
and actin microfilaments, which act to maintain and support cellular integrity and 
organise the positioning of intracellular components69,70.  
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The microfilaments are the smallest of the three cytoskeletal components consisting 
of filamentous actin (F-actin) fibres with diameters approximately 5-7 nm, the actin 
cytoskeleton is highly organised within the endothelium and each fibre is structured 
as an asymmetrical double helix71. Vimentin and keratin are the predominant 
intermediate filaments expressed in endothelial cells, these filaments have diameters 
approximately 10 nm and act to support the structure and shape of the endothelial 
cells72-74. Microtubules are the largest cytoskeletal component with diameters 
approximately 25 nm, these filaments exist as hollow tubes generated from 13 
protofilaments assembled from heterodimers of α and β globular tubulin peptides73. 
The three primary cytoskeletal components self-assemble into an interconnected 
filamentous network associated with motor proteins in the endothelial cytoplasm, 
generating and distributing tensional forces which co-ordinate essential cellular 
processes of motility, trafficking organelles and vesicles and cell division73,75,76.  
1.3.2. Actin dynamics 
Polymerisation of F-actin fibres from globular actin (G-actin) monomers occurs in 
three stages, the polymerisation process begins from nucleation in which a stable 
trimer of G-actin monomers is produced, as shown in figure 1.4. The second stage is 
the elongation phase which causes rapid assembly of the actin filaments through the 
addition of G-actin monomers at the barbed or plus end of the fibre76. ATP bound in 
the centre of the G-actin monomers is hydrolysed to ADP upon attachment to the F-
actin fibre71. The third stage is known as the steady state phase in which actin 
filament treadmilling stably maintains the length of the F-actin fibres. In this stage, G-
actin monomers are added to the barbed end of the actin fibres at the same rate as  
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Figure 1.4 Filamentous actin polymerisation 
Three globular actin (G-actin) monomers combine to form a nucleus in nucleation, 
which activates the elongation process in which G-actin monomers bind together to 
form long fibres known as filamentous actin (F-actin), the elongation process extends 
the length of the fibre. Actin treadmilling maintains the lengths of the F-actin fibres, as 
G-actin assembles at the + end and G-actin monomers disassemble at the – end. 
Upon binding of the monomers, ATP is hydrolysed causing an increase in energy 
and G-monomer dissociate with ADP bound. 
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the release of the monomers at the pointed or negative end, generating a polarised 
actin fibre77. 
The rate of F-actin polymerisation and remodelling of the actin organisation is 
regulated through associations with actin binding proteins (ABPs). The ABP profilin 
promotes actin polymerisation by binding to monomeric actin and driving the 
exchange of ADP to ATP78. Conversely, the ABP cofilin promotes disassembly of G-
actin monomers at the pointed end of the fibre and remains bound to the monomers 
preventing further polymerisation reactions73,78. ABPs that promote F-actin assembly 
are known as nucleating proteins, of which actin related protein 2/3 complex (Arp2/3) 
is responsible for crosslinking F-actin fibres and branching fibres by 70o, whereas 
formin nucleates unbranched filaments76,79.  
In quiescent endothelial cells, the actin network is organised as a web of polymeric 
semi-flexible fibres crosslinked by Arp2/376,80. A cortical actin rim is situated below 
the plasma membrane with the ends of the F-actin fibres bound to vinculin, which is a 
member of large dynamic protein assemblies known as focal adhesion complexes at 
the cell periphery71,81,82. The focal adhesion complexes consist of transmembrane 
integrin receptors, which connect actin cytoskeleton with the surrounding 
extracellular matrix enabling the cell to adhere to a substrate81. Additionally, the actin 
cytoskeleton can be organised into actin bundles or stress fibres. These stress fibres 
exist as tightly packed polarised filaments which are activated by MLCK and 
generate contractile forces by associating with myosin II and α-actinin, to direct cell 
migration and proliferation71,82.  
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In response to a stimulant such as VEGF or basic fibroblast growth factor (bFGF), 
endothelial cells undergo directed cell migration which is reliant on remodelling the 
actin cytoskeleton. The Rho family of small GTPases including Rac1, RhoA and 
Cdc42 are critical regulators of facilitating actin rearrangement for motility83. Cdc42 
regulates filopodia formation through association with Wilsott– Adrich syndrome 
protein (WASP) and Arp2/315. Filopodia are long cytoplasmic projections on the 
leading edge of the cell which contain tight bundles of parallel F-actin fibres and 
many receptors to sense the local microenvironment for guidance cues15. Through 
activation by p-21 activated kinase (PAK), Rac1 co-ordinates lamellipodia formation 
which involves rapid polymerisation of actin and actin crosslinking by Arp 2/315.  
RhoA mediates the formation of actin stress fibres, whereby 10-30 F-actin fibres are 
linked by α-actinin, fascin, espin and filamin; via activation of Rho associated kinase 
(ROCK) to create thick bundles of actin81,84-86.  
Actomyosin contractility regulates cellular morphology and motility, therefore the 
efficient function of the actin cytoskeleton with continual turnover of signalling 
molecules and focal adhesion proteins is critical for endothelial cells to extend into 
tubular structures6,87. An increase in actomyosin contractility has been detected upon 
endothelial tubule formation in vitro88. This enhancement of actomyosin contractility is 
driven by an increase in myosin light chain (MLC) phosphorylation mediated by 
ROCK89. The increase in contractility is likely to ensure endothelial junctional integrity 
and reduce vascular permeability71. Vascular endothelial cells constantly experience 
shear stress in vivo which induces mechanosignal transduction pathways which in 
turn organises the cytoskeleton and ensures that actin stress fibres are arranged 
parallel to the direction of blood flow in areas of high shear stress90,91.  
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1.3.3. Visualising the actin cytoskeleton 
The organisation and function of the actin cytoskeleton can be studied in fixed or live 
endothelial cells using a variety of different approaches. Visualising the actin 
cytoskeleton often involves the use of fluorescently labelled phalloidin or actin 
specific antibodies, since these techniques can disrupt actin function by preventing 
depolymerisation of the F-actin fibres they are better suited and used to image the 
actin cytoskeleton in fixed cells73,92. Fluorescent conjugates of the toxin phalloidin are 
able to bind with high affinity to single F-actin fibres, enabling visualisation and 
quantitation of the amount of F-actin fibres present in the cells93.  
Visualising the actin organisation in live cells can be achieved by performing 
microinjection of fluorescently labelled actin or carrying out cellular transfections to 
introduce and express fluorescently labelled actin within cells. Using this approach of 
binding large globular fusion proteins directly to actin can adversely affect actin 
function through the interference and attachment of such large proteins to the 
fibres94. Alternatively, the lifeact peptide is able to bind to individual F-actin fibres 
without compromising the function of the actin cytoskeleton, the lifeact peptide is 
currently the smallest known peptide consisting of 17 amino acids that is able to bind 
to F-actin95. When the lifeact peptide is conjugated to fluorescent proteins and 
expressed in eukaryotic cells, the actin cytoskeleton can be visualised using 
fluorescent live cell microscopy techniques95. 
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1.4. Models of angiogenesis  
1.4.1. Overview 
During angiogenesis, endothelial cells must undergo invasion, migration, proliferation 
and differentiation to form three dimensional tubular structures which undergo 
lumenogenesis, whilst interacting with surrounding cells and extracellular matrix 
(ECM) components6. There are many in vitro, ex vivo and in vivo assays which model 
the different aspects of the angiogenic process, a combination of multiple assays are 
typically used to identify compounds that modulate angiogenesis. 
1.4.2. In vitro assays 
1.4.2.1. Cellular viability assays 
Cellular viability assays are used to evaluate the cytotoxic effects of compounds at 
selected concentrations. The assay assesses mitochondrial activity and although it 
produces a readout which should correlate with the number of viable cells, this assay 
can give erroneous results if cellular treatments being examined perturbs 
mitochondrial function. Cell viability assays often use tetrazolium salt reduction, 
resazurin reduction, protease markers, ATP detection or flow cytometry for 
identification purposes96.  
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay uses a 
metabolic tetrazolium salt reduction reaction to assess cell viability. The tetrazolium 
salt is cleaved by lactate dehydrogenase enzymes in mitochondria of viable cells and 
the formation of the formazan salt can be detected at 540 nm using 
spectrophotometry techniques97. Other tetrazolium salts can also be used in the MTT 
assay such as 3'-[1-[(phenylamino)-carbonyl]-3,4-tetrazolium]-bis(4-methoxy-6-
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nitro)benzene-sulfonic acid hydrate (XTT), 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) or 4-[3-(4-
iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1)98-100.  
1.4.2.2. Cellular migration 
Upon angiogenic stimulation, endothelial cells undergo a migratory response by 
firstly degrading the surrounding ECM to allow for endothelial invasion into the 
perivascular region6. Several in vitro angiogenesis assays can be utilised to evaluate 
the migratory response induced by angiogenic factors, these include the Boyden 
chamber or transfilter assay, the teflon fence assay, phagokinetic track assay and the 
scratch wound assay101.  
In the scratch wound assay, a selected area of adhered endothelial cells is removed 
using a scraping tool from a confluent monolayer of cells. The cells at the edge of the 
scratch initiate directed migration to reform the monolayer due to stimulation from the 
release of cellular content from the damaged cells and the loss of cellular contact102. 
The rate of endothelial migration into the scratch area can be monitored using time 
lapse microscopy and imaging is usually performed using optical microscopy 
techniques such as phase contrast microscopy103. The rate of endothelial migration is 
determined by taking successive images of the same field of view usually over a 12 
hr time period and measuring the distance of cell migration into the scratch area 
using image analysis packages such as ImagePro Premier, Metamorph or 
ImageJ104,105. As well as determining the effect of compounds on the migratory 
response, this assay has been used to study the rearrangement of the cytoskeleton 
during migration as well as the role of specific genes and proteins including the Rho 
family GTPases103,106-109.  
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1.4.2.3. Endothelial sprouting 
The hanging drop spheroid angiogenesis assay is an in vitro angiogenesis assay that 
can be used to study endothelial invasion, migration and proliferation and is also 
commonly used to mimic tumour angiogenesis110-113. In this three dimensional assay, 
endothelial sprouts are rapidly produced as outgrowths from a multicellular 
endothelial mass known as a spheroid, once the spheroid has been embedded into 
an ECM component such as collagen. The end-point of the assay can be captured 
using optical light microscopy, which produces two dimensional images of a three 
dimensional spherical object. However, imaging the assay in this way can produce 
low contrast images of the endothelial sprouts due to light transmittance through the 
thin endothelial cells, contrasted by the densely packed multicellular spheroid which 
has greater light absorbance. Upon firstly reporting the protocol for this assay, Korff 
and Augustin recommended two approaches for analysing the spheroids; the first 
approach suggested was to measure the three longest endothelial sprouts for ten 
spheroids per experimental condition114. The second approach was to calculate a 
cumulative sprouting length by measuring the lengths of all sprouts per spheroid114. 
This particular analysis approach is currently widely used alongside the use of 
microscopy and image analysis software such as the DP-Soft Olympus imaging 
system to aid quantification of the endothelial sprouts115-118. An alternative approach 
for analysing the endothelial sprouting images includes determining the area 
occupied by the endothelial outgrowth119.  
Similar to ex vivo assays which require quantification of vessel outgrowths from the 
implanted or embedded tissue, endothelial sprouts can develop as tight clusters with 
multiple branching points connected to other sprouts, which can be challenging to 
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quantify manually. To overcome this problem, fluorescence labelling of cellular 
components such as the nuclei using Hoechst dye enable computer assisted 
quantification of the number of cells forming outgrowths120. To further enhance image 
contrast in the spheroid assay, fluorescent labelling of the endothelial cells can be 
performed to enable imaging using higher resolution fluorescence microscopy, 
Chung et al. used Calcein AM dye to specifically label viable cells green121.  
1.4.2.4. Matrigel tube formation assay 
Tubulogenesis assays represent the final stages of the angiogenic pathway involving 
cellular differentiation, morphological extension into tubular structures and 
lumenogenesis mimics the growth of smaller blood vessels such as the capillaries122-
124. Tube formation assays are dependent on the presence of ECM components 
surrounding the endothelial cells which promotes endothelial extension into three 
dimensional tubular structures125,126.  
Two dimensional tube formation assays involve plating endothelial cells directly on 
top of ECM components such as fibrin, collagen or onto matrigel which is the 
naturally derived basement membrane extract which is a protein rich mixture 
secreted by Engelbreth–Holm–Swarm (EHS) tumour cells127. Endothelial cells 
undergo attachment and rapidly differentiate to produce tubular networks within 3 hrs 
of being plated, the formation of tubules can be easily assessed for the lengths, 
number, junctions and end points using computerised software127-129. 
1.4.2.5. Co-culture tube formation assay 
The co-culture tube formation assay is another tube formation assay, first outlined by 
Bishop et al. in 1999 it involves culturing endothelial cells with connective stromal 
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cells of fibroblasts or smooth muscle cells for a period of 6 -14 days to stimulate the 
formation of three dimensional endothelial tubules that mimic capillary growth130. The 
endothelial cells are plated directly on top of the stromal cells which closely mimics 
the environment of in vivo endothelial cells, whereby the endothelial cells would be in 
contact with the blood or media and are able to interact with different cell types131. In 
the co-culture tube formation assay using fibroblasts, the fibroblasts secrete ECM 
components which act as a physical scaffold for the endothelial cells thereby 
influencing the development of tubular morphology132. Key ECM components 
secreted by fibroblasts include collagen I, IV, VI, fibronectin, tenascin-C and decorin, 
and endothelial cells use integrin mediated signalling to ensure stable adhesion and 
subsequent elongation into tubules, such as α1β3 integrin signalling to bind to 
collagen IV22,133. Importantly, the fibroblasts must also secrete pro-angiogenic factors 
such as VEGF to promote endothelial migration, fibroblasts secrete VEGF in 
response to being stimulated by bFGF which is supplied in the co-culture 
media134,135.  
Tubulogenesis assays have been used to study factors which influence and regulate 
the process of lumenogenesis. Lumen formation was firstly imaged in the co-culture 
tube formation assay in 1999 using transmission electron microscopy130. Since this 
time, in vitro endothelial lumenogenesis has been frequently studied using 
fluorescence microscopy, lumen formation can be identified within endothelial tubules 
formed via the co-culture tube formation assay by staining for the glycoprotein 
podocalyxin, a member of the CD34-sialomucins which localises to the apical cell 
surface within endothelial tubules undergoing lumenogenesis25,26. Signalling by the 
Rac1 guanine nucleotide exchange factor (GEF) dedicator of cytokinesis 4 (DOCK4) 
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has been proven to be necessary for lumen formation through rearrangement of the 
endothelial cytoskeleton in tubules developed in the co-culture tube formation 
assay26. 
To visualise the formation of endothelial tubular networks, endothelial cells can be 
fluorescently labelled prior to use in the tube formation assay or visualised using 
immunofluorescence with specific antibodies which target endothelial cells136. 
Immunostaining can also be used to image tubular networks, the endothelial specific 
glycoprotein CD31 can be targeted with a primary antibody, followed by a secondary 
antibody conjugated to alkaline phosphatase. The addition of the alkaline 
phosphatase substrate 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium 
(BCIP/NBT) enables visualisation of the endothelial tubules, which can be imaged 
with optical microscopy130. Specifically designed computer software packages such 
as AngioSys and Wimasis WimTube, which are both commercially available, can be 
used to analyse tubular network images. These analysis tools require high contrast 
images therefore post-processing image operations may be required to enhance 
visualisation of the tubular network against the image background. Post-processing 
operations can be performed using tools in the Image Processing Tool Kit in Adobe 
Photoshop CS2137. These image processing operations include binarisation to clearly 
identify the tubules in the image, removing image artefacts and noise pixels using 
Gaussian blurring, filling holes and enhancing the contrast and brightness of the 
image137. 
To analyse the tubular networks, AngioSys and Wimasis perform a series of 
processing operations on the tubular image to identify the numbers, lengths, tubular 
junctions and end-points. The main image processing operations include 
29 
 
thresholding which identifies the tubules within the image based on the pixel intensity 
values and skeletonisation which reduces all of the tubules to one pixel in diameter 
which can be rapidly analysed for the desired measurements. The analysis data 
generated by these two analysis tools can be saved as a CSV file which can be 
exported to Microsoft Excel for further quantification.  
Another tubular analysis tool is Leica QWin software, this software has been 
designed to process biological images and provide quantification. Guidolin et al. 
published a series of steps that could be performed using this software to analyse 
phase contrast tubular images, which included using an edge detection filter to 
identify the tubules, prior to thresholding and skeletonisation138. Another approach to 
analyse vascular images is to use plugins downloaded to the public domain Java-
based NIH ImageJ image processing program. The Angiogenesis Analyzer plugin 
can be used to analyse meshed cellular networks and can be applied to phase 
contrast tubular images as well as fluorescently labelled tubular images140. The 
plugin analyses the tubular network by skeletonising the network and the user can 
define the outputs for loops, nodes, branches and extremities, producing 
quantification on a wide number of image parameters139.  
1.4.3. In vivo models of angiogenesis 
1.4.3.1. Zebrafish overview 
Danio rerio, known as zebrafish are tropical freshwater teleost fish which during 
embryogenesis serve as an in vivo vertebrate model for studying angiogenesis. 
Zebrafish reproduce by external fertilisation, producing 100-200 transparent embryos 
per breeding pair140. At two days post-fertilisation (dpf) all internal organs of the 
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zebrafish have formed and at five dpf the larvae hatch and are able to swim to locate 
food, this rapid development and optical properties of the embryos lends itself to 
cardiovascular imaging, silencing genes and testing compounds that affect 
vasculogenesis and angiogenesis141-143. The zebrafish genome has been well 
characterised through the use of forward and reverse genetics which has identified 
vascular related genes with functional orthologues in humans; however, a whole 
genome duplication event occurred in the teleost lineage upon divergence from the 
telepod lineage, this caused gene redundancy which can be a limitation when 
studying this organism144.  
During embryogenesis oxygen diffuses into the developing zebrafish which allows 
the embryo to develop externally145. Passive diffusion of compounds from the 
surrounding embryonic media into the organism can be utilised to investigate the 
effects on vascular and embryonic development. Furthermore, embryonic gene 
expression can be easily modified through injection of phosphorodiamidate 
oligonucleotide morpholino oligomers (MOs) into the centre of the yolk at the one cell 
stage of development146. The MOs consist of around 25 nucleobases connected via 
a non-ionic phosphorodiamidate backbone with 6-membered methylenemorpholine 
rings147. Complementary base pairing of the morpholino bases to the targeted 
ribonucleic acid (RNA) prevents expression of the gene of interest147. There are two 
types of oligonucleotide morpholino that can be used to silence genes in zebrafish: 
those that target and block the process of protein translation by targeting the 5’ 
untranslated region (UTR) of messenger RNA (mRNA) which is situated upstream of 
the start codon thus preventing the ribosome from binding and producing the target 
protein148. The second type of oligonucleotide morpholino interferes with the splicing 
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process and prevents the spliceosome from binding to the target region; therefore 
MO injection causes steric blocking of the ribosome or spliceosome149. To determine 
the localisation of gene expression within zebrafish, in situ hybridisation can be 
performed on the organism as a whole150.  
1.4.3.2. The development of the vasculature in zebrafish 
The rapid embryonic development of zebrafish occurs in seven stages: zygote, 
cleavage, blastula, gastrula, segmentation, pharyngula and hatching151, the 
developmental processes that occur at each stage are outlined in table 1.1. The 
differentiation of blood cells occurs within the segmentation stage of development 
and the flow of blood is established in the later pharyngula stage151. During 
development, the multipotent haematopoietic stem cells migrate medially from the 
lateral mesoderm to form the intermediate cell mass (ICM), these cells differentiate 
into haematopoietic or endothelial cells during the formation of the yolk sac blood 
islands152,153. In situ hybridisation has shown that the expression of the ETS domain 
transcription factor friend leukemia integration 1 (fli1) initially overlaps GATA binding 
protein 2 (gata2) expression in the lateral mesoderm of zebrafish embryos, prior to 
divergence of the expression patterns, leading to fli1 specifically expressed in the 
developing vasculature and gata2 in regions of blood formation154. Investigation into 
the cloche zebrafish mutant revealed that the expression pattern of fli1 is one of the 
earliest genetic markers for angioblast production154. Fli1 gene expression is utilised 
in the transgenic Fli1:eGFPy1 (fli1-GFP) line of zebrafish generated by Lawson and 
Weinstein; these fish express EGFP throughout the vasculature endothelium 
enabling the development and growth of new blood vessels throughout 
embryogenesis to be easily visualised155. Other approaches to image the zebrafish  
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Table 1.1 Stages of embryonic zebrafish development  
Description of the embryonic developmental changes of zebrafish through each of 
the seven stages of development to adult fish, the table was adapted from Kimmel et 
al. (1995)151. 
 
Stage of 
embryonic 
development 
 
Time in hours 
post fertilisation 
(hpf) 
Description of development 
Zygote 
 
 
 
0 - 0.75 The fertilised egg completes the first zygotic 
cell cycle 
Cleavage 
 
 
 
0.75 – 2.15 2 – 7 cell divisions occur synchronously 
Blastula 
 
 
 
2.15 – 5.15 2 more metasynchronous rounds of cell 
division, midblastula transition, epiboly 
begins 
Gastrula 
 
 
 
5.15 – 10 Morphogenetic movements of involution, 
convergence and extension form the 
epiblast, hypoblast and embryonic axis 
Segmentation 
 
 
 
10 – 24 Development of somites, blood cells 
differentiate, pharyngeal arch primordia and 
neuromeres, organogenesis starts, tail 
forms 
Pharyngula 
 
 
 
24 – 48 Body axis straightens from its early 
curvature around the yolk sac, 
pigmentation, blood flow initiated, fins form 
Hatching 
 
 
 
48 - 72 Completion of primary organ systems, 
cartilage development in head, pectoral fin 
develops, hatching occurs 
Early larvae 
 
 
 
72 Inflation of swim bladder, food-seeking and 
active avoidance behaviour 
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vasculature include dye injection or alkaline phosphatase staining; however these 
techniques require fixation of the tissue therefore only a particular time point or end-
point of vascular development can be imaged133.   
The development of the zebrafish vasculature is initiated by angioblast migration to 
the embryonic midline from the lateral plate mesoderm, this gives rise to the first axial 
blood vessels of the zebrafish, the dorsal aorta (DA) and posterior cardinal vein 
(PCV)28,156. Angioblast differentiation into endothelial cells is co-ordinated initially by 
sonic hedgehog signalling, which induces VEGF signalling; this co-ordinated 
signalling promotes delta-like-4 (Dll4) expression in endothelial tip cells causing an 
initiation in endothelial spouting from the DA and promotes notch signalling in 
adjacent endothelial cells which decreases their sprouting behaviour155. 
VEGF and notch signalling tightly regulates the expression of ephrin B2 (EfnB2) in 
arterial angioblasts, whilst venous angioblasts express ephrin B4 (EfnB4) promoting 
ventral migration of these cells156. Repulsive signalling between EfnB2 and EfnB4 
controls the directional endothelial sprouting of these cells during the establishment 
of arterial and ventral vessels156. At approximately 17 hpf, the arterial and venous 
angioblasts differentiate into endothelial cells of arteries and veins and cellular 
junctions between the cells of these blood vessels are established, along with the 
presence of adherens junctions28. The first angiogenic vessels to form in the 
zebrafish are the ISVs at 24 hpf145. The formation of ISVs is stimulated by VEGFA 
signalling as activated endothelial cells sprout bilaterally from the DA; each tip cell 
extends filopodia to direct the vessel growth along the somite boundary and the stalk 
cells located behind the tip cell proliferate to extend the vessel length to 4-6 
endothelial cells per ISV29. As the ISVs approach the neural tube they separate into  
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Figure 1.5 The formation of the intersegmental blood vessels in zebrafish  
At 24 hpf, the endothelial cells begin to sprout from the dorsal aorta and the tip cells 
extend filopodia to undergo pathfinding to direct the growth of the intersegmental 
blood vessels (ISVs). At 30-40 hpf, the ISVs branch to form T junctions and VE-
cadherin becomes expresssed at the cellular junctions and lumen formation also 
begins at the ISVs. At 48 hpf, filopodia formation is inhibited and the dorsal 
longitudinal anastomatic vessel forms to connect the ISVs. There is continuous blood 
flow formation through complete lumenalisation in the ISVs. Figure was adapted from 
Leslie et al. (2007)160. 
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rostral and caudal branches and connect to form the dorsal longitudinal anastomotic 
vessel (DLAV), establishing the primary vessel network within the organism157, 
shown in figure 1.5. The mechanism of lumen formation in the ISVs has been widely 
debated18,29. At around 32 hpf, further angiogenic sprouting occurs from the PCV to 
produce the intersegmental veins and incorporate the lymphatic system, at 48 hpf a 
fully connected and elaborate vascular network is formed157-159.  
The relatively transparent nature of the zebrafish embryo offers great benefits from 
an imaging perspective when studying the zebrafish vascular system141. High image 
contrast can be achieved using the fli1-GFP zebrafish between the fluorescent 
endothelium and the surrounding tissues of the organism by treatment with1-phenyl 
2-thiourea (PTU), which can be added into media surrounding the embryos to 
prevent tyrosinase activity which would cause pigment formation from melanophores 
during melanogenesis161. 
1.4.3.3. Analysis of the zebrafish vasculature 
Fluorescence microscopy can be used to image the developing vascular system of 
fli1-GFP zebrafish and to assess vascular development the ISVs are frequently 
specifically targeted for analysis as these are the first angiogenic vessels to form145.  
Other real-time imaging methods used to study the vascular system include the use 
of laser polarised gases, which dissolve into the blood for magnetic resonance 
imaging and confocal microangiography, which are used in particular to study small 
vessels less than 100 µm in diameter162,163. 
A frequently used approach to analyse the ISVs is to manually classify the ISV 
growth into categories based on the appearance of vascular disruption, such as 
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‘mild’, ‘intermediate’ or ‘severe’ disruption164-167 or this assessment is alternatively 
represented by the number of ISVs that have connected or remain disconnected to 
the DLAV in the trunk and tail regions of the zebrafish168-177. As with other vascular 
images, semi-automated analysis methods using ImageJ or microscopy software 
such as the Nikon Imaging Software (NIS) Elements can be employed to aid the 
measurement calculations for the lengths of the ISVs178. 
As stated by Vogt et al. there is a lack of computer assisted analysis tools that can be 
applied directly to zebrafish vascular images and this often prevents this vertebrate 
model being used in high throughput screening studies179. This group created an 
automated image-based phenotypic analysis tool, whereby the ISVs of zebrafish can 
be quantified using Cognitive Network Technology when imaged using a high content 
reader179. A considerable advantage of this analysis method is its capability of 
analysing embryos in various orientations. Another computer based method reported 
by Tran et al. which analyses the ISVs involves implementing a quantitative 
screening approach using an interactive algorithm created using Discovery-
1/MetaMorph software and the MetaMorph Neurite Outgrowth application drop in; 
this method requires manual identification of the vessels of interest180. An alternative 
method to analyse endothelial cell sprouting from the DA includes the use of image 
registration methods to measure the incremental increase in the vessel lengths with 
time, this method focuses on the ability of the endothelial cells to initiate 
angiogenesis and therefore analysis of vessel connectivity is not required181,182.  In 
addition to providing quantitation, many of the analysis frameworks often give 
excellent visual representations of the vasculature such as representing the 
connecting vasculature as attributed vessel represent graphs (AVRG)183. 
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1.4.3.4. Genes studied using the zebrafish model 
In this project, a computational method was developed as an analysis tool to enable 
rapid quantification of the developed vasculature within zebrafish embryos. To test 
and evaluate the computational method, the analysis approach was applied to 
fluorescent zebrafish images which exhibited both normal and abnormal ISV 
formation. To achieve a range of vascular abnormalities the following genes were 
silenced at the one-cell stage during zebrafish embryogenesis by MO injection: C-
type lectin domain family 14, member A (CLEC14A), endothelial cell-specific 
chemotaxis regulator (ECSCR), epidermal growth factor, latrophilin and seven 
transmembrane domain-containing protein 1 on chromosome 1 (ELTD1), 
roundabout4 (ROBO4), vascular endothelial growth factor A (VEGF), regulator of 
calcineurin 1 (RCAN), ets-1 related protein (ETSRP) and ets related gene (ERG). 
1.4.3.4.1 Vascular endothelial growth factor A (VEGF) 
VEGF has been identified to be one of the most potent angiogenic factors and is 
fundamental throughout embryogenesis to generate a functional vascular system; the 
different VEGF isoforms generated by alternative splicing regulates blood vessel 
development through binding to the tyrosine kinase receptor VEGFR2 present on 
endothelial cell surfaces to induce migration and proliferation1,184-188. In mice, 
disruption of a single VEGF allele causes embryonic lethality between days 11-12188.   
1.4.3.4.2 C-type lectin domain family 14, member A (CLEC14A) 
CLEC14A is a tumour endothelial marker (TEM) that has been found to be expressed 
highly on tumour vasculature compared with normal tissue189; this C-type lectin was 
first identified as a TEM by Mura et al. in 2012. CLEC14A promotes and regulates 
angiogenesis by stimulating filopodia formation, endothelial migration and tube 
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formation189. Mura et al. showed that CLEC14A is initially expressed in the zebrafish 
at 12 hpf and it is specifically expressed within the DA, PCV and ISVs189.  
1.4.3.4.3 Endothelial cell-specific chemotaxis regulator (ECSCR) 
Vascular endothelial cells specifically express ECSCR as a cell surface glycosylated 
type I transmembrane protein, which regulates endothelial cell survival and 
chemotaxis190. Verma et al. showed by real-time polymerase chain reaction (PCR) 
that ecscr expression in zebrafish rapidly increases between 10 and 24 hpf, this 
correlates with the formation of the axial blood vessels and angioblast migration 
within the embryo166.  
1.4.3.4.4 Epidermal growth factor, latrophilin and seven 
transmembrane domain-containing protein 1 on chromosome 1 (ELTD1) 
ELTD1 is an orphan adhesion G-protein coupled receptor191. It has been reported by 
that ELTD1 is a regulator of angiogenesis which is upregulated within tumour 
endothelial cells and silencing the receptor in zebrafish embryos causes impaired 
vessel formation and sprouting191.  
1.4.3.4.5 Roundabout 4 (ROBO4) 
Roundabout (robo) receptors were initially identified as co-ordinators of axon 
guidance in neurons and repulsive signalling is mediated by the binding of slit protein 
ligands to the receptors192. De Smet et al. reported that ROBO4 expression is a 
requirement for the stabilisation of stalk cells during the angiogenic process15. 
ROBO4 is the predominant roundabout receptor that is expressed in the vasculature 
of zebrafish and it is expressed within angioblasts, in the DA, PCV and ISVs193. 
Bedell et al. showed that the injection of the ROBO4 targeted morpholino caused 
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misdirected and truncated ISVs and therefore concluded that ROBO4 was essential 
for directed sprouting of the ISVs193.  
1.4.3.4.6 Regulator of calcineurin 1 (RCAN) 
RCAN was identified by Fuentes et al. in 2000 using the yeast and mammalian two-
hybrid assays to be a binding protein of calcineurin 1, which is a calmodulin binding 
protein and a serine/threonine protein phosphatase194,195. Two RCAN isoforms exist; 
one has the inclusion of exon 1 (RCAN1.1) and the other exon 4 (RCAN1.4), the 
expression of RCAN1.4 is regulated by VEGF and has been shown to be important in 
regulating endothelial migration and upon knock down of RCAN1.4 endothelial cells 
become defective in undergoing tubular morphologies195-197.   
1.4.3.4.7 Ets-1 related protein (ETSRP) and ets related gene (ERG) 
Members of the ets transcription factor family play vital roles in embryonic 
development including vasculogenesis and angiogenesis, two of these transcription 
family members are ETSRP and ERG. ETSRP is firstly expressed at the two somite 
stage in zebrafish embryos correlating with the expression in angioblasts198. Erg is 
closely related and highly homologous to fli1 and zebrafish have only one gene 
responsible for the expression of ERG in the mesoderm during embryonic 
development168,199. Knocking down ETSRP has shown to cause defects in vascular 
development, whereas apparent normal vasculature was observed upon ERG 
silencing168,198. Interestingly, Ellett et al. reported a synergic functional interaction 
between ERG and ETSRP and therefore a double knock down to silence both ERG 
and ETSRP in zebrafish should reduce ISV development compared with silencing 
ETSRP alone168. 
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1.5. Imaging and analysing assays modelling angiogenesis 
1.5.1. Overview 
Imaging and analysis techniques are essential to our understanding of the molecular, 
cellular and functional processes within the angiogenic pathway. Being able to 
identify and assess factors such as the location, quantity, morphology and 
permeability of the vasculature, along with identifying the presence of specific 
vascular markers and determining the effect of compounds on angiogenesis, can 
only be evaluated upon the correct use of high resolution imaging modalities and 
appropriate analysis techniques. To analyse endothelial processes and 
vascularisation from in vitro, ex vivo and in vivo angiogenic images, quantification of 
endothelial migration, proliferation, sprouting or the global tubular network is usually 
assessed. 
1.5.2. Microscopy techniques 
1.5.2.1. Optical light microscopy 
An imaging modality widely used to study biological specimens is the transmitted or 
bright-field light microscope, which is able to image different types of samples due to 
the focussing ability of the long working distance objective lens200. In the brightfield 
imaging system, transillumination light is passed through a condenser lens to focus 
the light rays onto the specimen, light passes through the specimen to the objective 
lens and a magnified image is observed through an eye-piece or as a digital image 
via a charged couple device (CCD)201. This imaging set-up allows for fast image 
acquisition and different biological components within the specimen absorb varying 
amounts of light; this generates image contrast allowing visualisation of different 
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components within the specimen. A similar imaging system is used for phase 
contrast microscopy which produces an image dependent on the proportion of light 
interference from the biological specimen.  
Optical light microscopy techniques can allow for endothelial or vascular 
morphologies to be investigated however, thin biological specimens such as 
endothelial cells absorb only small amounts of light which generates low contrast 
images; this can produce undefined object boundaries within the image which can be 
problematic for analysis procedures. For accurate analysis, clear distinctions 
between the object of interest, background and other biological components are 
required; this is of particular importance for computer assisted analysis methods. In 
optical light microscopy this problem is coupled with low optical imaging resolution. 
Low resolution arises because there is overall illumination of the three dimensional 
specimen, therefore out of focus light contributes to image blurring. To reduce this 
problem, cells or proteins within the specimen can be labelled or stained to enhance 
the signal.  
1.5.2.2. Fluorescence microscopy 
Fluorescence microscopy is an optical microscopy technique and therefore the 
principle set up of image acquisition is similar to that of the brightfield imaging 
system, however the light source is selected at a specific wavelength to excite 
fluorophores from within the specimen known as the excitation wavelength. 
Fluorophores are chemical compounds that emit light upon excitation to higher 
energy states. Electrons from within the fluorophores are excited to higher energy 
states and upon their return to their original energy state release photons of light. The 
emitted light is distinguished from the original excitation light using a spectral  
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Figure 1.6 Imaging set-up of a confocal fluorescence microscope 
The light paths and imaging set-up of a confocal fluorescence microscope are 
shown, whereby the fluorophores from within the specimen are activated by the 
excitation light (blue) from the light source. Light emitted from the fluorophore from 
within the focal plane is refracted by the objective lens (red) and with use of the beam 
splitter is directed to the light detector. Whereas, light emitted from fluorophores 
outside of the focal plane (grey) do not contribute to the image as they are excluded 
by the aperture.  
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emission filter, which along with the dichroic mirror is specifically selected dependent 
on the fluorophore being imaged. To generate images of specimens containing 
multiple fluorophores, successive images for each fluorophore must be acquired and 
combined after image acquisition202,203. Fluorescence microscopy can be applied to 
fixed or live biological specimens and offers a higher signal-to-background ratio in 
comparison to brightfield microscopy204.Confocal fluorescence microscopy such as 
confocal laser scanning microscopy (CLSM) or confocal spinning disk microscopy 
(CSDM) offer significant imaging advantages over conventional epifluorescence 
microscopy, as the presence of an aperture excludes out-of-focus light which is 
emitted from fluorophores which are not present in the imaging focal plane, as shown 
in the confocal microscopy diagram in figure 1.6. Out-of-focus light can contribute to 
high background fluorescence resulting in a low image resolution; only light emitted 
from fluorophores from within the focal plane of the specimen is detected in confocal 
microscopy205,206. To further enhance imaging resolution, a series of single images 
from sequential focal planes can be captured at regular intervals along the z axis 
using confocal microscopy, known as optically sectioning the specimen. The images 
can be combined by compression to give a higher resolution maximum projection 
image of the specimen by improving the signal-to-noise ratio207,208. 
Fluorescence microscopy has proved to be a useful imaging tool for studying and 
understanding the molecular and functional aspects of angiogenesis. Using 
fluorescence microscopy techniques has enabled dynamic tracking of proteins and 
identification of protein and cellular interactions; use of fluorescent proteins has been 
widely used to study tumour angiogenesis and tumour progression by performing 
techniques such as expressing GFP in tumour vessels and RFP in tumour cells 
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permitting non-invasive whole body imaging in mice207-209. Fixing and staining 
angiogenic tissue samples using fluorescently tagged antibodies which target specific 
proteins is currently widely used in angiogenic research, as well as fluorescence 
vascular imaging making use of fluorescent imaging agents and carriers in vivo210-212.  
However, the limitations of using fluorescence microscopy to image the localisation 
of fluorophores include photobleaching which prevents the fluorophores producing a 
fluorescent signal as the electrons become permanently unable to be excited, this 
results in reduced spatial resolution in the acquired image213,214. Fluorophores can 
also exhibit spectral cross-talk between excitation and emission spectra215. Another 
limitation is specimen phototoxicity, when the electrons from within the fluorophores 
are excited they can participate in reactions involving molecular oxygen which 
produces reactive oxygen species (ROS); ROS adversely affects cell viability by 
damaging cellular proteins, lipids and nucleic acids216,217.  
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Chapter Two 
Materials and Methods  
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2.1 Reagents and equipment 
All reagents that were used in this PhD project were of analytical or molecular biology 
grade standard and if not stated otherwise the reagents were purchased from Sigma-
Aldrich. 
For general tissue culture, a CO2 humidified incubator (Sanyo) was used to maintain 
cell lines; it supplied a constant atmosphere of 5% CO2 at 37 
oC. For storing and 
growing zebrafish embryos, a 100 l laboratory incubator was used at 28.5 oC 
(Genlab). 
The centrifuges that were commonly used were: for 1.5 ml eppendorf tubes: Heraeus 
Pico 17 Microcentrifuge (Thermo Scientific), maximum speed 17000 x g. For 15 ml – 
50 ml volumes: Heraeus Biofuge Primo (Thermo Scientific), maximum speed 2576 x 
g. 
The contents of solutions that were used are mentioned within the relevant methods 
sections. 
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2.2 Antibodies 
2.2.1 Primary antibodies 
Primary antibodies were used for either immunofluorescence (IF) or 
immunohistochemistry (IHC), the concentrations used are outlined in table 2.1.  
Table 2.1 Primary antibodies 
Antibody Code Company Concentration 
Mouse monoclonal anti-
human CD31 
JC70A 
Dako 
Cytomation 
1.29 µg/ml (IHC) 
Goat polyclonal anti-human 
Podocalyxin 
AF1658 R & D Systems 0.4 µg/ml (IF) 
Rabbit polyclonal anti-
human Collagen IV 
Ab6586 Abcam 0.4 µg/ml (IF) 
 
2.2.2 Secondary antibodies 
Secondary antibodies were used for either immunofluorescence (IF) or 
immunohistochemistry (IHC) and the concentrations used are outlined in table 2.2. 
 
Table 2.2 Secondary antibodies 
Antibody Code Company Concentration 
Alexafluor 488 polyclonal 
donkey anti-rabbit IgG 
A21206 Invitrogen 4 µg/ml (IF) 
Alexafluor 488 polyclonal 
goat anti-mouse IgG 
A11001 Invitrogen 4 µg/ml (IF) 
Alexafluor 594 polyclonal 
goat anti-rabbit IgG 
A11067 Invitrogen 4 µg/ml (IF) 
Alexafluor 594 polyclonal 
goat anti-mouse IgG 
A11020 Invitrogen 4 µg/ml (IF) 
Goat polyclonal Anti-mouse 
IgG conjugated to Alkaline 
Phosphatase 
A4656 Sigma 
Used at 1:500 
(IHC) 
Rhodamine Ulex Europeaus 
Agglutinin I (UEA I) 
RL-1062 
Vector 
Laboratories 
0.02 mg/ml (IF) 
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2.3 Plasmids 
To enable visualisation of endothelial cells or tagged proteins using confocal 
microscopy, human umbilical vein endothelial cells (HUVECs) were transduced with 
plasmids to express the fluorescent proteins GFP or RFP. The plasmids that were 
used are described in table 2.3.  
Table 2.3 Plasmids 
Plasmid Company Use 
psPAX2 Addgene 
 
Lentiviral packaging plasmid 
pMD2G Addgene 
 
Lentiviral envelope plasmid 
pWPI Addgene Lentiviral plasmid used to 
express EGFP to facilitate 
tracking of cells 
pWPXL Addgene Lentiviral plasmid used to 
express EGFP to facilitate 
tracking of cells 
pEGFP-N1-lifeact A gift from Dr. Steve 
Thomas, University of 
Birmingham, UK. 
Contained the lifeact 
sequence between the 
EcoR1 and Age1 restriction 
sites in the multiple cloning 
site (MCS) 
pWPXL-lifeact-RFP 
 
A gift from Prof. Maddy 
Parsons, Kings College 
London, UK. 
Transduced cells expressed 
lifeact-RFP for F-actin 
visualisation 
pWPXL-lifeact-GFP 
 
Produced by Victoria 
Salisbury, University of 
Birmingham, UK. 
Transduced cells expressed 
lifeact-GFP for F-actin 
visualisation 
 
2.4 Inhibitor compounds 
2.4.1 Kinase inhibitor compounds 
The screen-well kinase inhibitor library was supplied by Enzo Life Sciences, code: 
BML-2832, the library contained 80 different small molecule kinase inhibitor 
compounds described in table 2.4. The IC50 values for the compounds were 
49 
 
determined from a combination of supplier’s information and scientific literature, the 
concentration of inhibitors used in the angiogenesis assays were ten times the IC50 
values. 
Table 2.4 Kinase inhibitor compounds 
Compound Target IC50 value 
PD-98059 MEK 55 µM 
U-0126 MEK 70 nM 
SB-203580 P38 MAPK 500 nM 
H-7·2HCl PKA, PKG, MLCK, PKC 6 µM 
H-9·HCl PKA, PKG, MLCK, PKC 70 µM 
Staurosporine Pan-specific 0.88 nM 
AG-494 EGFR, PDGFR 700 nM 
AG-825 HER1-2 350 nM 
Lavendustin A EGFR 11 nM 
RG-1462 EGFR 3 µM 
TYRPHOSTIN 23 EGFR 35 µM 
TYRPHOSTIN 25 EGFR 3 µM 
TYRPHOSTIN 46 EGFR 10 µM 
TYRPHOSTIN 47 EGFR 2.4 µM 
TYRPHOSTIN 51 EGFR 800 nM 
TYRPHOSTIN 1 Negative control 35 µM 
TYRPHOSTIN AG 1288 Tyrosine kinases 21 µM 
TYRPHOSTIN AG 1478 EGFR 3 nM 
TYRPHOSTIN AG 1295 Tyrosine kinases 2.5 µM 
TYRPHOSTIN 9 PDGFR 500 nM 
Hydroxy-2-
naphthalenylmethylphosphon
ic acid (Methylphosphonic 
acid) 
IRK 100 µM 
PKC-412 PKC 50 nM 
Piceatannol Syk 10 µM 
PP1 Src family 170 nM 
AG-490 JAK-2 5 µM 
AG-126 IRAK 50 µM 
AG-370 PDGFR 20 µM 
AG-879 NGFR 40 µM 
LY 294002 PI3-K 1.4 µM 
Wortmannin PI3-K 40 nM 
GF 109203X PKC 20 nM 
Hypericin PKC 3.3 µM 
Ro 31-8220 mesylate PKC 27 nM 
D-erythro-Sphingosine PKC 3 µM 
H-89·2HCl PKA 135 nM 
H-8 PKA, PKG 1.2 µM 
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HA-1004·2HCl PKA, PKG 170 µM 
HA-1077·2HCl PKA, PKG 10.7 µM 
2-Hydroxy-5-(2,5-
dihydroxybenzylamino)benzo
ic acid (Benzoic acid) 
EGFR, CaMK II 200 nM 
KN-62 caMK II 900 nM 
KN-93 caMK II 370 nM 
ML-7·HCl MLCK 700 nM 
ML-9·HCl MLCK 10 µM 
2-Aminopurine P58 PITSLRE β1 341.6 µM 
N9-isopropyl-olomoucine CDK 3 µM 
Olomoucine CDK 3 µM 
Iso-olomoucine Negative control 3 µM 
Roscovitine CDK 700 nM 
5-Iodotubericidin 
ERK2, CK1, CK2 Adenosine 
kinase 
10.9 µM 
LFM-A13 BTK 2.5 µM 
SB-202190 P38 MAPK 30 nM 
PP2 Src family 100 nM 
ZM 336372 cRAF 70 nM 
SU 4312 Flk1 800 nM 
AG-1296 PDGFR 400 nM 
GW 5074 cRAF 9 nM 
Palmitoyl-DL-carnitine PKC 12.59 µM 
Rottlerin PKC delta 100 µM 
Genistein Tyrosine kinases 12 µM 
Daidzein Negative control 12 µM 
Erbstatin analog EGFR 770 nM 
Quercetin·2H2O PI3-K 3.8 µM 
SU1498 Flk1 700 nM 
ZM 449829 JAK-3 20 µM 
BAY 11-7082 IKK pathway 10 µM 
5,6-dichloro-1-β-D-
ribofuranosylbenzimidazole 
(Ribofuranosylbenzimidazole) 
CK 2 10 µM 
2,2',3,3',4,4'-Hexahydroxy-
1,1'-biphenyl-6,6'-dimethanol 
dimethyl ether (Dimethyl 
ether) 
PKC alpha, gamma 50 µM 
SP 600125 JNK 90 nM 
Indirubin GSK-3 beta, CDK5 5 µM 
Indirubin-3'-monooxime GSK-3 beta 190 nM 
Y-27632·2HCl ROCK 3.55 µM 
Kenpaullone GSK-3 beta 230 nM 
Terreic acid BTK 10 µM 
Triciribine Akt pathway 130 nM 
BML-257 Akt 27 µM 
SC-514 IKK2 12 µM 
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BML-259 Cdk5 64 nM 
Apigenin CK-II 30 µM 
BML-265 EGFR 28.8 nM 
Rapamycin mTOR 0.1 nM 
 
2.4.2  Other inhibitor compounds 
All other inhibitor compounds that were used in the assays that model angiogenesis 
are described in table 2.5, along with the inhibitor concentrations that were used. 
Table 2.5 Other inhibitor compounds 
Compound Target Concentration Company 
PF-3758309 
 
P-21 activated 
kinase (PAK) 
1.25 - 5 µM Bioquote Ltd 
IPA-3 P-21 activated 
kinase (PAK) 
2.5 - 10 µM Tocris Bioscience 
Ibrutinib Bruton’s tyrosine 
kinase (BTK) 
5.0 nM - 15 µM 
Stratech Scientific 
Ltd 
AVL-292 
 
Bruton’s tyrosine 
kinase (BTK) 
50 nM 
Stratech Scientific 
Ltd 
Sunitinib Receptor tyrosine 
kinases 
0.1 – 1.0 µM 
Supplied by Dr. Mike 
Cross at the 
University of 
Liverpool, UK. 
 
2.5 Morpholino oligonucleotides 
All morpholino oligonucleotides (MOs) were purchased from Gene Tools. The RNA 
antisense morpholino oligonucleotide sequences were designed to block sites either 
involved in splicing pre-mRNA or by sterically preventing the binding of the 
translation initiation complex. All morpholino oligonucleotide sequences are listed in 
table 2.6. 
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Table 2.6 Zebrafish morpholino oligonucleotide sequences 
Morpholino Oligonucleotide Morpholino Oligonucleotide Sequence from 5’ – 3’ 
VEGFA Morpholino GTATCAAATAAACAACCAAGTTCAT 
VEGFA Mismatch GTAACAATTAAACAACCATGTTGAT 
ROBO4 Morpholino TTTTTTAGCGTACCTATGAGCAGTT 
ROBO4 Mismatch TTTTTTACCCTACGTATGACCACTT 
ECSCR UTR Morpholino GCGTAAGTCCAAATGACGTTCAATC 
ECSCR UTR Mismatch GGCAAACTCGAAATCACCTTCAATC 
ECSCR Splice Morpholino CATCAGTAGAAAACCTACCAAAGGC 
ECSCR Splice Mismatch CATGACTACAAAACCTACGAAACGC 
CLEC14 Morpholino ACCATCAGAAATCCATGTCTGCTC 
CLEC14 Mismatch CCTCTTACCTCAGTTACAATTTATA 
ELTD1 Morpholino CATTGGAGAACTGTGTAAAAACTCC 
ELTD1 Mismatch CATTGCACAACTGTCTAAATAGTCC 
ERG Morpholino CAGACGCCGTCATCTGCACGCTCAG 
ETSRP Morpholino TTGGTACATTTCCATATCTTAAAGT 
ETSRP Mismatch CAGTGAGACCTTAATTCAGTATAAC 
RCAN Morpholino ACTTCATTGTTTTCAGGTGCATGAC 
RCAN Mismatch ACATGATTCTTTTGAGCTGCATGAC 
 
2.6 Cell biology 
2.6.1 Mammalian cell culture 
HUVECs were isolated from umbilical veins of umbilical cords supplied by the tissue 
bank of the Human Biomaterials Resource Centre at the University of Birmingham. 
HUVECs were cultured in complete M199 (cM199) medium which was M199 media 
supplemented with 10% (v/v) foetal calf serum (FCS) (PAA Cell Culture Co.), bovine 
brain extract, 90 µg/ml heparin, 4 mM L-Glutamine, 100 units/ml penicillin and 
streptomycin (Invitrogen). HUVECs were cultured in cM199 media with the addition of 
antibiotics unless HUVECs were used for siRNA-mediated knock down of genes in 
which case HUVECs were cultured in cM199 media without antibiotics. 
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Human embryonic kidney 293T cells (HEK293Ts) and human dermal fibroblasts 
(HDFs) (PromoCell) were cultured in complete Dulbecco’s Modified Eagle’s Medium 
(cDMEM) which was DMEM supplemented with 10% (v/v) FCS (PAA Cell Culture 
Co.), 4 mM L-Glutamine and 100 units/ml penicillin and streptomycin (Invitrogen). All 
mammalian cell media was filtered using 0.22 µm pore filter units (Millipore) and 
stored at 4 oC. Prior to use all mammalian cell media was pre-warmed to 37 oC for 20 
mins in a water bath. 
 
Mammalian cells were cultured using plastic plates (Falcon) and incubated at 37 oC 
in a humidified 5% (v/v) CO2 atmosphere to allow cell proliferation. For plating and 
growing HUVECs, plates were pre-coated with 0.1% (w/v) gelatin in phosphate 
buffered solution (PBS) for 20 mins at 37 oC. For washing mammalian cells, 1x PBS 
solution was made from diluting 10x Dulbecco’s PBS (Life Technologies) with 
distilled water (dH20), which was autoclaved and stored at room temperature. PBS 
was made up to contain 140 mM NaCl, 10 mM Na2PO4, 2.7 mM KCl, 1.76 mM 
KH2PO4 at pH 7.4. 
2.6.2  Passaging and counting cells 
For cell detachment, cultured cells were washed 3 times with PBS before being 
trypsinised with 0.1% (w/v) trypsin-EDTA (Life Technologies) in PBS solution. 6 ml 
media was added to a 10 cm plate for cell collection as the presence of FCS in the 
culture media inhibited trypsin activity. The cell solution was centrifuged at 195 x g for 
5 mins and the cell pellet was re-suspended in media. HUVECs and HDFs were 
passaged 1:3 once a week and HEK293Ts 1:10 twice a week onto 10 cm plates. To 
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count cells, 10 µl cell suspensions were added to a haemocytometer counting 
chamber (Neubauer).  
2.6.3 Storing cells 
For storing cells, cell pellets were resuspended in 10% (v/v) dimethyl sulfoxide 
(DMSO) and 90% (v/v) FCS and the cell solution was gradually frozen to -80 oC. 
Cells were then transferred to liquid nitrogen storage. 
2.6.4 Fluorescently labelling mammalian cells 
2.6.4.1 Fluorescently labelling cells with cytoplasmic dyes 
To provide high resolution images of endothelial tubulogenesis and sprouting, 
endothelial cells were fluorescently labelled with cytoplasmic dyes such as 
CellTracker dyes (Invitrogen) or carboxyfluorescein succinimidyl ester (CFSE) (Life 
Technologies). Alternatively HUVECs were transduced to express a fluorescent 
protein such as GFP or RFP. 
 
CFSE was stored as a 10 mM stock solution in DMSO, dilutions were made in PBS 
and cells were labelled at a final concentration of 5 µM. Harvested HUVECs were 
incubated for 10 mins at 37 oC with the CFSE labelling solution. Two washing steps 
were performed using 5 ml of cM199 and centrifugation at 195 x g for 5 mins. Finally 
the labelled cells were re-suspended in 1 ml cM199. Similarly, HUVECs were labelled 
with CellTracker dyes using a final concentration of 10 µM in PBS and incubated for 
30 mins at 37 oC.  
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2.6.4.2 Lentiviral transduction of HUVECs 
HEK293Ts were used as lentiviral producer cells to produce HUVECs that expressed 
GFP. Lentivirus was produced as follows, 3 x 106 HEK293T cells were plated onto a 
10 cm plate 24 hrs prior to polyethylenimine (PEI) transfection using lentiviral 
plasmids: 3.3 µg psPAX2 (packaging vector), 1.3 µg pMD2G (envelope vector) and 
4.4  µg pWPI or pWPXL (transfer vector) carrying the GFP gene of interest 
(Addgene). The 9 µg plasmid DNA and 36 µl 1 mg/ml PEI was added into 1 ml 
OptiMEM and mixed by low speed vortexing. The transfection media was incubated 
for 10 mins at room temperature before addition drop-wise into the culture media of a 
confluent 10 cm plate of HUVECs. The transfected HEK293T plate was incubated at 
37 oC for 48 hrs then the lentiviral media was collected. 
 
To transduce HUVECs to generate GFP expressing cells, the collected lentiviral 
media was centrifuged at 195 x g for 5 mins and filtered with a 0.45 µm2 pore syringe 
filter (Corning). 90 µg/ml heparin, bovine brain extract and 8 µg/ml polybrene was 
added to the lentiviral media before being added to 1 x 106 seeded HUVECs. The 
lentiviral media remained on the HUVECs for 24 hrs at 37 oC before the media was 
replaced with fresh cM199. 
2.6.5 Fluorescence activated cell scanning (FACS) 
To determine whether cells were fluorescently labelled, a Becton Dickinson 
FACSCalibrature and Becton Dickinson CellQuest Pro software was used to 
measure and analyse the intensity of the fluorescence emission from cells. 
Approximately 3 x 105 cells were placed in 1 ml cell culture media and kept on ice 
prior to analysis.  
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2.6.6 Immunofluorescence 
To study the localisation of endothelial proteins in adhered HUVECs compared with 
the localisation in endothelial tubules, HUVECs were either plated directly onto sterile 
coverslips to form a confluent monolayer or were co-cultured on the coverslips with 
HDFs in the co-culture tube formation assay, as described in section 2.7.1.  
To prepare the coverslips, each coverslip was placed into 1 M HCl for 10 mins on a 
rotating falcon tube holder, rinsed 5 times with ddH20 before being stored in 70% 
(v/v) ethanol. The coverslips were washed 10 times with PBS before seeding cells 
onto them. Pre-coated gelatin coverslips were used for the culture and 
immunofluorescence of HUVECs.  
To fix and stain proteins within endothelial cells, the media from the cultured cells 
was removed using an aspirator, washed 3 times with PBS and fixed for 10 mins 
using 4% (w/v) paraformaldehyde (PFA) in PBS at room temperature. The cells were 
washed 3 times using PBS, neutralised for 10 mins with 50 mM ammonium chloride. 
The cells were washed 3 times with PBS then permeabilised with 0.1% (v/v) triton 
x100 in PBS for 4 mins, then washed again 3 times with PBS. Blocking buffer 
containing 10% (v/v) foetal calf serum (FCS), 3% (w/v) bovine serum albumin (BSA), 
0.1% (v/v) Tween-20, 0.01% (w/v) NaN3 was added to the cells for 1 hr at room 
temperature. The cells were incubated with 50 µl primary antibody in blocking buffer 
for 30-60 mins by manually removing the coverslips from the plates using tweezers. 
The droplets of primary antibody-blocking buffer were pipetted onto parafilm before 
the coverslip was placed onto the droplet. The coverslips were washed 3 times with 
PBS before the cells were incubated with 50 µl secondary antibody in blocking buffer 
solution for 30-60 mins at room temperature. As a marker for endothelial cells, 
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rhodamine labelled Ulex (Vector Laboratories) was added in addition to the 
secondary antibody in blocking buffer.  
The cells were then washed 3 times with PBS and once with dH20 before being 
mounted onto glass slides using 5.5 µl ProLong Gold Antifade reagent with DAPI 
(Invitrogen) or Vectashield mounting medium with or without DAPI (Vector 
Laboratories).  The glass slides were placed in darkness overnight and the coverslip 
was secured in place the following morning with clear nail vanish. Mounted coverslips 
were stored at -20 oC. To study the localisation of endothelial proteins, a Zeiss 780 
Zen confocal microscope was used. 
2.6.6.1 Co-culture staining of podocalyxin and collagen IV 
Apical and basal cell surface markers podocalyxin and collagen IV were stained to 
investigate lumen formation in endothelial tubules formed using the co-culture tube 
formation assay. Cells were plated and cultured on coverslips in wells of a 24 well 
plate. The co-culture media was removed from the wells and washed 3 times with 
PBS, the cells were then fixed using 4% (w/v) PFA in PBS at room temperature for 
20 mins. The cells were permeabilised with 0.1% (v/v) triton x100 in PBS for 20 mins. 
The cells were then blocked with 0.5% (w/v) BSA in PBS for 20 mins at room 
temperature. 200 µl of primary antibody solution of podocalyxin and/or collagen IV in 
blocking buffer was added to the cells and incubated at 4 oC overnight. The following 
morning, the wells were washed 3 times with PBS, each wash lasted 5 mins. The 
secondary antibodies in blocking buffer were added to the cells and incubated for 1 
hr at room temperature. Any unbound antibody was removed by 3 washing steps 
using PBS, before the cells were mounted onto glass slides as described in section 
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2.6.6. The stained endothelial tubules were imaged using a Zeiss 780 Zen confocal 
microscope. 
2.7 Endothelial assays 
2.7.1 Co-culture tube formation assay 
The tube formation assay is an organotypic assay that enables visualisation of the 
endothelial morphological differentiation stages in angiogenesis. The tube formation 
assay can provide information on the stages of cell migration and proliferation and 
allows for assessment of the ability of endothelial cells to develop into three 
dimensional tubules which mimic the appearance of small blood vessels. The 
development of tubules in the co-culture tube formation assay relies on the secretion 
of extracellular matrix (ECM) components by fibroblasts; endothelial cells use the 
matrix as a scaffold to support cellular extension and expansion into tubules125,126.  
To image endothelial tubule growth using confocal microscopy, 6.9 x 104 HDFs were 
plated onto matTek dishes (MatTek Corporation) in cDMEM and incubated at 37 oC 
for 5 days to allow secretion of ECM from the HDFs. Fresh cDMEM media was 
replaced on the fourth day of culture. 6.9 x 104 fluorescently labelled HUVECs in 
cM199 were plated directly on top of HDFs and the media was replaced every other 
day, as outlined in figure 2.1.To perform live-cell imaging of endothelial tubules, the 
co-culture media was removed immediately before imaging and replaced with 
imaging media which contained DMEM that lacked phenol red, supplemented with 
10% (v/v) FCS, 90 µg/ml heparin, 4 mM L-Glutamine, 100 units/ml penicillin and 
streptomycin and bovine brain extract. Endothelial tubules were imaged on a Nikon 
A1R inverted confocal microscope and a Zeiss 780 Zen confocal microscope. 
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Figure 2.1 Procedure for the co-culture tube formation assay 
A) Step-by-step procedure of the co-culture tube formation assay involving the co-
culture of endothelial cells (HUVECs) on top of human dermal fibroblasts (HDFs) to 
form endothelial tubules, B) Schematic diagram of the co-culture tube formation 
assay. Fluorescently labelled endothelial cells are plated directly on top of cultured 
fibroblasts, co-culture stimulates the extension of the endothelial cells into three 
dimensional tubules. Confocal microscopy can be used to visualise the fluorescent 
endothelial tubular network.  
Co-culture tube formation assay procedure: 
Day 1: Plate and culture human dermal fibroblasts (HDFs) 
Day 3: Grow endothelial cells (HUVECs) 
Day 4: Feed HDFs by refreshing cDMEM media 
Day 5: Plate HUVECs directly on top of HDFs 
Day 7: Feed co-culture by refreshing cM199 media 
Day 9: Feed co-culture by refreshing cM199 media 
Day 11: Feed co-culture by refreshing cM199 media 
End point: Fix and stain endothelial tubules or perform live-cellular imaging 
A 
B 
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The cells were kept on a heated stage at 37 oC throughout imaging and the cell 
media was replaced with cM199 after imaging to continue to culture the cells. 
2.7.1.1 Histological staining of endothelial cells 
Histologically staining endothelial cells was performed to image the extensive 
network of tubules formed in the co-culture tube formation assay and to analyse 
tubule growth and branching. The protocol for co-culturing HUVEC and HDFs to 
develop tubules was performed as described in section 2.7.1 using a 12-well plate 
and 3 x 104 cell densities. After 6 days of co-culture with replacement of media every 
other day, the cells were washed once with 1 ml PBS and fixed for 30 mins with 70% 
(v/v) ethanol cooled to -20 oC. The wells were then washed twice with 1 ml PBS and 
incubated with 400 µl 1.29 µg/ml mouse monoclonal Anti-human CD31 primary 
antibody (Dako) in 1% (w/v) BSA-PBS for 1 hr at 37 oC. Unbound primary antibody 
was removed by washing 3 times with 1 ml PBS. The cells were then incubated for 1 
hr at 37 oC with 400 µl secondary antibody goat polyclonal Anti-mouse IgG 
conjugated to alkaline phosphatase diluted 1:500 in 1% (w/v) BSA in PBS. Cells were 
washed twice with 1 ml PBS and 3 times with 1 ml dH20 before adding 500 µl alkaline 
phosphatase substrate SigmaFAST 5-bromo-4-chloro-3-indolyl phosphate/ nitro blue 
tetrazolium (BCIP/NBT). The SigmaFAST BCIP/NBT had been dissolved in 10 ml 
dH20, the substrate remained on cells for 25 mins at room temperature. The 
phosphatase reaction was stopped by washing with dH20 and the wells were left to 
dry in darkness overnight at room temperature. A Leica MZ16 optical microscope 
was used to image the histological stained endothelial cells.   
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2.7.2 Matrigel tube formation assay 
Natural basement membrane extract matrigel (VWR International) was thawed on ice 
and used immediately once thawed. Prior to the addition of 70 µl of 10 mg/ml 
matrigel to each well of a 12-well plate (Falcon), each well was rinsed with PBS; the 
plate was then incubated at 37 oC for 30 mins to allow the matrigel to solidify. 1.4 x 
105 HUVECs in cM199 medium containing inhibitors if required were plated into each 
well, on top of the solidified matrigel. The plate was incubated at 37 oC, 5% CO2 
atmosphere for 12 hrs to allow endothelial tubular networks to form.  
Images of the tubules were captured using the IncuCyte Imaging system (Essen 
BioScience) 12 hrs after the cells were plated. Four images per condition were 
captured and analysed. The ImageJ plugin Angiogenesis Analyzer was used to 
analyse the tubular images and the mean number of meshes was measured.  
2.7.3  Scratch wound assay 
6 x 103 HUVECs were plated in wells of a 96-well plate, which had been pre-coated 
with gelatin two days prior to scratching.  The cells were maintained at 37 oC in a 5% 
CO2 atmosphere. A scratch in the monolayer of cells was made using the IncuCyte 
scratcher, to remove debris the cells were washed once with PBS. To screen the 
effect of different kinase inhibitors on cell migration, the kinase inhibitors were added 
to the cells in a total volume of 100 µl in cM199. To monitor cell migration, images 
were captured by the IncuCyte Imaging system (Essen BioScience) immediately, 6 
hrs and 12 hrs after the scratch was made. Analysis of scratch wound closure was 
calculated by the IncuCtye software and checked manually. 
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2.7.4 Hanging drop spheroid angiogenesis assay 
Cultured HUVECs were trypsinised and counted as described in section 2.6.2, if 
required the HUVECs were also fluorescently labelled with CFSE as described in 
section 2.6.4.1. Spheroids were formed from 1000 cells and 60 spheroids were 
generated per condition. HUVECs were resuspended in 20% (w/v) methylcellulose 
stock solution in cM199 at 5 x 104 cells/ml. 20 µl of cell solution was pipetted into 
wells of a Nunc 60-well microplate and inverted overnight at 37 oC, 5% CO2 
atmosphere to generate spheroid masses via the hanging drop method, the 
schematic diagram for the assay is shown in figure 2.2. After 24 hrs the spheroids 
were embedded in a collagen matrix, by firstly making a solution of 3.35 mg/ml type I 
collagen from rat tail diluted in 10x DMEM in dH20. 10 µl 5 N sodium hydroxide was 
added to the solution before mixing with a second solution containing 1.2% (w/v) 
methylcellulose solution in cM199.  
The spheroids were collected from the microplate and centrifuged at 195 x g for 5 
mins. The spheroid pellet containing 60 spheroids was resuspended in 200 µl 
collagen solution, which was transferred into a well of a 24-well plate. The cells were 
incubated at 37 oC, 5% CO2 atmosphere for 10 mins before 100 µl cM199 was added 
on top of each well of embedded spheroids. If required, inhibitors were added into the 
100 µl culture media. The plate was placed at 37 oC, 5% CO2 atmosphere for 16 hrs 
before fixing and imaging on a Zeiss 780 Zen confocal microscope or a Leica MZ16 
optical microscope.  
For studying endothelial sprouting, time-course imaging of the spheroids was 
performed using the CellIQ System which captured fluorescence and phase contrast 
images every hour for the duration of 27 hrs. 
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Figure 2.2 Schematic diagram of the hanging drop spheroid angiogenesis 
assay 
1) Suspend HUVECs in cM199 media containing 20% (w/v) methylcellulose and 
pipette 20 µl droplets into a 60-well microplate and invert overnight, 2) at the base of 
the droplet a multicellular spheroid mass forms over the course of 24 hrs, 3) embed 
multiple spheroids in an extracellular matrix of collagen and add cM199 media to the 
embedded spheroids, 4) the spheroids rapidly undergo endothelial sprouting. 
Suspend HUVECs in 20% 
(w/v) methylcellulose 
solution 
 
Create spheroid 
masses using hanging 
drops 
Embed spheroids in an  
ECM component and add cM199 media 
Spheroids produce endothelial sprouts 
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2.7.4.1 Fixing and mounting endothelial spheroids 
Culture media was removed from the wells of embedded spheroids and the 
spheroids were washed 3 times with PBS before 4% (w/v) PFA was added for 30 
mins at room temperature for fixation. The PFA was removed and the embedded 
spheroids were washed 3 times with PBS before curved forceps were used to 
remove the embedded spheroids from the well and were mounted onto a glass slide. 
8-10 µl vectashield mounting medium with DAPI (Vector Laboratories) was added 
before a coverslip was placed over the spheroids and left to set. Imaging of the 
spheroids was carried out using a Zeiss 780 Zen confocal microscope.  
2.7.5  Cell viability assay 
The WST-1 cell proliferation kit (Cayman Chemical) was used to assess the cytotoxic 
effects of inhibitor concentrations on HUVECs. Mitochondrial dehydrogenases of 
viable cells were able to cleave the tetrazolium salt WST-1 to formazan, which was 
detected by measuring the absorbance of light at 450 nm.  
6 x 103 HUVECs were plated in wells of a 96-well plate which had been pre-coated 
with gelatin, inhibitors in cM199 were added to cells in a total volume of 100 µl. Two 
controls were used; control wells either contained 100 µl cM199 without cells or 100 
µl DMSO in cM199 with cells. The 96-well plate was incubated at 37 oC, 5% CO2 
atmosphere for 24 hrs then 10 µl WST-1 was added to each well, excluding the 
media only control wells. The plate was placed onto an orbital shaker for 1 min 
before incubation for 2 hrs at 37 oC. The light absorbance of each well was measured 
at 450 nm by a microcell reader. Four repeats were performed for each inhibitor 
compound and a mean absorbance value was calculated. 
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2.8 Microbiology and cloning 
2.8.1  Cloning procedure 
All cloning reagents of restriction enzymes and their corresponding buffers were 
purchased from New England Biolabs (NEB).  
The lifeact-GFP sequence from the pEGFP-N1 plasmid was inserted into the 
lentiviral pWPXL plasmid; the cloning procedure which was performed is outlined in 
figure 2.3. The lifeact-GFP sequence was amplified from the pEGFP-N1-lifeact 
plasmid using the VS1 forward primer with the sequence 5’-TAGTAGGTTTAAAC 
ACCATGGGCGGTGTCGCAGATTTGATCAAG-3’ and VS2 reverse primer with the 
sequence 5’-CTACTACCCGGGTTATGATCTAGAGTCGCGGCC-3’ to add in the 
SmaI and PmeI restriction enzyme sites to enable both the pWPXL plasmid and the 
lifeact-GFP sequence to be cut using the same restriction enzymes. The amplified 
DNA was then cut with SmaI and PmeI (NEB) and the linearised plasmid and insert 
were purified from gel electrophoresis using the GeneJET Gel Extraction Kit 
(Fermentas). Ligations were set up with a 1:3 ratio of pWPXL:lifeact-GFP insert using 
T4 ligase (NEB). α-select gold chemically competent E.coli were transformed with the 
pWPXL-lifeact-GFP plasmid and the bacterial colonies were expanded in LB broth 
containing 0.1 mg/ml ampicillin. The plasmid was purified from bacterial culture using 
the GeneJET plasmid miniprep kit (Fermentas) and the Qiagen plasmid maxi kit 
(Qiagen). All DNA sequencing was carried out by the Functional Genomics & 
Proteomics Laboratory, School of Biosciences at the University of Birmingham, UK. 
The primers used for sequencing the pEGFP-N1 plasmid were the forward primer: 
MCS N1: PL_MCS_N1 with the sequence 5’-GTCGTAACAACTCCGCCC-3’ and  
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Figure 2.3 Cloning procedure to insert the lifeact-GFP sequence into the 
pWPXL plasmid to replace the original GFP gene 
The lifeact-GFP sequence from pEGFP-N1 was amplified and SmaI and PmeI 
restriction sites were added to the sequence using PCR. The same restriction 
enzymes; SmaI and PmeI were used to digest pWPXL to allow for the insertion of the 
lifeact-GFP insert. The products of the digestion reactions were separated using 
agarose gel electrophoresis and purified to obtain the linearised plasmid and insert. A 
ligation reaction using ligase, the insert and the plasmid generated the new construct 
consisting of the pWPXL plasmid with the lifeact-GFP sequence inserted. The 
construct was introduced into gold E.coli by heat-shock transformation and the 
bacteria were grown on LB agar plates containing ampicillin antibiotic. Selected 
colonies were expanded in LB broth overnight at 37 oC on an orbital shaker. DNA 
mini- and maxi-preparations were performed to extract the plasmid from lysed 
bacteria. A series of restriction digestion reactions and sequencing were performed 
to verify the correct site of insertion and ensure no DNA mutations had taken place. 
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reverse primer: PL_BEFORE_EGFP2 with the sequence 5’-GCTTGCCGTAG 
GTGGCAT-3’.  
To measure DNA concentrations 2 µl of plasmid DNA solution was loaded onto a 
NanoDrop ND-1000 Spectrophotometer (LabTech) for assessment and as a way of 
storing DNA and plasmid constructs, 30 % (v/v) glycerol was mixed in a 1:1 ratio with 
bacterial culture and stored at -80 oC.  
2.8.2 Bacterial culture 
E.coli containing the pEGFP-N1 plasmid was streaked onto Luria Bertani (LB) agar 
plates containing 0.03 mg/ml kanamycin. The bacterial plate was incubated at 37 oC 
overnight. The following day bacterial colonies were grown up in liquid LB broth with 
kanamycin.  
E.coli containing the pWPXL-lifeact-GFP plasmid was streaked onto LB agar plates 
containing 0.1 mg/ml ampicillin antibiotics and E.coli colonies were expanded in LB 
broth containing ampicillin.  
2.8.3 Purification and sequencing of DNA 
The pEGFP-N1 plasmid and the pWPXL-lifeact-GFP plasmid were purified from 
bacterial cultures either by producing small quantities of plasmid using the GeneJET 
plasmid miniprep kit (Fermentas) or via larger size production using the Qiagen 
plasmid maxi kit (Qiagen). For both plasmid production procedures the 
manufacturer’s instructions were followed for the production and purification of DNA.   
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2.8.4 Amplifying the lifeact-GFP insert using polymerase chain reaction 
(PCR) 
To introduce the SmaI and PmeI restriction enzyme sites into the lifeact-GFP 
sequence for subsequent insertion into the pWPXL plasmid, PCR was performed to 
amplify the sequence using specifically designed primers VS1 and VS2 as mentioned 
in section 2.8.1. 
100 µl PCR mix was made up containing: 5 µl pEGFP-N1 plasmid, 1 µl phusion 
enzyme, 1 µl forward primer VS1, 1 µl reverse primer VS2, 2 µl 10 nM 
deoxyribonucleotides (dNTPs), 20 µl 5x HF buffer and 70 µl PCR H20. The PCR 
program was performed as follows: 10 sec initial denaturation at 98 oC, followed by 
30 cycles of denaturation at 98 oC for 10 secs, annealing at 55 oC for 30 secs and 
elongation at 72 oC for 1 minute.  
After PCR, a 10 µl sample of the PCR mix was run in gel electrophoresis on a 1.5% 
(w/v) agarose gel alongside a 1 kb DNA ladder (GeneRuler) to ensure that the 
amplification process was successful. 
2.8.5 DNA separation and purification 
DNA was separated using DNA agarose gel electrophoresis; 1-2% (w/v) agarose 
gels were made from dissolving agarose powder (VWR International) in Tris acetate 
EDTA (TAE) buffer solution. The TAE solution was made up to contain 1 mM EDTA, 
40 mM Tris-base, 18 mM glacial acetic acid. The gels were stained with SYBR Safe 
DNA stain (Invitrogen) to allow for DNA visualisation under ultraviolet (UV) light.  Gels 
were suspended in TAE buffer solution to separate DNA strands which had been 
labelled with 6x loading dye. A 1 kb DNA ladder (Fermentas) was loaded alongside 
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DNA samples to check the sizes of DNA samples. DNA bands were visualised using 
the Gene Genius Bio Imaging System (Syngene). 
DNA bands were manually cut out of the DNA agarose gels using a scalpel and 
extraction of the DNA from the agarose gel was performed following the instruction 
manual of the GeneJET Gel Extraction Kit (Fermentas). 
2.8.6 Restriction digestion reactions of DNA 
Restriction digests were performed to cut the GFP gene out from pWPXL to allow for 
the insertion of the lifeact-GFP sequence. The restriction digest reactions contained  
5 µg plasmid DNA or purified PCR products, 2.5 µl restriction enzyme and 5 µl 10x 
restriction enzyme buffer with 5 µl 10x BSA if required for enzyme activity. The total 
volume of the restriction digestion reactions was scaled between 10–50 µl dependent 
on if the digestion reaction was for diagnostic purposes.  
2.8.7 DNA ligation reaction to create the pWPXL-lifeact-GFP plasmid 
DNA ligation was performed to ligate the lifeact-GFP DNA insert into the linearised 
pWPXL plasmid. The ligation reaction, alongside controls were performed at room 
temperature using 2 µl T4 Ligase (NEB), 2 µl 10x ligase buffer and 150 ng insert, 50 
ng vector in a DNA volume of 16 µl. The total ligation reaction was in 20 µl volume 
solutions, kept at room temperature for 2 hrs.  
2.8.8 Heat-shock transformation 
Heat shock transformation was performed to introduce the pWPXL-lifeact-GFP 
plasmid into competent bacteria. 5 µl plasmid DNA generated by the ligation process 
in section 2.8.7 was added to 50 µl α-select gold chemically competent E.coli. The 
transformation mix containing the bacteria and plasmid DNA was incubated on ice for 
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30 mins before being heat shocked for 30 secs at 42 oC in a water bath. The 
transformation mix was then placed back on ice for 1 min. 100 µl LB was added to 
the transformation mix and was placed at 37 oC in a shaking incubator for 1 hr. The 
transformed bacteria were spread onto LB agar plates containing antibiotics and 
placed in an incubator at 37 oC overnight. 
2.9 Zebrafish methods 
2.9.1 Strains and maintenance of zebrafish 
The in vivo model of angiogenesis that was used in this study was the Danio rerio, 
commonly known as the zebrafish, which is a widely used vertebrate model. The 
stable transgenic line of zebrafish Tg[fli1:EGFP] (fli1-GFP) generated by Weinstein 
and Lawson was used in this study155. The fli1-GFP zebrafish expressed the EGFP 
protein in the vascular endothelium throughout embryogenesis driven by the fli1 
promoter which created the ideal model for studying and visualising the growth and 
development of the vascular system in this organism.   
The fish were maintained at the  
.   
2.9.2 Breeding of transgenic zebrafish and maintenance of embryos 
To achieve vascular imaging of the zebrafish, transgenic fli1-GFP zebrafish were 
bred to produce embryos. Adult female and male zebrafish were placed in a breeding 
tank separated by a divider overnight. The following morning the divider was 
removed and embryos were collected in 1x E3 media which contained 34.8 g NaCl, 
1.6 g KCl, 5.8 g CaCl2, 9.78 g MgCl2, which was kept at 28.5 
oC. The 1x E3 media 
was made by diluting a 60x E3 stock solution of E3 media into 1L with dH20, with the 
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addition of 100 µl 1% methylene blue (Sigma) to prevent fungal infections. A 60x E3 
stock solution was made from dissolving 34.8 g NaCl,1.6 g KCl, 5.8 g CaCl2,9.78 g 
MgCl2 into a total volume of 2 l ddH20. At 24 hpf, the 1x E3 media surrounding the 
zebrafish embryos was changed with 1x E3 media containing 80 µM 1-phenyl 2-
thiourea (PTU) to prevent embryonic pigment formation.  
2.9.3 Morpholino oligonucleotide injections 
Antisense morpholino oligonucleotides were ordered from Gene Tools (USA). The 
morpholino oligonucleotides were reconstituted into ddH20 and were microinjected 
into transgenic fli1-GFP zebrafish embryos at the 1-cell stage of development. The 
concentrations of morpholino oligonucleotide solutions which were used ranged from 
0.2-0.8 ng per embryo. Phenol red was co-injected alongside the morpholino 
oligonucleotide solution to act as a tracer for the injection procedure. Mismatched 
morpholino oligonucleotides were injected into 1-cell stage embryos as controls to 
the gene targeting morpholino oligonucleotide sequences.  
2.10 Imaging and image analysis 
2.10.1  Imaging the zebrafish vasculature 
Prior to imaging the zebrafish embryos, each embryo was manually dechorionated 
using forceps and anesthetised prior to imaging using 1-2 drops of MS-222 in E3 
media to ensure the movement of embryos was minimised. The zebrafish were then 
placed onto MatTek dishes and imaged using a Zeiss 780 Zen microscope. Embryos 
were imaged at varying developmental time points including 24 hpf, 26 hpf, 28 hpf, 
30 hpf, 36 hpf, 48 hpf and 72 hpf.  
72 
 
Confocal image sections of the embryonic zebrafish vascular system were 
compressed using Zen 2012 Zeiss microscopy software and the subsequent 
vasculature images were analysed using the developed ImageJ Zebrafish 
Vasculature Analysis Macro or IMARIS software to assess and quantify the numbers 
of vessel segments, junctions, end-points, the total and average vessel lengths. 
2.10.2 Image analysis software 
Optical images of histologically stained endothelial cells were analysed using 
AngioSys Image Analysis software (Cellworks). Fluorescent endothelial spheroid 
images were analysed using the designed Spheroid Analysis ImageJ plugin (National 
Institutes of Health). The matrigel tube formation images were analysed using the 
ImageJ Angiogenesis Analyzer plugin (National Institutes of Health). The scratch 
wound assay images were analysed using the IncuCyte software (Essen 
Bioscience). The Zen 2012 Zeiss microscopy software was used to process and 
generate compressed confocal z-stacks of endothelial tubular images and zebrafish 
vasculature images. The zebrafish vasculature analysis macro was generated using 
ImageJ (National Institutes of Health) to allow for quantification of the zebrafish 
vascular system. The alternative zebrafish vasculature analysis method was created 
using IMARIS x64 7.6.5 software (Bitplane).  
2.10.3 Statistical analysis 
Unless stated otherwise, all assays were performed at least three times with similar 
results.  
GraphPad Prism 6 software was used to statistically analyse data, determine the 
Pearson product moment correlation coefficients (R values) and the coefficient of 
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determination values (r2 values) and plot correlation graphs. The statistical tests 
which were used for the data sets are outlined in the results section, often the non-
parametric Mann-Whitney test was performed on data sets which does not assume a 
normal distribution of the data. To compare two independent data sets an unpaired 
Student’s t-test was performed. The p values were indicated in the results as follows: 
p ≤ 0.0001 as ****, p ≤ 0.001 as ***, p ≤ 0.01 as **, p ≤ 0.05 as *, p > 0.05 as ns for 
non-significant.  
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 Chapter Three 
Investigating lumen formation 
within endothelial tubules 
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3.1. Chapter summary 
The aim of this chapter was to utilise and develop various fluorescent imaging 
techniques to study the process of lumenogenesis within endothelial tubules formed 
using the in vitro co-culture tube formation angiogenesis assay. In this chapter, 
different fluorescent imaging approaches are presented which involved labelling the 
endothelial cytoplasm or actin cytoskeleton prior to using the endothelial cells in the 
co-culture tube formation assay to enable tubular imaging using confocal microscopy.  
The structure for this chapter is as follows: section 3.2 chapter introduction, section 
3.3 establishing optimal conditions for the co-culture tube formation assay, section 
3.4 using fluorescent cytoplasmic dyes to study lumen formation, section 3.5 
visualising the uptake of fluorescence media into lumenal spaces of tubules, section 
3.6 staining of tubular apical and basolateral cell surface markers, section 3.7 
expressing the lifeact peptide to outline developing lumens and visualise filopodia 
formation, section 3.8 visualising cellular interactions and lumen formation by using a 
mixture of lifeact-GFP and lifeact-RFP expressing cells, section 3.9 chapter 
discussion.  
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3.2. Chapter introduction 
The development of vascular sprouts during angiogenesis involves endothelial 
invasion, migration and proliferation; the endothelial sprouts continue to elongate 
creating three dimensional tubules which fuse with existing blood vessels to form part 
of an elaborate cardiovascular network14. The newly formed vessels must produce an 
intracellular lumen encapsulated by endothelial cells to enable blood flow. Following 
lumenogenesis, there is re-establishment of the basement membrane and 
attachment of mural cells to stabilise and strengthen the vessel1.  
The co-culture tube formation assay assesses the ability of endothelial cells to 
undergo tubulogenesis126. In this widely used in vitro assay modelling angiogenesis, 
endothelial cells are plated and cultured directly on top of fibroblasts to mimic the 
growth of small blood vessels such as the capillaries130. In this chapter, the co-culture 
tube formation assay was used to establish endothelial tubules and investigate the 
process of lumenogenesis.  
The cellular and molecular mechanisms involved within in vivo and in vitro lumen 
formation have been widely debated by the scientific community and at present there 
is evidence to support two models of endothelial lumenogenesis; the vacuole fusion 
mechanism and the endothelial cell rearrangement mechanism. In the vacuole fusion 
mechanism, small intracellular vesicles fuse together to form vacuoles within the 
endothelial tubules, these large intracellular vacuoles fuse with adjacent cell vacuoles 
creating a large open channel spanning through several endothelial cells32,218. This 
mechanism of lumenogenesis has been supported by Kamei et al. which observed 
vacuole fusion within intersegmental blood vessels (ISVs) in zebrafish18. The second 
mechanism of lumen formation is the endothelial cell rearrangement mechanism, 
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where the lumen develops from an extracellular space between adjacent endothelial 
cells. This process is initiated by cell surface polarisation which establishes apical 
and basolateral surfaces due to interactions of RAS interacting protein 1 (RASIP1) 
and aided by the recruitment of negatively charged dextran sulphate and CD34-
sialomucins which are repositioned to the apical cell surface23. An extracellular space 
is created between the apical surfaces of the cells which is subsequently expanded 
by actomyosin contractility, causing rearrangement of endothelial morphology23. The 
endothelial tubular lumen is further enlarged by the removal of cellular junctions by 
the action of proteolysis mediated by membrane type I matrix metalloproteinases 
(MT1-MMP) allowing an influx of surrounding fluid31. The aortic lumen in mouse 
embryos was found by Strilić et al, 2009 to develop extracellularly, supporting this 
mechanism of lumenogenesis25.  
3.3. Establishing optimal conditions for the co-culture tube formation 
assay 
To study the structure of the endothelial tubules, it was important to establish the 
appropriate co-culture media constituents to achieve optimal growth of the 
endothelial tubules in the co-culture tube formation assay. Typically in our laboratory 
this assay is performed using bovine brain extract as a bFGF containing growth 
supplement, however to determine if the substitution of basic fibroblast growth factor 
(bFGF) with bovine brain extract lead to an enhancement of tubular development, 
endothelial tubular growth in the two conditions was compared. Additionally, VEGF 
was added to the media to determine if there was further enhancement of tubular 
growth when this pro-angiogenic factor was present. 
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In this study, endothelial cells were plated directly on top of fibroblasts and were co-
cultured for six days in M199 media containing FCS, heparin, penicillin and 
streptomycin with either bovine brain extract or 10 ng/ml bFGF, with or without the 
presence of 10 ng/ml VEGF. The co-cultures were fixed and histologically stained on 
the sixth day of co-culture and representative images of the endothelial tubules are 
shown in figure 3.1A. The images of the tubular networks were analysed and tubules 
were quantified using AngioSys software. The number of endothelial tubule junctions 
and mean tubule length were calculated and are shown in figure 3.1B.  
Endothelial tubular growth occurred in all co-culture media conditions tested, 
statistical analysis using an ANOVA test and a Dunnett post-test revealed that there 
were no statistical differences in the growth of the tubules formed in the different 
media constituents. Furthermore, the addition of VEGF to the co-cultures did not 
statistically enhance tubular formation further; this result revealed that the fibroblasts 
must have secreted a high concentration of VEGF into the surrounding media in 
response to being stimulated by bFGF, so the addition of the 10 ng/ml VEGF was not 
enough to cause a further increase in tubule growth. Since no significant statistical 
differences were calculated between the four co-culture media conditions, the 
standard approach of using cM199 with bovine brain extract was used for 
subsequent studies using the co-culture tube formation assay with endothelial cells 
and fibroblasts.  
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Figure 3.1 Both basic fibroblast growth factor and bovine brain extract 
promoted tubule formation and was not enhanced by the addition of VEGF 
 
A) Histologically stained endothelial tubular images formed after six days in co-
culture media containing either bovine brain extract or 10 ng/ml bFGF with or without 
10 ng/ml VEGF, scale: 1 mm. B) Bar charts showed the AngioSys software analysis 
of the tubular images, an ANOVA and Dunnett post-test revealed the p values were 
non-significant between the different media constituents, n = 3 with different cords, 
error bars show the SEM. 
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3.4. Using fluorescent cytoplasmic dyes to study lumen formation 
To visualise at high resolution the three dimensional structure of endothelial tubules, 
confocal microscopy was required to optically section the tubules to obtain image 
slices which can be compressed to enable detailed visualisation of the endothelial 
tubules. The optical image slices were examined individually for the formation of 
lumens within the endothelial tubule and were also used to create three dimensional 
reconstructions to interactively visualise the tubules from all different angles. 
To generate fluorescent tubules, firstly endothelial cells were transduced to express 
cytoplasmic GFP using the lentiviral plasmids pWPI and pWPXL. The fluorescently 
labelled endothelial cells were used in the co-culture tube formation assay to produce 
fluorescent tubules which were imaged after two days of co-culture; images of these 
tubules are shown in figure 3.2A. Limitations of this study were that the GFP 
expressing tubules could only be imaged using epifluorescence microscopy due to 
the relatively low fluorescence emission from these tubules therefore only the overall 
morphology of the tubules was observed. Further structural details of the tubules 
such as filopodia formation or the development of lumens could not be visualised.  
A second fluorescence labelling method involved labelling endothelial cells with 5 µM 
CFSE produced endothelial tubules with higher fluorescence emission than GFP 
expressing tubules. When visualised with confocal microscopy the CFSE labelled 
tubules enabled higher resolution tubular images to be captured, as shown in figure 
3.2C shows the appearance of an endothelial tip cell and a tubular lumen. 
 
 
81 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 CFSE labelled endothelial cells produced high fluorescence 
emission allowing the structure of endothelial tubules to be imaged with 
confocal microscopy 
A) Epifluorescence images revealed low intensity fluorescence emission from tubules 
expressing GFP via pWPI and pWPXL transduction. B) Epifluorescence image of a 
CFSE labelled tubule. C) Confocal microscopy images of a tip cell and lumen 
formation within CFSE labelled tubules. Endothelial tubules were imaged after 2 days 
of co-culture in the tube formation assay, scale: 100 µm. 
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Figure 3.3 CFSE labelled endothelial cells continued to produce high 
fluorescence emission from cells days after labelling 
Fluorescence Activated Cell Scanning (FACS) plots of the fluorescence emission 
from unlabelled HUVECs (black) and A) GFP expressing HUVECs from pWPI and 
pWPXL transduction (green), B) HUVECs labelled with 5 µM CFSE (orange), FACS 
analysis was performed immediately after labelling and 2, 4 and 6 days after 
labelling. 
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Fluorescence activated cell scanning (FACS) analysis of endothelial cells expressing 
cytoplasmic GFP via pWPI and pWPXL transduction as well as labelling endothelial 
cells with CFSE revealed that the cells were successfully transduced and were 
fluorescently labelled.  The FACS plots analysing the GFP expressing cells and the 
CFSE labelled cells compared with the unlabelled endothelial cell control sample are 
shown in figure 3.3, the shift in the fluorescence emission peak compared with the 
unlabelled endothelial control confirmed that the cells were successfully labelled.  
CFSE passively diffuses into the cellular cytoplasm, where it becomes covalently 
coupled to amines inside the cell through cleavage of the acetate groups by 
intracellular esterases219. Once modified the fluorescent carboxyfluorescein 
succinimidyl ester can stably exist in the cell without leaking out, which permits its 
usage as a cell proliferation dye219. The FACS analysis showed that labelling 
endothelial cells with CFSE produced an intense fluorescence signal immediately 
after labelling compared with the unlabelled endothelial control and the GFP 
expressing endothelial cells. The FACS plot showed that the fluorescence emission 
in CFSE labelled cells remained high for around four days, which was sufficient for 
monitoring the development and growth of the endothelial tubules. Observation of 
tubules in culture showed that the fluorescence emission from the CFSE labelled 
tubules remained relatively high after six days and therefore CFSE proved to be a 
useful fluorescence dye for labelling endothelial cells prior to use in the co-culture 
tube formation assay to monitor tubule growth and development. 
To determine whether CFSE labelling of endothelial cells caused any adverse effects 
on tubule formation, the co-culture tube formation assay was performed using 
endothelial cells that had been labelled with 5 µM CFSE and tubular growth was 
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compared with that of unlabelled endothelial cells. The endothelial cells were co-
cultured with fibroblasts for six days before being fixed and histologically stained; the 
histological tubular images are shown in figure 3.4A. The assay was repeated using 
endothelial cells from three different cords and the images were analysed using 
AngioSys software. Statistical analysis using a Student’s t-test revealed that there 
were no significant differences in tubule formation when using unlabelled or CFSE 
labelled endothelial cells in the co-culture tube formation assay. The bar charts in 
figure 3.4B show quantification of the numbers of tubules, junctions and mean tubule 
length with unlabelled and CFSE labelled tubules.  
Since labelling endothelial cells with CFSE did not significantly affect tubular 
formation, this fluorescence dye was used to determine if endothelial lumenogenesis 
occurred within tubules formed in this assay. CFSE labelled endothelial tubules were 
produced using the co-culture the formation assay and were optically sectioned using 
confocal microscopy at 1 µm intervals to investigate the process of lumen formation. 
As shown in figures 3.5A and 3.5B, developing lumens within CFSE labelled 
endothelial tubules were visualised, the opening and closing of the lumenal space 
can be observed in the sections which confirmed that this intracellular process occurs 
within tubules formed in this assay. This finding was also confirmed by the 
visualisation of an enclosed tubular lumen surrounded by plasma membrane in the 
xyz plane which was generated by the selection of a transverse section across the 
tubule which spanned across the developing lumen, shown in figure 3.5C. 
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Figure 3.4 Labelling endothelial cells with CFSE did not significantly affect 
tubule formation 
 
Unlabelled and 5 µM CFSE labelled endothelial cells were plated on top of fibroblasts 
and co-cultured for six days before being histologically stained. A) Histologically 
stained tubular images, scale bar: 1 mm. B) The histologically stained tubular images 
were analysed using AngioSys software, the bar charts showed the quantification of 
the number of tubules, junctions and mean tubule length formed when using 
unlabelled and CFSE labelled endothelial cells in the tube formation assay. Statistical 
analysis was performed using a Student’s t-test, where the p values were non-
significant for all parameters, n = 3, error bars show the SEM. 
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Figure 3.5 Lumen formation was visualised in CFSE labelled endothelial 
tubules using the co-culture tube formation assay 
Endothelial cells were labelled with 5 µM CFSE and plated directly onto fibroblasts 
and co-cultured for six says prior to optical sectioning using confocal microscopy.    
A) A series of optical sections showed the formation of a lumen within an endothelial 
tubule, optical sections were taken every 1 µm, scale: 50 µm. B) Higher magnification 
images of the developing lumen within the CFSE labelled tubule, scale: 25 µm. C) At 
the position indicated by the red dotted line in the tubular image, a xyz plane was 
generated showing an enclosed tubular lumen surrounded by plasma membrane, 
scale: 25 µm. 
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To acquire mechanistic information about the process of lumen formation in tubules 
formed using the co-culture tube formation assay and determine whether lumens 
were formed via the vacuole fusion process or the endothelial cell rearrangement 
mechanism, a two colour fluorescence labelling approach was taken. CFSE labelling 
of endothelial cells was performed alongside labelling cells with 5 mM CellTracker 
orange, the two sets of fluorescently labelled endothelial cells were mixed prior to 
plating onto the fibroblasts. Two examples of lumen formation are shown in figure 
3.6, the greyscale image revealed the difficulty in imaging and identifying the 
presence of lumens using a single fluorescence channel and the two coloured image 
allowed visualisation of lumens between cells that were labelled with different 
fluorescence dyes.  
Endothelial tubules formed using CFSE labelled endothelial cells and CellTracker 
orange labelled endothelial cells were imaged on the seventh day of co-culture and 
the tubules were imaged using confocal microscopy and visually assessed for the 
presence of lumen formation. 137 endothelial tubules were imaged using two colour 
confocal microscopy, each tubular image was converted to greyscale for visual 
assessment and each tubule was studied for the presence of lumen formation. Upon 
the identification of lumenal formation within an endothelial tubule, the corresponding 
two coloured fluorescence image was examined to determine if the lumen had 
formed via the endothelial cell rearrangement mechanism or the vacuole fusion 
mechanism. There are clear morphological differences in the appearance of lumens 
developed via the two different lumenogenesis mechanisms; the presence of a 
curved and elongated lumen flanked by two endothelial cells was a visual indication 
of the endothelial cell rearrangement mechanism, as shown in the tubular images in  
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Figure 3.6 Evidence of the endothelial cell rearrangement mechanism was 
observed within endothelial tubules formed using cells labelled with CFSE and 
CellTracker orange 
Endothelial cells were labelled with either 5 µM CFSE (green) or 5 mM CellTracker 
orange (orange) and were mixed prior to plating on top of fibroblasts. Imaging was 
performed on the seventh day of co-culture. Greyscale and corresponding coloured 
images of endothelial tubules showed evidence of lumen formation, scale: 100 µm. 
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figure 3.6, where an extracellular space developed into the lumen between adjacent 
endothelial cells, which were often labelled with different coloured fluorescent dyes. 
Whereas, endothelial lumens which form via the vacuole fusion mechanism often 
initially have several small circular lumenal spaces within close proximity showing the 
presence of vacuoles. During lumenal expansion there is vacuole fusion and larger 
irregular shaped lumens can be observed. Upon quantitation of the tubular images, 
74.5% tubules contained lumens, all of these lumens were formed via the endothelial 
cell rearrangement mechanism. The high percentage of tubules containing lumens 
also provided evidence that the co-culture tube formation assay is a suitable assay to 
study the later processes of angiogenesis including endothelial extension into tubules 
and lumen formation. 
3.5. Visualising the uptake of fluorescence media into lumenal spaces 
of tubules 
To provide further evidence that endothelial tubules developed lumens in the co-
culture tube formation assay, red fluorescent dextran tracer was added into the co-
culture media two days prior to imaging CFSE labelled endothelial tubules. The 
tubules were formed over a period of six days and upon imaging the dextran tracer 
was visualised within some stalk cells of the tubules, indicated by the arrows in figure 
3.7.  
The presence of dextran tracer inside the tubules revealed that the tubules were in 
the initial stages of lumen development as the lumenal space was relatively small 
measuring approximately 8 µm. Visualising the endothelial tubules in this way was  
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Figure 3.7 Tubular lumens take up fluorescent dextran tracer from surrounding 
culture media 
Dextran Texas red fluorescent dye was added to the co-culture media two days prior 
to imaging endothelial tubules labelled with 5 µM CFSE. The red fluorescent tracer 
was taken up into luminal spaces within some stalk cells of endothelial tubules as 
indicated by the arrows, scale: 50 µm. 
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able to confirm that lumens developed within the tubules formed in the co-culture 
tube formation assay. 
3.6. Staining of tubular apical and basolateral cell surface markers 
Prior to lumen formation, the endothelial cells exist as a cord of cells connected by 
cellular junctions. As stated by Herbert and Stainier, the first stage of endothelial 
tubular lumenogenesis involves establishing the apical and basolateral cell surfaces 
via polarisation, this step is followed by the redistribution of junctional proteins and 
the glycoprotein podocalyxin is repositioned to the apical endothelial cell 
membrane23. Podocalyxin is then responsible for the recruitment of F-actin and 
moesin to this surface which aids in expanding the lumen23.  Therefore, podocalyxin 
is an apical cell surface marker for the process of lumenogenesis. 
The ECM secreted by the fibroblasts in the co-culture tube formation assay acts as a 
scaffold for the endothelial cells and therefore plays a critical role in influencing the 
tubular morphology. Collagen I, IV and VI are key components of the basal lamina 
along with other matrix proteins including fibronectin, tenascin-C and decorin22. 
Endothelial cells use α1β3 integrin mediated signalling to adhere to collagen IV 
providing an anchoring mechanism to enable extension and elongation to form 
successful tubules. Collagen IV is a basolateral cell surface marker for the process of 
lumenogenesis. 
In this study, lumen formation was further investigated by staining for the presence 
and localisation of podocalyxin and collagen IV in endothelial tubules on the seventh, 
fourteenth and twenty-first day of co-culture in the co-culture tube formation assay, 
the corresponding images are shown in figure 3.8.  
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Figure 3.8 Lumen formation was confirmed within endothelial tubules by 
staining for apical and basolateral cell surface markers 
Endothelial tubules formed using the co-culture tube formation assay were stained on 
the seventh, fourteenth and twenty-first day of co-culture for the cell surface markers 
podocalyxin and collagen IV. Tubule formation was identified with collagen IV 
staining and lumen formation was identified with podocalyxin staining. The arrows in 
the podocalyxin images indicate which regions of the tubules formed lumens; a 
tubular lumen region was also outlined with a red box and shown at higher 
magnification. The higher magnification podocalyxin stained images shows the 
accumulation of podocalyxin expression on the apical tubular surface during tubular 
formation in the co-culture tube formation assay, scale: 50 µm.  
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Staining for podocalyxin and collagen IV in the investigation of lumen formation 
confirmed that both apical and basal cell surface markers were present on tubules 
from day seven through to twenty-one of co-culture. Collagen IV was imaged on the 
basal surface of the tubules, whereas podocalyxin was imaged on the apical 
surfaces. An advanced tubular network was observed on day twenty-one of co-
culture, which was evident due to the strong staining of collagen IV on the tubules. 
The images of the stained endothelial tubules also revealed that there was an 
increase in the level of apical podocalyxin expression on the tubules from day seven 
to fourteen of co-culture, as shown in the high magnification podocalyxin images in 
figure 3.8. There was a large increase in podocalyxin expression between day seven 
to fourteen, however the level of podocalyxin on day twenty-one appeared to be 
comparable to that of day fourteen. 
The confocal tubular images were quantified for tubule and lumen formation through 
the visualisation of collagen IV and podocalyxin, ten fields of view on days seven, 
fourteen and twenty one of co-culture were assessed. The quantification revealed 
that there was a 60.42% increase in tubule formation from day seven to twenty-one 
of co-culture, as the number of endothelial tubules on day seven was 29, on day 
fourteen was 26 and on day twenty-one was 48. The percentage of tubules 
containing lumens remained high for the duration of the assay with 75.86% tubular 
lumens present on day seven, 73.08% on day fourteen and 68.75% on day twenty-
one.  
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3.7. Expressing the lifeact peptide to outline developing lumens and 
visualise filopodia formation 
F-actin is recruited to the lumen by podocalyxin prior to lumen expansion in 
developing tubules23. Therefore, to visualise the organisation of the actin 
cytoskeleton in endothelial tubules undergoing lumen formation, endothelial cells that 
had been transduced to express the lifeact peptide fused to fluorescent proteins were 
used in the co-culture tube formation assay. 
Endothelial cells were transduced to express the pWPXL-lifeact-GFP or lifeact-RFP 
plasmids and were plated directly onto fibroblasts in the co-culture tube formation 
assay. Live-cell imaging to study the actin dynamics of the tubules was performed to 
visualise the organisation of the actin fibres within the endothelial tubules during co-
culture. 
The confocal image in figure 3.9A shows the actin organisation in an adhered 
endothelial cell; fibrous networks of F-actin fibres were distributed as a web 
throughout the cell and the presence of an actin rim was visualised at the plasma 
membrane which clearly outlined the cellular edges. Using endothelial cells which 
expressed the lifeact peptide conjugated to the fluorescent proteins GFP and RFP in 
the co-culture tube formation assay allowed excellent visualisation of the organisation 
of the actin fibres at the branching points of the tubules, shown in figure 3.9B and 
revealed the F-actin fibres present within the large numbers of filopodia on the 
surface of the tip and stalk cells, shown in figure 3.9C. The F-actin fibres were shown 
to be present in a structurally organised manner along the full length of the tubules 
with thicker actin fibres situated at the tubular edges.  
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Figure 3.9 Expression of the lifeact peptide conjugated to fluorescent proteins 
within endothelial cells enabled the organisation of the actin cytoskeleton to be 
visualised 
A) Confocal image of an endothelial cell which expressed the lifeact-GFP plasmid,   
B) Confocal images of endothelial tubules expressing the lifeact-GFP plasmid,        
C) lifeact-RFP plasmid. Imaging was performed on the sixth day of the co-culture 
tube formation assay, scale: 50 µm. 
Lifeact-GFP 
Lifeact-GFP 
Lifeact-RFP 
A 
B 
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Visualising the lifeact expressing endothelial tubules revealed that the F-actin fibres 
were situated around the endothelial lumens, the lumens predominantly formed 
within stalk cells of the tubules; however as shown in the examples in figures 3.10 
and 3.11, lumens were also observed within tip cells. Imaging the actin filaments 
within the tubule of figure 3.10 revealed that there was a large lumenal space in the 
centre of the tip cell which was close to a vesicle. The optical sections of the tubule 
showed the lumen undergoing expansion by the fusion of vacuoles indicated by the 
irregular shape of the lumen. The xyz planes in figures 3.10B and 3.10C were 
generated from transverse tubular sections and showed that both the developing 
lumen and nearby vacuole were surrounded by plasma membrane. Similarly, the 
developing lumen and nearby vacuole within the tip cell of the tubule, shown in figure 
3.11 were encapsulated by plasma membrane as shown by the xyz planes in figures 
3.11B and 3.11C.  
To further investigate tubular lumen formation, the image pixel intensity values were 
studied and provided further evidence and confirmation that lumens formed within the 
endothelial tubules. An optical slice of a lifeact-GFP expressing tubule shown in 
figure 3.11A was analysed using ImageJ for the greyscale pixel intensity values 
spanning across the tubule as indicated by the yellow line in figure 3.12A. A pixel 
intensity value of zero in the binary image indicated black in colour and signified the 
image background, whereas a value of 255 indicated a colour of white which signified 
the fluorescent tubular object in the image.  
The corresponding pixel intensity plot in figure 3.12A revealed that the lumenal space 
in the tubule correlated with a similar pixel intensity as the background. The lumenal 
area had a measured pixel intensity value of approximately 15-20. The pixel value of  
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Figure 3.10 Expressing lifeact in endothelial tubules allowed developing 
lumens and vacuoles to be visualised 
An endothelial tubule expressing lifeact-GFP was imaged on day six of co-culture. A) 
Optical sections of a lifeact-GFP expressing tubule were taken every 1 µm using 
confocal microscopy, B) at the position indicated from the red dotted line on the 
endothelial tubule image, xyz planes of the developing lumen and C) vacuole were 
generated showing that the lumen and vacuole were surrounded by plasma 
membrane, scale: 50 µm.   
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Figure 3.11 Use of lifeact in endothelial tubules allowed visualisation of lumens 
and filopodia extensions 
An endothelial tubule expressing lifeact-GFP was imaged on day six of co-culture. A) 
Optical sections of a lifeact-GFP expressing tubule were taken every 1 µm using 
confocal microscopy, B) at the position indicated from the red dotted line on the 
endothelial tubule image, xyz planes of the developing lumen and C) vacuole were 
generated showing that the lumen and vacuole were surrounded by plasma 
membrane, scale: 20 µm.  
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Figure 3.12 Lumen formation was confirmed by analysing the image pixel 
intensities and visualising 3D projections of endothelial tubules 
A) An optical section of a tubule was analysed for pixel intensities and the 
corresponding graph was plotted which was calculated based on pixel intensities 
along the yellow line, scale: 20 µm. B) Three dimensional projectional images of the 
compressed confocal optical sections of a lifeact-GFP expressing tubule which was 
rotated to observe the endothelial tubule from different angles. 
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the lumen was slightly higher than the image background intensity value of zero due 
to the presence of the endothelial tubular surface below the lumen as the tubule is 
three dimensional. The intensity plot also revealed that the diameter of the lumen 
was approximately 6 µm. The optical image sections of the tubule were compressed 
and three dimensional reconstructional images of the tubule were generated using 
ImageJ, some examples of the different angles of the projections are shown in figure 
3.12B. The three dimensional reconstructions enabled visualisation of the tubule and 
lumen from all different angles allowing the actin organisation and the structure of the 
tubule to be studied in detail. By selecting different slices to view in this way the 
lumen was clearly observed in the centre of the tubule which was surrounded by the 
endothelial tubular surface which had formed filopodia.  
Expressing the lifeact peptide to visualise the F-actin fibres also proved useful for 
studying the presence of filopodia along with studying lumen formation, comparable 
images visualising endothelial tubular filopodia formation could be achieved by 
staining the endothelial tubules for the expression of the endothelial specific 
glycoprotein CD31. The image in figure 3.13A showed that CD31 was localised on 
the surface of endothelial cells and showed increased expression at cell-cell contacts 
in adhered cells. Visualising the localisation of CD31 in the co-culture assay as 
shown in figure 3.13B revealed that the glycoprotein was expressed on the tip and 
stalk cells of the tubules and provided clear visualisation of endothelial filopodia 
formation. However, to visualise the localisation of this protein, the tubules must be 
fixed and stained therefore expressing the lifeact peptide had the advantage of live 
cell imaging and monitoring the formation of filopodia with the development of the 
tubules.  
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Figure 3.13 Filopodia were clearly observed on endothelial tubules by staining 
for the endothelial specific glycoprotein CD31 
A) Endothelial cells were plated directly onto coverslips and cultured to form a 
confluent monolayer of cells before immunofluorescence was performed to study the 
localisation of the endothelial glycoprotein CD31 (green) , shown to be expressed on 
the surface of the endothelial cells with increased expression at cell-cell contacts. 
Nuclei were stained with DAPI (blue), scale: 50 µm. B) Endothelial cells were 
cultured for seven days with human dermal fibroblasts in the co-culture tube 
formation assay before immunofluorescence was performed. Rhodamine labelled 
ulex (red) was used to selectively bind to endothelial glycoproteins and glycolipids 
allowing the endothelial cells to be clearly distinguished from the fibroblasts in the 
assay, scale: 50 µm. 
CD31 / DAPI CD31 / ULEX / DAPI A B 
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3.8. Visualising cellular interactions and lumen formation by using a 
mixture of lifeact-GFP and lifeact-RFP expressing cells  
Migrating cells extend filopodia to facilitate in directed movement; these long 
cytoplasmic projections not only sense the micro-environment for chemotropic cues 
but they also play a role in aiding cell-cell interactions. To visualise the structure of 
the actin cytoskeleton and the interactions between the endothelial cells during the 
formation of tubules, endothelial cells which expressed pWPXL-lifeact-GFP or lifeact-
RFP were mixed prior to plating on top of fibroblasts in the co-culture tube formation 
assay. 
The image in figure 3.14A shows endothelial tubules consisting of lifeact-GFP and 
lifeact-RFP expressing cells extending filopodia from the tip cells towards the other 
endothelial tubule in close proximity to participate in cellular interactions. Upon 
studying the two coloured optical section images in figure 3.14B it was apparent that 
the tubule was composed of lifeact-GFP and lifeact-RFP endothelial cells undergoing 
lumen formation. The lifeact-GFP cell in the tubule was surrounded by the lifeact-
RFP cells and there were two additional lumenal areas present in the lifeact-GFP 
cell, the lifeact-RFP cell appeared to be underneath the lifeact-GFP cell. The two 
colour fluorescence images of the endothelial tubules provided greater understanding 
of the development of the tubules in comparison to studying one colour images. To 
investigate if the developing lumen within the tubule was surrounded by plasma 
membrane, a transverse section of the tubule spanning the lumenal region was 
selected and a xyz plane was created. The xyz plane shown in figure 3.14C showed 
that the developing lumen was enclosed by plasma membrane.   
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Figure 3.14 Filopodia and developing lumens formed within endothelial tubules 
expressing lifeact-GFP and lifeact-RFP 
Endothelial cells expressing lifeact-GFP and lifeact-RFP were mixed prior to plating 
on top of fibroblasts in the co-culture tube formation assay, the F-actin organisation 
was imaged on the seventh day. A) Greyscale and coloured fluorescence image of 
filopodia extensions from lifeact-GFP and lifeact-RFP HUVECs in a tubule, B) 
Greyscale compressed confocal image of a lifeact-GFP and lifeact-RFP tubule, C) at 
the position indicated from the red dotted line on the endothelial tubule image, a xyz 
plane showed the developing lumen was surrounded by plasma membrane scale: 50 
µm. 
Lumen 
Filopodia Filopodia 
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Using confocal microscopy alongside the expression of the lifeact peptide conjugated 
to the two different fluorescent proteins GFP and RFP enabled the mechanism of 
lumenogenesis within endothelial tubules formed in this assay to be investigated. 
Endothelial tubules formed using either cells expressing lifeact-GFP, lifeact-RFP or a 
mixture of both cell types were imaged on the seventh day of co-culture and twenty 
five tubules per cell type were assessed and quantified for lumen formation. The 
endothelial tubules were imaged using one or two colour confocal microscopy 
dependent on if the tubules consisted of lifeact-GFP, lifeact-RFP or a mixture of the 
two endothelial cell types. The imaged tubules were assessed for the presence of 
lumen formation by converting the coloured fluorescence images to greyscale which 
enabled clear visualisation of the endothelial tubules and lumens. To further study 
lumenogenesis in endothelial tubules formed using a mixture of lifeact-GFP and 
lifeact-RFP expressing cells, the corresponding coloured fluorescence image was 
examined, which permitted greater understanding of how the endothelial cells were 
arranged within the tubules. There were morphological differences of the lumens 
formed using the two different mechanisms, as outlined in the example images in 
figure 3.15. As mentioned previously in section 3.4, the presence of a curved and 
elongated lumen between adjacent endothelial cells showed the endothelial cell 
rearrangement mechanism, whereas circular lumenal spaces showed the presence 
of vacuoles. The tubular images were manually assessed for the presence of lumen 
formation and the observed mechanism of lumenogenesis.  
Quantification of the tubular images revealed that lumenogenesis occurred within the 
tubules that were formed using lifeact-GFP, lifeact-RFP and a mixture of lifeact-GFP 
and lifeact-RFP expressing cells. The highest percentage of lumen formation  
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Figure 3.15 Example images of the endothelial lumenogenesis mechanisms 
observed in tubules which expressed the lifeact peptide conjugated to 
fluorescent proteins 
Example confocal images of endothelial tubules which produced lumens via the 
vacuole fusion and the endothelial cell rearrangement mechanisms. The endothelial 
tubules were produced using the co-culture tube formation assay using lifeact-GFP, 
lifeact-RFP and a mixture of lifeact-GFP and lifeact-RFP expressing endothelial cells 
and imaged on the seventh day of co-culture, scale: 20 μm. 
Lifeact-GFP Lifeact-GFP 
Lifeact-RFP Lifeact-RFP 
Lifeact-GFP / Lifeact-RFP Lifeact-GFP / Lifeact-RFP 
Vacuole fusion  
lumenogenesis mechanism 
Endothelial cell rearrangement 
lumenogenesis mechanism 
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Table 3.1 Quantification of the lumenogenesis mechanisms that were observed 
during endothelial tubule formation 
The quantification of lumen formation and the lumenogenesis mechanisms were 
determined by manually assessing tubular images generated from the co-culture 
tube formation assay. Twenty five images for each cell type used in the co-culture 
assay using either lifeact-GFP, lifeact-RFP or a mixture of lifeact-GFP and lifeact-
RFP expressing cells were analysed. The tubular images for each cell type used in 
the assay were taken from three different co-culture assays performed on different 
days and were pooled together to calculate percentage values of tubular lumen 
formation and the observed lumenogenesis mechanism. 
 
Lifeact-GFP 
expressing 
HUVECs 
Lifeact-RFP 
expressing 
HUVECs 
Lifeact-GFP and 
Lifeact-RFP 
expressing 
HUVECs 
Tubules without 
lumen formation 
10 13 12 
Tubules with lumen 
formation 
15 12 13 
Percentage of lumen 
formation 
60.00% 48.00% 52.00% 
Vacuole fusion 
lumenogenesis 
mechanism 
6 3 4 
Endothelial cell 
rearrangement 
lumenogenesis 
mechanism 
9 9 9 
Percentage of 
lumens formed via 
the vacuole fusion 
mechanism 
40.00% 25.00% 30.77% 
Percentage of 
lumens formed via 
the endothelial cell 
rearrangement 
mechanism 
60.00% 75.00% 69.23% 
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occurred in lifeact-GFP expressing tubules, 60.00% of these tubules formed lumens, 
followed by 52.00% for mixed lifeact-GFP and lifeact-RFP tubules and 48.00% for 
lifeact-RFP expressing tubules. Interestingly, both mechanisms of lumen formation 
were observed in tubules using all three cell types; however, as shown in table 3.1, a 
higher percentage of lifeact-GFP expressing tubules formed lumens via the vacuole 
fusion mechanism in comparison to the lifeact-RFP expressing tubules. Whereas, 
more lifeact-RFP expressing tubules formed lumens via the endothelial cell 
rearrangement mechanism compared to the lifeact-GFP expressing tubules. The 
endothelial tubules formed from a mixture of lifeact-GFP and lifeact-RFP expressing 
cells showed percentage values in between those of the individual lifeact-GFP and 
lifeact-RFP expressing tubules. Although overall assessment of the endothelial 
tubules formed using the expression of the lifeact plasmids showed that the 
endothelial cell rearrangement mechanism was the dominant mechanism by which 
lumens developed in tubules formed using the co-culture tube formation assay, with 
75.00% of lifeact-RFP tubular lumens formed using this mechanism, 69.23% of 
lifeact-GFP and lifeact-RFP tubules and 60.00% of lifeact-GFP tubules.  
3.9. Chapter discussion 
The results presented in this chapter confirmed that endothelial tubules formed using 
the co-culture tube formation assay develop lumens during co-culture with 
fibroblasts. In the co-culture tube formation assay, the elongation of the endothelial 
cells and subsequent growth of the tubules is highly dependent on the fibroblasts 
depositing extracellular matrix components, which acts as a suitable scaffold to 
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support the extension of the endothelial cells into tubular structures132. Importantly, 
the fibroblasts must secrete pro-angiogenic factors such as VEGF to promote 
endothelial migration and encourage tubule formation134,135. The fibroblasts secrete 
VEGF in response to being stimulated by bFGF, which was present in the bovine 
brain extract solution within the co-culture media; bFGF also stimulates the growth of 
the endothelial cells as well as the fibroblasts135.  
The fluorescent endothelial labelling techniques presented in this chapter, alongside 
confocal microscopy confirmed that lumens were formed in endothelial tubules 
generated using the co-culture tube formation assay, the techniques revealed clearly 
that lumen formation is initiated in both tip and stalk cells within tubules. The use of 
highly emissive fluorescent dyes and proteins to label the endothelial cells were 
essential for imaging the tubular structure and to distinguish between the endothelial 
cells and the fibroblasts in the co-cultures. Labelling of the endothelial cells prior to 
use in the assay with the cell proliferation dye CFSE achieved high levels of 
fluorescence emission from the cytoplasm of the endothelial tubules for the duration 
of the assay allowing the development of the tubules to be monitored effectively with 
confocal microscopy. CFSE was able to maintain a long cellular retention time due to 
becoming covalently bound to lysine residues inside the endothelial cells220. This 
method of CFSE labelling endothelial tubules was used in conjunction with the 
addition of dextran fluorescence dye into the co-culture media to confirm lumen 
formation via the vacuole fusion mechanism. Using a fluorescence tracer is a 
commonly used method to investigate lumen formation, Yang et al. studied lumen 
formation within endothelial cells on collagen gels by visualising the uptake of 6-
carboxyfluorescein into endothelial lumenal spaces35. Similarly Kamei et al. used 
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carboxyrhodamine and showed that the fluorescence dye was endocytosed in 
endothelial cells cultured in collagen matrices18. The results from this study showing 
the internalisation of dextran fluorescence dye in CFSE labelled tubules was 
consistent with that observed by others that pinocytosis is responsible for the uptake 
of the dye. To investigate this result further, the plasma membrane could be 
fluorescently labelled and visualisation of membrane invaginations at the tubular 
edges with subsequent vesicle and vacuole formation would further support this 
observation.  
The observation of tip cell lumens through imaging the organisation of the tubular 
actin cytoskeleton in this study showed that the process of lumenogenesis is not 
restricted to stalk cells in tubules that form in the co-culture tube formation assay. 
The main function of the tip cells is to sense the microenvironment to guide the 
direction of vascular growth, hence their presence at the front of the endothelial 
sprout, whereas stalk cells are located behind the tip cell to elongate the vessel 
through proliferation and participate in lumenogenesis15. The lumen would 
progressively increase in size as it expands and extend into tip cells; however the 
images in this study showed that lumens also initiate and develop in tip cells in 
tubules formed in the co-culture assay.  
The most useful technique for clearly visualising the presence and morphology of 
endothelial lumens formed in the co-culture tube formation assay was achieved by 
imaging the tubular actin cytoskeleton. Imaging the organisation of the actin 
cytoskeleton was achieved by expressing the lifeact peptide conjugated to the 
fluorescent proteins GFP and RFP alongside using confocal microscopy. It is known 
that F-actin is a major structural component of cells, required to generate mechanical 
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and tensile forces which co-ordinate cellular shape and motility87. The efficient 
function of the actin cytoskeleton is critical for the endothelial cells to undergo 
morphological changes and extend into the complex tubular structures. This new 
technique for imaging endothelial lumens was possible since the 17 amino acid 
lifeact peptide was able to bind to the actin fibres without compromising the formation 
of tubules95. Using this technique enabled excellent visualisation of the actin fibres in 
tip and stalk cells as well as enabling studies of the cytoskeletal organisation at the 
tubular branching points and of the filopodia extensions along the tubular surface. 
Actin fibres were present in filopodia on the surface of both tip and stalk cells, to play 
essential roles in cellular interactions and sensing the local environment for ephrins 
and semaphorins to direct tubular growth14. 
Interestingly, visualising the actin cytoskeleton using lifeact expression showed that 
there were thicker and presumably stronger cables of actin located around the 
developing lumen, revealing that the shape of the lumen appeared to be 
strengthened and supported by the actin cytoskeleton during expansion. Thicker 
actin fibres were also imaged at the tubular edges, which would act to distribute 
contractile forces throughout the endothelial cell to direct motility and extension into 
tubular morphologies. Since the actin fibres outlined the boundary of the lumenal 
spaces within the endothelial cells, it was possible to clearly observe the lumenal 
morphologies. Due to the morphological differences in the lumenal appearance 
developed by the two lumenogenesis mechanisms of lumen formation it was possible 
to visually assess and quantify the lumenogenesis mechanisms observed within the 
tubules.  
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Both the vacuole fusion and endothelial cell rearrangement mechanisms of 
lumenogenesis were visualised in the endothelial tubules and upon assessment of 
the tubular images it was revealed that endothelial lumens generated using the co-
culture tube formation assay formed predominantly from the endothelial cell 
rearrangement mechanism. However, 40.00% of lumens formed within lifeact-GFP 
tubules developed via the vacuole fusion mechanism, 25.00% in lifeact-RFP tubules 
and 30.77% in lifeact-GFP and lifeact-RFP tubules, although it is possible that the 
observed vacuoles were actin formations that would not contribute to the formation of 
a continuous lumen.  Imaging the vacuole fusion mechanism of lumenogenesis was 
not observed using the two colour fluorescence labelling of endothelial cells using 
CFSE and CellTracker orange cytoplasmic dyes. Therefore it could be possible that 
the binding of the lifeact peptide to the individual actin fibres could disrupt the 
dynamic nature of the F-actin fibres and induce cellular stress due to disrupted actin 
cytoskeletal function. Alternatively, the lifeact peptide may alter the mechanisms of 
actin polymerisation and/or branching, so as to influence the mechanism of vacuole 
formation. Furthermore, lentiviral transduction of endothelial cells to express the 
lifeact peptide conjugated to fluorescent proteins could have caused adverse cellular 
effects due to overexpression of the peptide. However, the absence of cellular 
blebbing which is also a visual indication of cellular stress would suggest that 
lumenogenesis via vacuole formation was not simply due to cellular stress. With the 
caveat that the lifeact peptide may affect lumen formation, these data indicate that 
imaging the organisation of the actin cytoskeleton enables better visualisation of the 
intracellular tubular structure compared with labelling the endothelial cytoplasm with 
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fluorescent dyes. Therefore, allowing the intracellular process of lumen formation to 
be studied in greater detail.  
To further investigate whether the process of lifeact binding to the actin fibres or 
transfecting the endothelial cells caused the formation of cellular vacuoles, 
fluorescently labelled phalloidin staining would be performed on the co-cultures and 
the tubular actin cytoskeleton would be imaged and studied for the formation of 
vacuoles. However, due to the presence of the fibroblasts in the co-culture it could be 
challenging to image the endothelial cytoskeleton this way.  
Further work to continue investigating lumen formation within endothelial tubules 
formed using the co-culture tube formation assay, would be to use live-cell time lapse 
confocal microscopy to image at high resolution the process of lumen development 
within endothelial tubules using the established fluorescent techniques presented in 
this chapter. Firstly, lifeact expressing endothelial cells would be used in the co-
culture assay and time lapse microscopy would permit real time visualisation of the 
process of lumenogenesis from the initial stages of tubule formation through to the 
establishment of a stable lumen that extends as an intracellular channel through 
many endothelial cells. Unfortunately, it was not possible to perform time-lapse 
imaging during this project as there was not a suitable microscope that could be used 
for this study. Performing time lapse imaging would provide valuable insights and aid 
the investigation into the mechanisms of lumen formation in endothelial tubules 
formed using this assay. There would however be challenging imaging requirements 
for this study as the same field of view would need to be imaged over the course of 
several weeks to study the development of the same endothelial tubules.  
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Chapter Four 
Designing, testing and 
evaluating a computer based 
method to analyse endothelial 
sprouting for screening 
purposes 
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4.1. Chapter summary 
The aim of this chapter was to design, test and evaluate a new computer based 
analysis tool for quantifying endothelial sprouting from fluorescently labelled 
spheroids generated using the in vitro hanging drop spheroid angiogenesis assay. To 
test the designed ImageJ Spheroid Analysis plugin, this analysis tool was applied to 
fluorescently labelled spheroid images which expressed a wide range of endothelial 
sprouting phenotypes. The different sprouting phenotypes were generated through a 
kinase inhibitor screen, in which a library of 80 small molecule kinase inhibitors were 
added into the assay and endothelial sprouting was quantified using the plugin. The 
resulting plugin outputs were evaluated and discussed, as well as compared to the 
manual process of measuring the total sprouting length of the spheroids.   
A further aim of this project which is presented in this chapter was to screen kinases 
to identify those which have roles in endothelial sprouting, migration and tube 
formation and this data has been presented in analysis heat map tables to enable 
easy identification of kinase inhibitors which affected these processes. 
The structure for this chapter is as follows: section 4.2 chapter introduction, section 
4.3 presents the computer based analysis tool designed to analyse endothelial 
sprouting, section 4.4 testing and evaluating the computer based analysis tool, 
section 4.5 screening kinases to identify those with roles in sprouting angiogenesis, 
section 4.6 applying the computer based analysis tool to spheroids treated with p-21 
activated kinase (PAK) inhibitors, section 4.7 applying the computer based analysis 
tool to spheroids treated with Bruton’s tyrosine kinase (BTK) inhibitors, section 4.8 
screening kinases to identify those with roles in endothelial migration and tube 
formation, section 4.9 chapter discussion.  
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4.2. Chapter introduction 
In vitro angiogenesis assays are widely used to understand the pathways and 
interactions involved in the formation of new blood vessels and determine the 
effectiveness of pro- or anti-angiogenic agents. Angiogenesis is a complex process 
and at present there is not an individual assay that encompasses all aspects of 
angiogenesis. In vitro angiogenesis assays generally focus on a particular cellular 
process involved in angiogenesis such as endothelial migration, proliferation or tube 
formation; therefore there is a vital requirement to use multiple assays when 
screening compounds to identify and determine which parts of the angiogenic 
process are affected.  
In the initial stages of angiogenesis, endothelial cells degrade the surrounding 
basement membrane and migrate towards an angiogenic stimulus; this process 
involves endothelial invasion, migration and proliferation which can be studied in 
detail using the in vitro hanging drop spheroid angiogenesis assay. In this assay, 
multicellular masses of endothelial cells are generated and embedded into an ECM 
component to produce a three dimensional model of angiogenesis110-113. To 
determine the effect of compounds or identify genes involved in endothelial sprouting 
the resulting lengths or numbers of the spouts can be quantified. In this chapter, the 
ImageJ Spheroid Analysis plugin was used to rapidly analyse these sprouting 
parameters automatically. 
There are many widely used in vitro angiogenesis assays that can be employed to 
study the migratory response of cells; one of these is the scratch wound 
angiogenesis assay in which an area of cells is removed from a confluent monolayer 
of endothelial cells101. Successive images can be taken to monitor the rate of scratch 
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closure through cell migration and the rate or percentage of closure can be 
calculated to determine the effects of angiogenic agents or to identify genes that 
regulate cell migration103,109.  
The final stages of angiogenesis involve cell differentiation and the formation of three 
dimensional tubular structures. The ability of endothelial cells to form these structures 
in the presence of angiogenic compounds can be tested using the matrigel tube 
formation angiogenesis assay128,129. The network of tubules can be easily quantified 
by measuring the number of complete loops formed within the endothelial network 
using an automated ImageJ plugin known as Angiogenesis Analyzer, which is widely 
and freely available and enables the effect of compounds on the angiogenic pathway 
to be easily assessed. 
4.3. Computer based analysis tool designed to analyse endothelial 
sprouting 
The hanging drop spheroid angiogenesis assay is an in vitro assay used to study the 
process of endothelial sprouting. Firstly in this study, time-course imaging was 
performed to monitor the development and formation of endothelial sprouts from the 
spheroids once embedded in type I collagen; this revealed that the multicellular 
spheroids rapidly initiated the process of sprouting angiogenesis. Extensive 
endothelial sprouting was visualised within two hours after the spheroid masses were 
embedded in collagen, as shown in figure 4.1. After the initial stage of extensive 
sprouting, endothelial cell remodelling was observed as shown in the images from 
5.5 hrs to 12.5 hrs after embedding, where many of the highly motile and dynamic 
endothelial cell sprouts underwent retraction whilst other sprouts extended.  
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Figure 4.1 A time lapse experiment demonstrating that endothelial sprouting is 
a dynamic process 
Phase contrast time-lapse images enabled visualisation of the process of endothelial 
sprouting from an endothelial cell spheroid formed using the hanging drop spheroid 
assay over a 27.5 hr time period, scale: 200 µm. 
 
2 hrs after embedding 5.5 hrs 
9 hrs 12.5 hrs 
16 hrs 
24 hrs 
19.5 hrs 
27.5 hrs 
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Imaging the spheroids 16 hrs after collagen embedding enabled visualisation of a 
stable network of endothelial sprouts formed from the spheroid mass as shown in 
figure 4.1. At this time point, the endothelial cells had formed elongated sprouts 
which connected to nearby sprouts through the formation of branching points. The 
time course study revealed that after 16 hrs, the tip cells started to migrate from the 
stalk cells from within the sprout, which destabilised the endothelial network and 
resulted in disconnected sprouts, an example image at 24 hrs has been shown in 
figure 4.2. Imaging the spheroids at later time points such as at 48 hrs showed that 
all of the tip cells as well as the stalk cells had migrated from the spheroid mass and 
as a result no endothelial sprouts were observed. In conclusion, time-lapse imaging 
of the process of endothelial sprouting revealed that 16 hrs after collagen embedding 
was a suitable time point for imaging the spheroids formed using the hanging drop 
spheroid angiogenesis assay. 
In addition, the images in figure 4.1 and 4.2 revealed the challenge of analysing 
endothelial sprouting from phase contrast or brightfield microscopy images, these 
imaging modalities do not allow for the spheroids to be imaged at high resolution. 
The hanging drop spheroid assay generates three dimensional cellular aggregates 
and endothelial sprouting occurs on all sides and from angles on the spherical 
surface. To improve imaging resolution and enhance the visualisation of the sprouts, 
the endothelial cells were fluorescently labelled with a highly emissive cytoplasmic 
dye CFSE prior to the formation of spheroids and were subsequently imaged by 
taking optical sections with confocal microscopy.  
 
119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 A stable endothelial sprouting network was observed sixteen hours 
after embedding the spheroids in collagen 
Brightfield light microscopy images of endothelial spheroids formed using the 
hanging drop spheroid angiogenesis assay at 16, 24 and 48 hours after being 
embedded in a collagen I matrix, scale: 200 µm. 
16 hrs  
24 hrs 
48 hrs 
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Initially I determined the analysis requirements and conceptual design of a computer 
based analysis tool that would automatically analyse endothelial sprouting from 
fluorescent spheroid images generated from the in vitro hanging drop spheroid 
angiogenesis assay. The computerised plugin was specifically designed to measure 
a range of sprouting parameters including the total length of the endothelial sprouts 
formed within the image, the number of endothelial sprouting segments that were 
produced, the number of endothelial junctions and the number of end points formed 
by the sprouts. The Java code for the Spheroid Analysis plugin was written by 
Christopher Meah (Physical Sciences of Imaging in the Biomedical Sciences Doctoral 
Training Centre, University of Birmingham) based on fluorescent spheroid images 
that exhibited a normal sprouting phenotype; an example image and the image 
processing steps of the plugin is shown in figure 4.3. One of the aims of this chapter 
was to test the capabilities of the plugin and determine if the computerised analysis 
tool was able to automatically process a wide range of sprouting phenotypes and to 
evaluate the outputs generated by the Spheroid Analysis plugin.  
Figure 4.3 shows the image processing steps performed automatically by the 
Spheroid Analysis plugin. Initially the compressed fluorescent confocal spheroid 
image was loaded into ImageJ where it underwent a series of processing steps. 
Firstly, the fluorescent spheroid image was automatically converted into a binary 
image, binarisation clearly identified the endothelial cellular objects within the image 
and they appeared white in the image, whereas the image background appeared 
black, as shown in step two of figure 4.3. A mask of the binarised image data was 
created which was a visual representation of the endothelial sprouting network. The 
spheroid mass was excluded from the analysis procedure as only the endothelial 
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sprouts were required for analysis, therefore the mask of the spheroid mass was 
excluded at this stage. The remaining mask of the endothelial sprouting network was 
then used to generate two images, one which showed which sprouts were connected 
to the spheroid mass, thereby showing which endothelial cells had elongated into 
sprouts and a separate image showing which sprouts were disconnected from the 
mass, revealing which cells had migrated away from the spheroid, as shown in 
images 4 and 5 of figure 4.3. The mask of the sprouting network including the 
connected and disconnected sprouts was skeletonised using the inbuilt Skeletonize 
(2D/3D) plugin, which eroded the edges of the mask in a series of iterations until all 
of the sprouts were one pixel in diameter. Each pixel within the skeletonised network 
was analysed using the inbuilt Analyze Skeleton plugin (2D/3D). Each pixel was 
analysed according to its neighbouring pixels and was assigned as either a segment, 
junction or end point pixel. A segment pixel was assigned if the pixel had exactly two 
neighbouring pixels within the skeleton, a junction if it had more than two 
neighbouring pixels or an end point if it had zero or one neighbouring pixel. An 
endothelial segment within the skeletonised network was defined as a connected 
region of segment pixels. At the ends of each endothelial segment there was either a 
junction or an end point pixel, therefore endothelial segments were separated by two 
end point pixels, two junctional pixels or one end point and one junctional pixel, see 
figure 7.1 in section 7.1 of the appendix for further information on these parameters.  
The resulting outputs of the analysis procedure by the ImageJ plugin were 
automatically produced in a single table upon completion of analysis. The table of 
analysis included quantification on the following parameters of the total number of 
sprouting segments, endothelial junctions, end points, total sprouting length and  
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Figure 4.3 The ImageJ Spheroid Analysis plugin can be used to analyse 
endothelial sprouting from fluorescent spheroid images 
A) The image processing steps performed by the ImageJ Spheroid Analysis plugin: 
1) Original fluorescent spheroid image, 2) Binarised spheroid image, 3) Mask of the 
endothelial sprouts excluding the spheroid mass, 4) Mask of the sprouts connected  
to the spheroid mass, 5) Mask of the sprouts disconnected  to the spheroid mass, 6) 
Skeletonised spheroid image, scale: 200 µm, B) An image of the analysed network of 
sprouts, the sprouting segments are shown in light blue, the endothelial junctions in 
dark blue, the end points in red, C) Sprouting distribution plot showing the 
fluorescence intensity of the pixels within the image against the distance from the 
spheroid mass. 
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average sprouting length in pixels. In addition to the table of outputs generated by the 
plugin, a final image was produced showing the analysed network overlaid on top of 
the original spheroid image, as shown in figure 4.3B. The sprouting segments were 
shown in the final image in a light blue colour, the pixels that were identified as 
junctions were shown in dark blue and the end point pixels were shown in red. The 
final overlaid image enabled clear visual identification of the endothelial cells that had 
been successfully analysed and allowed determination of how accurate the analysis 
process had been. 
The plugin also allows the user to modify the analysis procedure if required by 
enabling the exact diameter of the spheroid to be inputted prior to the analysis 
procedure. Furthermore, the Spheroid Analysis plugin was able to generate a 
fluorescence intensity profile for the spheroid image shown in figure 4.3C; this 
intensity profile was generated by calculating the number of high fluorescence 
intensity pixels from within concentric ring bands from the spheroid mass until the 
edges of the image were reached. In this way, the fluorescence intensity profile was 
able to give an indication of the spouting distribution in the image.  
4.4. Testing and evaluating the computer based analysis tool 
A library of 80 small molecule kinase inhibitors was used in the hanging drop 
spheroid assay to produce a range of endothelial sprouting phenotypes which could 
be used to test and evaluate the capabilities of the ImageJ Spheroid Analysis plugin. 
The plugin was applied to five fluorescent spheroid images per inhibitor treatment 
and due to the large number of inhibitor molecules used in the assay, the screen was 
performed in 8 batches and corresponding DMSO treated control spheroids were 
imaged for each batch. In this way, the Spheroid Analysis plugin was tested on 
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spheroid images which exhibited a wide range of spouting phenotypes including 
normal sprouting, hyper-sprouting, few sprouts and no sprouts, example images 
have been shown in figure 4.4.  
For the purpose of testing the Spheroid Analysis plugin, all 80 kinase inhibitor 
compounds were used at their selected concentrations, it was possible that some 
inhibitors would induce cytotoxic effects on the endothelial cells and as a result would 
produce few or no endothelial sprouts during the hanging drop spheroid assay. 
However, it was important to test that the plugin would be able to accurately analyse 
these sprouting phenotypes and therefore these compounds were included during 
the evaluation stages of the plugin. As outlined in section 4.8, a cell viability assay 
was performed on a monolayer of endothelial cells and those compounds which 
affected cellular viability were excluded from the scratch wound and matrigel assay 
screen. However, it should be noted that the cell viability assay was performed by 
adding the inhibitor compounds to a monolayer of endothelial cells which could have 
induced higher cytotoxic effects compared to those in the hanging drop spheroid 
assay, whereby the endothelial cells were surrounded and embedded in collagen. 
For example, D-erythro-sphingosine at 3 μM concentration induced hypersprouting in 
the spheroid assay while causing cytotoxicity in the endothelial monolayer at the 
same concentration. 
As shown in the analysed spheroid network images in figure 4.4, the ImageJ plugin 
was able to accurately identify the regions of endothelial spouts within the images. 
The Spheroid Analysis plugin was able to quantify all sprouting phenotypes including 
hyper-sprouting of spheroids, which was of particular interest as such images would  
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Figure 4.4 The Spheroid Analysis ImageJ plugin was capable of analysing a 
range of sprouting morphologies 
Examples of fluorescent spheroid images captured on a confocal microscopy and 
analysed using the ImageJ Spheroid Analysis plugin, The capabilities of the Spheroid 
Analysis ImageJ plugin to analyse endothelial sprouting was tested using fluorescent 
images with a range of different endothelial sprouting morphologies including:  A) no 
sprouts, B) few sprouts, C) many sprouts, scale: 200 µm. 
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be extremely difficult to analyse manually using the frequently used method of 
measuring the lengths of the endothelial sprouts. To determine and verify the 
accuracy of the results generated by the ImageJ plugin, 25 spheroid images were 
manually assessed for the total sprouting length and the number of sprouting 
junctions formed by the spheroids. To manually analyse the total sprouting length, 
the segmented line tool in ImageJ was used to measure the lengths of each 
individual endothelial sprout per spheroid and the total sprouting length was 
calculated using Microsoft Excel. This manual analysis process was able to calculate 
the total sprouting length per spheroid in approximately 3 minutes, although this 
depended on the number of sprouts within the image. To determine the number of 
endothelial junctions formed by the sprouts, the multi-point tool in ImageJ was used 
to count each endothelial junctional region within the image, this tool automatically 
numbered the selected points and the resulting output per spheroid could be 
generated in approximately 1 minute. 
This manual analysis procedure generated results on the parameters of total 
sprouting length and the number of endothelial junctions in approximately 4 minutes. 
In comparison, the ImageJ Spheroid Analysis plugin processed an image 
automatically within 36 seconds, generating quantification on a number of sprouting 
parameters including the number of endothelial sprouting segments, the number of 
sprouting end points and the average sprout length, in addition to producing a 
fluorescence intensity plot for the image.  
Twenty five spheroid images were analysed using the manual analysis procedure 
and the ImageJ plugin and the outputs from both methods were compared, the 
graphs showing the relationship between the two sets of results is shown in the plots  
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Figure 4.5 A linear relationship was calculated upon measuring the total 
sprouting length using the ImageJ plugin and manual analysis of spheroids  
Twenty five fluorescent spheroid images from the kinase screen were analysed for 
the total sprouting length and number of endothelial junctions formed in the images 
using a manual analysis approach and the computerised ImageJ Spheroid Analysis 
plugin. The correlations between the two data sets were determined by calculating an 
r2 value, whereby a result of 1.0 indicates an entirely linear relationship and 0.0 
indicates there is no linear relationship. 
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in figure 4.5. The r2 values for the parameters of total sprouting length and the 
number of endothelial junctions were calculated to determine if there was a linear 
relationship between the data generated by the two analysis methods. The plots in 
figure 4.5 showed that a linear relationship was determined for the total sprouting 
length, with an r2 value of 0.978, where a value of 1.0 indicates an entirely linear 
relationship. The high r2 value confirmed that the results generated by the ImageJ 
plugin for the total sprouting length were comparable to those generated by the 
manual analysis method. The plot showed that as the sprouting length increased; the 
manual analysis method calculated slightly smaller lengths than the ImageJ method; 
which was likely to have been due to the difficulty in manually analysing complex 
sprouting networks by individually outlining each endothelial sprout within the image.   
The graph for the number of endothelial junctions shown in figure 4.5 revealed that 
the manual analysis method consistently measured fewer numbers of junctions 
compared with the results generated by the ImageJ method; this relationship was 
confirmed with an r2 value of 0.727. The ImageJ plugin used a highly sensitive 
algorithm to assess each individual pixel within the image, in this way this method 
was able to identify single pixels as junctions; therefore junctional pixels which were 
very close to one another would have been classified as multiple junctional pixels by 
the ImageJ method, whereas the manual analysis approach would identify such 
regions as a single junction. The manual analysis method of counting the number of 
junctions became more challenging as the endothelial sprouting network became 
more elaborate. The higher level of detection achieved by the ImageJ plugin enabled 
the images to be studied in greater detail than by using the manual method.  
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In conclusion, it was found that the image outputs were generated 6.7 times faster by 
the ImageJ Spheroid Analysis plugin in comparison to the manual analysis method 
and that the results of the Spheroid Analysis plugin were comparable to the manual 
method for determining the total sprouting length. The ImageJ analysis method 
achieved a greater level of sensitivity and detection therefore higher numbers of 
junctions were also measured using the ImageJ plugin. Upon studying the images of 
the analysed sprouting network generated by the plugin, it was confirmed that the 
plugin results were accurate and that this automated analysis method could be used 
to rapidly quantify endothelial sprouting of fluorescently labelled spheroids.  
The ImageJ Spheroid Analysis plugin was able to record quantitative information on 
different endothelial sprouting parameters, which included the total and average 
sprouting lengths, the numbers of endothelial sprouting segments, junctions and end-
points. All of the parameters were measured independently; however the average 
sprouting length was derived from the measurements of the total sprouting length 
and the number of sprouting segments. To investigate how the generated outputs for 
each parameter measured by the plugin related to the other parameters and to 
identify any correlations between these measured parameters, the spheroid images 
from the kinase inhibitor screen were analysed using the Spheroid Analysis plugin 
and the Pearson product moment correlation coefficients (R) and p values from a 
Students t-test were calculated.   
The R and p values for the parameters have been shown in table 4.1; the results 
revealed that all of the correlations between each parameter were highly significant, 
with the highest correlation calculated between the number of sprouts and the 
number of end points with the highest R value of 0.983 and a p value of <1.0 x 10-30.  
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Table 4.1. Significant correlations were identified between the different 
parameters measured using the Spheroid Analysis plugin.  
The Pearson product moment correlation coefficient (R) values and p values from a 
Student’s t-test were calculated to determine correlations between the parameters of 
the number of sprouting segments, number of endothelial junctions, number of end 
points, total and average sprout lengths measured using the ImageJ Spheroid 
Analysis plugin. The correlation values were calculated using the mean values for the 
8 DMSO controls and 80 small molecule inhibitor compounds used in the hanging 
drop spheroid angiogenesis assay in the kinase screen.  
 
 R values 
 
 
P values 
Number of 
Sprouting 
Segments 
Number 
of 
Junctions 
Number 
of End 
Points 
Total 
Sprouting 
Length  
Average 
Sprouting 
Length  
Number of 
Sprouting 
Segments 
 
0.735 0.983 0.805 0.667 
Number of 
Junctions 
3.445 x 10-16 
 
0.830 0.945 0.839 
Number of 
End Points 
<1.0 x 10-30 1.581 x 10-23 
 
0.893 0.771 
Total 
Sprouting 
Length 
3.308 x 10-21 <1.0 x 10-30 <1.0 x 10-30 
 
0.942 
Average 
Sprouting  
Length  
1.277 x 10-12 1.702 x 10-24 1.641 x 10-18 <1.0 x 10-30 
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This high correlation was closely followed by the correlation between the total 
sprouting length and the number of endothelial junctions as well as the average 
sprouting length with an R value of 0.945 and 0.942 respectively and p values of <1.0 
x 10-30. These strong correlations suggested as expected that as the complexity of 
the endothelial sprouting network increased, a greater number of sprouts and sprout 
length, junctions and end points were detected. The lowest correlation was 
calculated between the number of sprouts and the average sprout length with an R 
value of 0.667 and p value of 1.277 x 10-12, this result was highly significant indicating 
that all parameters measured by the plugin would be useful and can be used to 
assess endothelial sprouting. Correlation graphs were plotted using the data 
generated by the ImageJ Spheroid Analysis plugin for the hanging drop spheroid 
images studying the effect of the different kinase inhibitors, to give a visual 
representation of the correlation between the different parameters measured within 
the images. The mean value for each inhibitor and control images were plotted to 
study each parameter individually against the other parameters. A line of best fit was 
plotted onto the graphs to give an indication of the degree of correlation between the 
two parameters. The correlation plots in figures 4.6 and 4.7 showed that a range of 
sprouting phenotypes were assessed using the plugin, however there were more 
images which expressed a low endothelial sprouting phenotype, this result was 
expected since kinases play essential roles in cellular processes such as 
proliferation, differentiation and migration therefore inhibiting them was likely to affect 
endothelial sprouting.  
Figure 4.6 showed the most significant correlations that were measured between the 
parameters, with the highest correlation observed between the number of sprouting  
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Figure 4.6 The highest correlation was calculated between the number of 
endothelial segments and end points 
Correlation graphs were plotted using the mean values generated by the ImageJ 
Spheroid Analysis plugin from the kinase screen; each point represents an inhibitor 
from the screen performed using the hanging drop spheroid angiogenesis assay. The 
Pearson product moment correlation coefficient (R) values and p values from a two 
tailed t-test were calculated and statistical differences have been shown **** 
indicates p ≤ 0.0001. 
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Figure 4.7 The smallest correlation was determined between the number of 
segments and the average sprout length 
Correlation graphs were plotted using the mean values generated by the ImageJ 
Spheroid Analysis plugin from the kinase screen; each point represents an inhibitor 
from the screen performed using the hanging drop spheroid angiogenesis assay. The 
Pearson product moment correlation coefficient (R) values and p values from a two 
tailed t-test were calculated and statistical differences have been shown **** 
indicates p ≤ 0.0001. 
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segments and the number of end points, these parameters directly correlated to each 
other until approximately 70 segments were measured, at higher numbers of 
segments there was greater variation in the numbers of end points detected. Strong 
correlations were also observed between the total sprouting length and the numbers 
of endothelial junctions, end points and average sprouting length which suggested 
that as the stalk cells elongated to expand the endothelial network, there was 
detection of the enhancement in the sprout lengths and connectivity of the sprouts.  
The smallest correlation between the parameters was calculated between the 
average sprout length and the number of segments, as shown in figure 4.7. A high 
degree of variability between these parameters was observed; however the general 
trend for this plot was that as increased numbers of endothelial segments were 
detected in the images, the average sprout length also increased. The strong 
correlation results identified in this study revealed that the parameters of total and 
average sprouting length, the numbers of segments, junctions and end points would 
all provide informative data on the sprouting phenotype formed by the spheroids 
generated in the hanging drop spheroid angiogenesis assay.  
4.5. Screening kinases to identify those with roles in sprouting 
angiogenesis 
Protein kinases play essential roles in the regulation, activation and localisation of 
many cellular proteins involved in signalling cascades through the action of adding a 
phosphate group on to target substrate proteins.  A library of small molecule kinase 
inhibitor compounds were added into the hanging drop spheroid angiogenesis assay 
to identify the effects the kinase inhibitors had on the processes on endothelial 
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sprouting. In this way, a wide range of spheroid images showing different sprouting 
phenotypes were generated and used to test the capabilities of the Spheroid Analysis 
plugin as previously described in section 4.4. Using this approach, the quantitative 
results generated by the Spheroid Analysis plugin on the total and average vessel 
length, the numbers of sprouting segments, junctions and end points could be used 
to identify important kinases with roles in angiogenic processes.   
Example images of the spheroids have been shown in figure 4.8 and revealed that 
the spheroids which formed in the presence of DMSO developed elongated 
endothelial sprouts with various junctions that lead to further connections with other 
sprouts.  In comparison, treatment with the various inhibitor compounds resulted in 
the formation of many spheroids with fewer or no endothelial sprouts produced from 
the spheroid mass, as previously outlined in the correlation graphs in figures 4.6 and 
4.7. Example images of the spheroids generated in this assay have been shown in 
figure 4.8, the addition of 14 μM LY 294002 which inhibited phosphoinositide 3-
kinase (PI3K) caused complete absence of endothelial sprouting, whereas the 
addition of 7 μM AG-494 or 30 μM RG-1462 through targeting epithelial growth factor 
receptor kinase (EGFR) reduced endothelial sprouting compared with the DMSO 
treated control.   
The ImageJ Spheroid Analysis plugin was used to analyse the effects of the inhibitor 
compounds on endothelial sprouting. Bar charts of the results generated on the 
parameters of total and average sprouting length and the numbers of segments, 
junctions and end points for eight inhibitor compounds are shown in figure 4.9, with 
the bar charts for all of the tested compounds shown in the appendix. The bar charts 
in figure 4.9 revealed that a similar and consistent pattern of results was observed  
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Figure 4.8 The hanging drop spheroid angiogenesis assay can be used to 
screen different inhibitors and determine their effects on sprouting 
angiogenesis 
HUVECs were labelled with 5 µM CFSE prior to use in the hanging drop spheroid 
angiogenesis assay, the spheroids were treated with different kinase inhibitors or 
DMSO as the control and confocal images were taken 16 hrs after embedding the 
spheroids in collagen, scale: 200 µm. 
DMSO Control 
Inhibitor: RG-1462 Inhibitor: AG-494 
Inhibitor: LY 294002  
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Figure 4.9 ImageJ Spheroid Analysis results for inhibiting kinases in the 
hanging drop spheroid angiogenesis assay 
The ImageJ Spheroid Analysis plugin was used to analyse fluorescent spheroid 
images generated by the hanging drop spheroid angiogenesis assay with confocal 
imaging 16 hrs after collagen embedding. The effect of adding the kinase inhibitors 
U-0126, SB-203580, staurosporine, AG-494, AG-825, H-7.2HCl, lavendustin A and 
RG-1462 on the total and average sprouting length, the number of sprouting 
segments, junctions and end points was determined.  Statistical analysis was 
performed using the Mann-Whitney test, n=5 spheroids, ** indicates p ≤ 0.01 and * 
indicates p ≤ 0.05. The error bars are the SEM. 
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between the different parameters measured from the fluorescent spheroid images for 
the various inhibitor compounds. Measuring the total sprouting length, average 
sprouting length and the number of junctions in the spheroid images caused the 
highest degree of difference between the control and inhibitor images, therefore 
allowing easy identification of the effect of the inhibitor on endothelial sprouting. 
Along with identifying a high degree of difference between the control and inhibitor 
images, measuring the total sprouting length would give a global understanding of 
the extent of endothelial sprouting. Whereas, measuring the number of junctions 
would provide informative information on the endothelial connectivity and complexity 
of the sprouting network that had developed. Therefore, these two parameters are 
the most useful parameters, determining the average sprouting length could also be 
considered, however this parameter was derived from the measurements of total 
sprouting length and the number of segments. 
Smaller differences between the control and inhibitor images were observed upon 
measuring the number of sprouting segments and the number of end points. 
Studying these parameters could provide additional information on sprouting 
morphology however migrated cells were often identified as small sprouting 
segments with several end points, therefore studying these parameters alone would 
not necessarily be informative on sprouting morphology, except for extreme sprouting 
phenotypes such as no sprouts or hyper-sprouting, where there are large and 
apparent differences in the number of segments or end points. 
To identify the kinase inhibitors which affected endothelial sprouting, a heat map 
table was generated shown in table 4.2, which enabled easy visualisation and 
determination of the effects on the different aspects of sprouting measured by the 
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plugin. The results in table 4.2 revealed that many of the inhibitor compounds 
reduced sprouting compared to the control spheroids, as indicated by the orange and 
red colours in the table. In general, if a reduced sprouting phenotype was observed 
due to the addition of a kinase inhibitor compound, the plugin generated results that 
indicated this phenotype in all of the sprouting parameters that were measured within 
the image.  
Interestingly, the heat map table identified two compounds which caused an increase 
in sprouting detected by three parameters which suggested hyper-sprouting of these 
spheroids. A significant increase in the connectivity of the endothelial sprouts was 
detected by measuring the number of junctions within these images for both of the 
compounds, as indicated by the dark green colour in the table. The first was a pan-
specific kinase inhibitor staurosporine; the plugin also identified increased numbers 
of segments and end points for the treatment with this compound. The second 
inhibitor was D-erythro-sphingosine which targeted protein kinase C (PKC), in 
addition to the increased number of endothelial junctions formed by the treatment of 
this molecule, enhanced numbers of end points and extended total sprouting length 
were measured, in comparison to the control images. As outlined by the previous 
results, measuring the number of end points within the spheroid images was useful 
for the identification of hyper-sprouting phenotypes.  
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Table 4.2 Heat map table showing the effect of kinase inhibitors on the process 
of sprouting angiogenesis 
The ImageJ Spheroid Analysis plugin was used to quantify the total and average 
sprouting length, numbers of segments, junctions and end points from spheroid 
images to study the effect of kinase inhibitors on endothelial sprouting. The hanging 
drop spheroid assay was performed with the addition of each inhibitor at a 
concentration value ten times its IC50 value. The IC50 values for all inhibitors can be 
found in table 2.4 on page 49. Five spheroids per inhibitor were analysed and 
normalised to the corresponding controls. Each percentage boundary was plotted in 
a different colour to reflect the result, red (0-40% of control), orange (41-80%), yellow 
(81-120%), light green (121-160%), dark green (161-200%). The compounds in grey 
were used at concentrations which did not pass the cell viability assay. 
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PD-98059 MEK 
   
  
U-0126 MEK 
   
  
SB-203580 P38 MAPK 
   
  
H-7·2HCl PKA, PKG, MLCK, PKC 
   
  
H-9·HCl PKA, PKG, MLCK, PKC 
   
  
Staurosporine Pan-specific 
   
  
AG-494 EGFR, PDGFR 
   
  
AG-825 HER1-2 
   
  
Lavendustin A EGFR 
   
  
RG-1462 EGFR 
   
  
TYRPHOSTIN 23 EGFR 
   
  
TYRPHOSTIN 25 EGFR 
   
  
TYRPHOSTIN 46 EGFR 
   
  
TYRPHOSTIN 47 EGFR 
   
  
TYRPHOSTIN 51 EGFR 
   
  
TYRPHOSTIN 1 Negative control 
   
  
  0-40% Highly below control 
  41-80% Below control 
  81-120% Similar to control 
  121-160% Above control 
  161-200% Highly above control 
 
141 
 
 
 
 
 
Compound 
 
 
 
 
Target S
e
g
m
e
n
ts
 
J
u
n
c
ti
o
n
s
 
E
n
d
 P
o
in
ts
 
T
S
L
 
A
S
L
 
TYRPHOSTIN AG 1288 Tyrosine kinases 
   
  
TYRPHOSTIN AG 1478 EGFR 
   
  
TYRPHOSTIN AG 1295 Tyrosine kinases 
   
  
TYRPHOSTIN 9 PDGFR 
   
  
Methyl-phosphonic acid IRK 
   
  
PKC-412 PKC 
   
  
Piceatannol Syk 
   
  
PP1 Src family 
   
  
AG-490 JAK-2 
   
  
AG-126 IRAK 
   
  
AG-370 PDGFR 
   
  
AG-879 NGFR 
   
  
LY 294002 PI 3-K 
   
  
Wortmannin PI 3-K 
   
  
GF 109203X PKC 
   
  
Hypericin PKC 
   
  
Ro 31-8220 mesylate PKC 
   
  
D-erythro-Sphingosine PKC 
   
  
H-89·2HCl PKA 
   
  
H-8 PKA, PKG 
   
  
HA-1004·2HCl PKA, PKG 
   
  
HA-1077·2HCl PKA, PKG 
   
  
Benzoic acid EGFR, CaMK II 
   
  
KN-62 caMK II 
   
  
KN-93 caMK II 
   
  
ML-7·HCl MLCK 
   
  
ML-9·HCl MLCK 
   
  
2-Aminopurine P58 PITSLRE β1 
   
  
N9-isopropyl-olomoucine CDK 
   
  
Olomoucine CDK 
   
  
Iso-olomoucine Negative control 
   
  
Roscovitine CDK 
   
  
5-Iodotubericidin 
ERK2, CK1/2, adenosine 
kinase 
   
  
LFM-A13 BTK 
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SB-202190 P38 MAPK 
   
  
PP2 Src family 
   
  
ZM 336372 cRAF 
   
  
SU 4312 Flk1 
   
  
AG-1296 PDGFR 
   
  
GW 5074 cRAF 
   
  
Palmitoyl-DL-carnitine PKC 
   
  
Rottlerin PKC delta 
   
  
Genistein Tyrosine kinases 
   
  
Daidzein Negative control 
   
  
Erbstatin analog EGFR 
   
  
Quercetin·2H2O PI 3-K 
   
  
SU1498 Flk1 
   
  
ZM 449829 JAK-3 
   
  
BAY 11-7082 IKK pathway 
   
  
Ribofuranosylbenzimidazole CK II 
   
  
Dimethanol dimethyl ether PKC α, γ 
   
  
SP 600125 JNK 
   
  
Indirubin GSK-3 β, CDK5 
   
  
Indirubin-3'-monooxime GSK-3 β 
   
  
Y-27632·2HCl ROCK 
   
  
Kenpaullone GSK-3 β 
   
  
Terreic acid BTK 
   
  
Triciribine Akt 
   
  
BML-257 Akt 
   
  
SC-514 KK2 
   
  
BML-259 Cdk5 
   
  
Apigenin CK-II 
   
  
BML-265 EGFR 
   
  
Rapamycin mTOR 
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4.6. Applying the computer based analysis tool to spheroids treated 
with p-21 activated kinase (PAK) inhibitors 
P-21 activated kinases (PAKs) consist of a six membered family of enzymes which 
have biological roles in controlling cellular movement and motility as well as 
regulating the organisation of the actin cytoskeleton222. To determine if PAKs have a 
role in sprouting angiogenesis, two PAK inhibitors PF-3758309 and IPA-3 were 
added into the culture media of the hanging drop spheroid angiogenesis assay and 
the spheroids were imaged 16 hours after collagen embedding. Endothelial sprouting 
was analysed using the ImageJ Spheroid Analysis plugin.  
The quantitative results generated by the Spheroid Analysis plugin revealed that the 
addition of 1.25 µM and 5.0 µM PF-3758309 into the spheroid assay caused a 
significant reduction in endothelial sprouting compared with the DMSO control 
treated spheroids, as shown in the spheroid images and bar charts of analysis in 
figure 4.10. A similar pattern of results was observed for the different sprouting 
parameters; the most significant reductions were detected in the numbers of 
junctions and the total length of the endothelial sprouts with treatment using PF-
3758309. PF-3758309 is a pan-specific inhibitor of PAKs and therefore inhibited all 
PAK isoforms.  The analysis results in figure 4.10 also showed that treatment with 
varying concentrations of IPA-3 resulted in comparable sprouting to the DMSO 
controls; since IPA-3 is highly specific for PAK1, this sprouting result revealed that 
PAK1 is not required to produce endothelial sprouts in this assay.  
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Figure 4.10 P-21 activated kinase (PAK) inhibitor PF-3758309 significantly 
reduced endothelial sprouting 
Fluorescent endothelial spheroids were formed using the hanging drop spheroid 
angiogenesis assay and treated with either DMSO or a PAK inhibitor. A) Confocal 
images of the spheroids 16 hrs after collagen embedding, scale: 200 µm, B) Analysis 
of the spheroid images performed using the Spheroid Analysis plugin. Statistical 
analysis was performed using the Mann-Whitney test, n=5 spheroids, ** indicates p ≤ 
0.01 and * indicates p ≤ 0.05. The error bars are the SEM. 
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4.7. Applying the computer based analysis tool to spheroids treated 
with Bruton’s tyrosine kinase (BTK) inhibitors 
Bruton’s tyrosine kinase (BTK) and bone marrow kinase in chromosome X (BMX) are 
members of the Tec family of non-receptor protein tyrosine kinases223. BTK plays 
crucial roles in many signal transduction cascades within B lineage lymphoid cells 
regulating cell survival, differentiation and adhesion224. Whereas, BMX is highly 
expressed in endothelial cells and it has been reported that in response to ischemia, 
BMX is activated by focal adhesion kinase (FAK) to induce angiogenesis by 
promoting cell migration and tube formation225. 
The BTK inhibitor ibrutinib also inhibits the related Tec family kinase BMX and it was 
of interest to determine how inhibition of BMX, affected sprouting in this cell type226. 
In addition, other BTK inhibitors LFM-A13 and AVL-292 which were also highly likely 
to inhibit BMX were tested in this assay. The inhibitor compounds were added to the 
hanging drop spheroid assay and endothelial sprouting was imaged 16 hrs after 
collagen embedding and analysed using the ImageJ Spheroid Analysis plugin.  
Ibrutinib inhibits BTK and BMX by binding covalently to its target kinase preventing 
the auto-phosphorylation event of the protein227,228. The addition of ibrutinib in the 
assay significantly reduced the numbers of endothelial sprouts, junctions and end 
points formed by the spheroids, however no statistical differences were found 
between the average and total lengths of the sprouts in comparison to the DMSO 
controls. Images of the spheroids which were treated with the BTK inhibitors are 
shown in figure 4.11.  
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AVL-292 is a highly selective inhibitor of BTK which like ibrutinib prevents BTK auto-
phosphorylation229. Figure 4.11 shows that AVL-292 treatment significantly affected 
endothelial sprouting with reduced numbers of endothelial sprouting segments, 
junctions, end points, average and total sprout lengths calculated.  
LFM-A13 binds to the BTK catalytic site therefore preventing activation of its 
downstream targets230. The addition of LFM-A13 also significantly reduced the 
numbers of junctions formed by the endothelial sprouts as well as the average and 
total sprout lengths as shown in the images and bar charts of analysis in figure 4.11.  
The quantitative analysis generated by the Spheroid Analysis plugin enabled the 
effect of the BTK inhibitors on the process of endothelial sprouting to be effectively 
studied using the different parameters. The addition of the inhibitor compounds into 
the assay caused a range of endothelial sprouting phenotypes due to the variations 
in specificity and selectivity of the compounds to their target protein. The inhibitor 
compounds had different modes of action and it is likely that other endothelial 
kinases would have been additionally inhibited with the use of these inhibitor 
compounds in the assay. Since it was determined that the inhibitor compounds 
affected endothelial sprouting, it was likely that these BTK inhibitors additionally 
target the endothelial expressed tyrosine kinase BMX. 
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Figure 4.11 Bruton’s tyrosine kinase (BTK) inhibitors significantly reduced 
endothelial sprouting  
Fluorescent spheroids were formed using the hanging drop spheroid angiogenesis 
assay. Spheroids were treated with either a BTK inhibitor: 5 nM ibrutinib, 50 nM AVL-
292, 25 µM LFM-A13, or DMSO control. A) Confocal images 16 hrs after collagen 
embedding, scale: 250 µm, B) Image analysis performed using the Spheroid Analysis 
plugin. Statistical analysis was performed using the Mann-Whitney test, n=5 
spheroids, ** indicates p ≤ 0.01,* indicates p ≤ 0.05. The error bars are the SEM. 
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4.8. Screening kinases to identify those with roles in endothelial 
migration and tube formation 
To determine whether the small molecule kinase inhibitor compounds differentially 
affected endothelial behaviour, the library of kinase inhibitors were added to the 
scratch wound angiogenesis assay and the matrigel tube formation assay, in addition 
to the hanging drop spheroid angiogenesis assay to identify the effects the kinase 
inhibitors had on the processes of endothelial cell migration and tube formation.  
For the assays, the inhibitor compounds were used at a concentration of ten times 
their IC50 values as described in chapter two section 2.4.1. Firstly, to determine the 
effect of the inhibitor concentrations on the viability of the endothelial cells, a cell 
viability assay involving the tetrazolium salt WST-1 was used to provide 
spectrophotometric quantification at 450 nm. The 80 small molecule inhibitor 
compounds were added to a monolayer of endothelial cells and the cell viability 
results revealed that the addition of 25 inhibitors at this concentration resulted in 
metabolically inactive endothelial cell populations, these inhibitors are identified by 
grey bars in figure 4.12. The addition of the inhibitor compounds that caused less 
than a 50% cell survival rate were excluded from the scratch wound and matrigel 
tube formation assays, this resulted in 55 inhibitor compounds that were used at their 
tested concentration for screening purposes within the assays and these inhibitors 
are shown as black bars in figure 4.12.  
The scratch wound migration assay was used to specifically identify kinases that had 
roles in cell motility and migration. The closure of the scratch was monitored and the 
percentage of closure at 12 hrs was calculated and normalised to the rate of scratch  
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Figure 4.12 Bar charts showing the effect of the inhibitor concentrations on cell 
viability 
HUVECs were cultured with the kinase inhibitors and cleavage of the tetrazolium salt 
WST-1 was measured by determining the light absorbance at 450 nm, n=4 
experiments, four absorbance measurements were taken for each inhibitor and the 
mean percentage of cell survival rate was calculated and plotted. The inhibitor 
compounds identified in grey caused cell death, whereas the inhibitors identified in 
black were used for screening purposes. 
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closure of the DMSO treated controls. The images in figure 4.13 showed that the 
DMSO control scratch had nearly closed 12 hrs after the scratch was made due to 
migration of the endothelial cells into the area of the scratch. In comparison, the rate 
of scratch wound closure was reduced in the presence of many of the inhibitor 
compounds including tyrphostin 46 which targeted and inhibited EGFR. As shown in 
figure 4.13, a scratch was still evident within the endothelial monolayer after 12 hrs; 
such result implied that endothelial migration was dependent on EGF signalling.   
Analysis of the scratch images to determine the percentage of scratch wound closure 
after 12 hrs revealed that 18 of the inhibitors caused significant reductions in the rate 
of scratch closure, shown in figure 4.14. Six of the inhibitors which reduced scratch 
closure targeted EGFR and three of the inhibitors inhibited PDGFR, both of these 
kinases are known to play vital roles in signalling cascades.  
Interestingly, the rate of scratch wound closure was significantly enhanced upon the 
addition of indirubin which targeted glycogen synthase kinase-3 (GSK-3)β and cyclin-
dependent kinase 5 (CDK5), this result was unexpected since treatment with 
indirubin has been shown to reduce tumour angiogenesis231. Zhang et al. showed 
that indirubin inhibited endothelial cell proliferation using an MTS proliferation assay 
and additionally induced cell apoptosis231. 
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Figure 4.13 The scratch wound angiogenesis assay was used to screen 
kinases for those with roles in cell migration 
The scratch wound assay was performed in the presence of kinase inhibitors or 
DMSO as the control; the images were taken 0, 6, 12 hrs after the scratch was made 
in a confluent monolayer of HUVECs and the rate of scratch wound closure was 
monitored to track cell migration, scale: 400 µm. 
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Figure 4.14 Analysis of the scratch wound angiogenesis assay identified that 
eighteen inhibitors significantly affected cell migration 
The percentage of scratch width closure at 12 hrs was calculated and normalised to 
the DMSO control, n=4 experiments and an average value for scratch closure was 
calculated. Statistical differences were determined using a Mann-Whitney test, *** 
indicated p ≤ 0.001, ** indicated p ≤ 0.01 and * indicated p ≤ 0.05. 
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The matrigel tube formation assay was used to specifically identify kinases that had 
roles in regulating endothelial tube formation. The numbers of endothelial loops 
formed by the tubular structures in the presence of the inhibitors was quantified and 
normalised to the number of loops formed by the endothelial cells in the presence of 
DMSO as the control. The example images in figure 4.15 show that a fully connected 
network of tubules formed in the presence of DMSO, whereas the treatment with the 
kinase inhibitors caused a range in the severity of defective tubular formation. The 
images in figure 4.15 showed that the addition of H-7·2HCl which inhibited  PKA, 
PKG, MLCK, PKC, tyrphostin 46 which inhibited EGFR and tyrphostin 9 which 
inhibited PDGFR all caused abnormal tubular growth.  
Upon analysis of the tubular images, 32 kinase inhibitors produced statistical 
differences between the numbers of loops formed by the endothelial cells compared 
to the number of loops formed in the presence of DMSO, as shown in figure 4.16. 
Ten of these inhibitors targeted EGFR which would indicate that EGFR was required 
for endothelial tubular formation as well as cell migration. Significant reductions were 
also observed upon the addition of inhibitors that targeted PDGFR. Interestingly, two 
inhibitor compounds Piceatannol and Y-27632.2HCl caused significant increases in 
the numbers of loops formed; these inhibitors targeted Syk and ROCK respectively.  
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Figure 4.15 The matrigel tube formation assay was used to screen kinases with 
roles in endothelial tubulogenesis 
The tube formation assay was carried out with the addition of the kinase inhibitors or 
the DMSO control and images of the tubular networks were taken after 12 hrs, scale: 
800 µm. 
 
DMSO Control Inhibitor:  H-7·2HCl 
Inhibitor: Tyrphostin 46 Inhibitor: Tyrphostin 9 
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Figure 4.16 Analysis of the matrigel tubular images confirmed that 28 inhibitors 
significantly affected endothelial tubulogenesis 
Image analysis was performed using the Angiogenesis Analyser ImageJ plugin, the 
number of tubular loops was calculated as a percentage and normalised to DMSO 
controls, n=4 images of tubule formation for each inhibitor.Statistical differences were 
determined using a Student’s t- test, where **** indicated p ≤ 0.0001, *** indicated p ≤ 
0.001, ** indicated p ≤ 0.01, * indicated p ≤ 0.05. Error bars represent the SEM.  
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The combined results from the hanging drop spheroid angiogenesis assay, the 
scratch wound assay and the matrigel tube formation assay used to assess the 
response to the addition of kinase inhibitors in the different assays modelling aspects 
of angiogenesis were normalised to their corresponding controls and percentage 
values were generated and displayed as a heat map in table 4.3. The total sprouting 
length was chosen to represent the data for endothelial sprouting as this parameter 
was able to give an understanding of how the overall sprouting network was affected 
by the addition of the inhibitor compound. The heat map table enabled easy 
visualisation and determination of the effects the kinase inhibitor compounds had on 
the processes of endothelial sprouting, migration and tube formation.  
The results in table 4.3 showed that there were 14 inhibitor compounds which 
reduced endothelial activity in all three assays compared to the controls, as shown by 
the orange and red colours in the table. Six of these compounds inhibited the action 
of EGFR which reduced cell migration, tube formation and endothelial sprouting; 
these inhibitors were AG-494, RG-1462, tyrphostin 25, tyrphostin 46, benzoic acid 
and erbstatin analog. Four inhibitors also reduced cell migration, tube formation and 
endothelial sprouting by targeting PDGFR and the addition of PKC-412 reduced 
endothelial activity most severely by inhibiting PKC as shown by the red boxes for all 
three assays. The only inhibitor which was identified to increase endothelial activity in 
more than one assay was H-8 which acted on PKA and PKG, the addition of H-8 
caused increased cell migration and tube formation but reduced endothelial sprouting 
length.  
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Table 4.3 Heat map table to show the screening results of the kinase inhibitors 
on endothelial migration, tube formation and sprouting.  
The combined data generated from the scratch wound assay (figure 4.14), the 
matrigel tube formation assay (figure 4.16) and the hanging drop spheroid assay 
(total sprouting length from table 4.2 and figure 7.2 found in the appendix) for each 
inhibitor was normalised to their corresponding control data sets and the percentage 
was plotted in a different colour to reflect the result, red (0-40% of control), orange 
(41-80%), yellow (81-120%), light green (121-160%), dark green (161-200%). Each 
inhibitor was used at a concentration of ten times their IC50 values and the IC50 
values for the inhibitors are stated in table 2.4 on page 49. 
 
 
  0-40% Highly below control 
  41-80% Below control 
  81-120% Similar to control 
  121-160% Above control 
  161-200% Highly above control 
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U-0126 MEK 
   SB-203580 P38 MAPK 
   H-7·2HCl PKA, PKG, MLCK, PKC 
   Staurosporine Pan-specific 
   AG-494 EGFR, PDGFR 
   AG-825 HER1-2 
   Lavendustin A EGFR 
   RG-1462 EGFR       
TYRPHOSTIN 25 EGFR       
TYRPHOSTIN 46 EGFR       
TYRPHOSTIN 47 EGFR       
TYRPHOSTIN 51 EGFR       
TYRPHOSTIN AG 1288 Tyrosine kinases       
TYRPHOSTIN AG 1478 EGFR       
TYRPHOSTIN AG 1295 Tyrosine kinases       
TYRPHOSTIN 9 PDGFR       
PKC-412 PKC       
Piceatannol Syk       
PP1 Src family       
AG-490 JAK-2       
AG-370 PDGFR       
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LY 294002 PI 3-K       
Wortmannin PI 3-K       
GF 109203X PKC       
Hypericin PKC       
Ro 31-8220 mesylate PKC       
H-89·2HCl PKA       
H-8 PKA, PKG       
Benzoic acid EGFR, CaMK II       
KN-62 caMK II       
KN-93 caMK II       
ML-7·HCl MLCK       
N9-isopropyl-olomoucine CDK       
Olomoucine CDK       
Iso-olomoucine Negative control       
Roscovitine CDK       
LFM-A13 BTK       
SB-202190 P38 MAPK       
PP2 Src family       
ZM 336372 cRAF       
SU 4312 Flk1       
AG-1296 PDGFR       
GW 5074 cRAF       
Erbstatin analog EGFR       
Quercetin·2H2O PI3-K       
SU1498 Flk1       
SP 600125 JNK       
Indirubin GSK-3 β, CDK5       
Indirubin-3'-monooxime GSK-3 β       
Y-27632·2HCl ROCK       
Kenpaullone GSK-3 β       
Triciribine Akt       
BML-259 Cdk5       
BML-265 EGFR       
Rapamycin mTOR       
159 
 
4.9. Chapter discussion 
One of the aims of this chapter was to test and evaluate a new ImageJ plugin which 
had been designed to analyse endothelial sprouting. The automated computer based 
analysis method was tested by applying the plugin to a range of fluorescently labelled 
sprouting images generated by using a large library of kinase inhibitors within the 
hanging drop spheroid angiogenesis assay. The results presented in this chapter 
showed that the plugin is a useful and valuable tool for analysing endothelial 
spheroid images generated from the spheroid assay. The results confirmed that the 
plugin was able to rapidly generate quantification on a number of sprouting 
parameters, generating results comparable and 6.7 times faster than the manual 
method for calculating the total sprouting length of spheroids. Importantly, the highly 
sensitive plugin was able to accurately analyse a large range of sprouting 
phenotypes including hyper-sprouting which would be highly challenging to analyse 
using the manual method of measuring the lengths of the sprouts.  
The brightfield and phase contrast microscopy images of the hanging drop spheroids 
outlined the problems faced when imaging and analysing the three dimensional 
structure of the sprouting spheroids. These imaging modalities did not allow for the 
spheroids to be imaged at high resolution as these techniques only capture one focal 
plane in a single image therefore many of the cellular sprouts appeared out of focus. 
The images presented the problem of incomplete object boundaries with minor 
distinctions observed between the image object of the endothelial cells and the 
image background of the collagen matrix. To improve the imaging resolution and to 
define the localisation of the endothelial cells in the sprouting process, the cells were 
fluorescently labelled with a high emission cytoplasmic dye CFSE prior to the 
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formation of spheroids. Confocal microscopy was used to generate optical sections 
of the sprouting spheroids which were compressed to generate a highly fluorescent, 
high resolution image of the spheroids which provided a clear distinction between the 
endothelial cells and background and as a result were easier to analyse.  
A widely used approach for analysing endothelial sprouting from spheroid images is 
to count the number or measure the lengths of the sprouts, often computer software 
such as DP-Soft Olympus or ImageJ can be used to aid this manual analysis 
method. The user of these software tools can measure along the lengths of each 
individual sprout and manually record the lengths to present an average or total 
sprout length per condition233. However, such methods can be labour intensive, time 
consuming and subjective.   
In this chapter, an ImageJ plugin known as Spheroid Analysis was used to analyse 
endothelial sprouting, this method of analysis enabled rapid and objective 
quantification of a number of different image parameters. Testing the plugin revealed 
that it was able to rapidly analyse a wide range of sprouting phenotypes including 
hyper-sprouting which would be problematic and time consuming to analyse 
manually. The plugin was able to analyse the images rapidly with quantitative outputs 
generated 6.7 times faster than the manual analysis method of measuring the total 
sprouting length. The plugin would be suitable for analysing both small and large 
imaging based studies such as for screening purposes as outlined in this study. The 
plugin effectively and efficiently analysed 440 spheroid images allowing the 
assessment and identification of kinases with roles in endothelial sprouting. As well 
as providing useful information on the average and total sprouting lengths, number of 
endothelial sprouts, junctions and end points, the plugin was able to give an 
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indication of the sprouting distribution represented in the image through the 
generation of a fluorescence intensity profile plot.  
The plugin relied on a highly fluorescent spheroid image; therefore spheroids were 
labelled with 5 μM CFSE to enable accurate analysis of endothelial sprouting. At 
present, the plugin requires a single coloured fluorescence image with one spheroid 
per image. Future advancements in the development of the plugin would include 
adaptations which would allow multiple spheroids per image to be analysed thus 
speeding up the imaging process and possibly providing a user selection tool which 
would allow the user to select which spheroids within the image to analyse. Further 
work would also include advancing to analysing two coloured fluorescence images, 
enabling the dynamics between tip and stalk cells to be studied and quantified. 
The ImageJ Spheroid Analysis plugin was used to rapidly analyse spheroids treated 
with a range of PAK and BTK inhibitors. PAKs consist of a six membered family of 
enzymes which have biological roles in controlling cellular movement and motility, as 
well as regulating the organisation of the actin cytoskeleton222. PAKs become 
activated from the binding of the Rho family of GTPases including Rac1 and 
Cdc42222,233,234. The pan specific inhibitor PF-3758309 targets group B 
serine/threonine kinase PAKs as well as also inhibiting group A PAKs, although PF-
3758309 is considerably less active against this PAK subfamily235. It was identified by 
Murray et al. that PF-3758309 acts through competitive binding of the ATP site within 
the PAKs catalytic domain to prohibit the phosphorylation event of a Rho-family 
guanine nucleotide exchange factor GEF-H1235. Therefore, it was unsurprising that 
the addition of PF-3758309 into the spheroid assay caused significant reductions in 
endothelial sprouting compared with the DMSO control treated spheroids. Deacon et 
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al. identified that the other PAK inhibitor IPA-3 to be a highly selective non-
competitive PAK1 inhibitor236. Treatment with different concentrations of IPA-3 
resulted in comparable sprouting to the DMSO controls, proving that PAKs targeted 
with PF-3758309 but not IPA-3 are important for endothelial sprouting.  
BTK and BMX are members of the Tec family of protein tyrosine kinases which play 
crucial roles in many signal transduction cascades within B lineage lymphocytes and 
bone marrow derived cell lineages regulating cell events such as survival, 
differentiation and adhesion224,228. BTK is not expressed in endothelial cells, however 
in this study it was shown that the action of the BTK inhibitors AVL-292 and LFM-A13 
affected the process of endothelial sprouting as identified by analysing the spheroid 
images using the Spheroid Analysis plugin. The mechanisms behind the action of the 
BTK inhibitors has been well characterised, many inhibitors prevent activation 
through prevention of an auto-phosphorylation event, targeting the tyrosine residue at 
position 551237. Ibrutinib inhibits both BTK and BMX by covalently binding to the 
target protein and all BTK inhibitors used in this study were known to prevent the 
auto-phosphorylation event of BTK227-230,238. It was likely that these inhibitor 
compounds were targeting BMX, a BTK related tyrosine kinase which is highly 
expressed in endothelial cells to reduce endothelial sprouting223. The results from the 
use of these inhibitors in the hanging drop spheroid assay therefore identified that 
BMX is required for endothelial sprouting.  
The kinase inhibitor compounds from the small molecule inhibitor library were used to 
target specific kinases within endothelial cells to determine the effects of inhibiting 
the action of these proteins on endothelial sprouting, migration and tube formation. 
However, it is highly likely that each kinase inhibitor compound inhibits other protein 
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kinases in addition to their presumed target protein kinases. Many small molecule 
inhibitors have broad specificity profiles and cause inhibition of more than one protein 
kinase, additionally the compounds do not always only target additional kinases 
which have closely related or highly similar primary structures43,44. Kinases play 
crucial roles in signal transduction pathways, therefore kinase inhibitor screens can 
be used as useful tools for identifying potential new roles or involvement of these 
proteins in cellular pathways. However, interpreting the results of kinase inhibitor 
screens should be approached with caution due to the low specificity these 
compounds have to their targets.  
A particular example of the broad specificity profiles exhibited by small molecule 
kinase inhibitors was outlined in this study; PDGFR is not expressed in endothelial 
cells however the treatment with four PDGFR kinase inhibitors into the hanging drop 
spheroid assay, the scratch wound assay and the tube formation assay caused 
significant reductions in endothelial activity in all three assays. PDGFR is activated 
through the binding of the PDGF ligand causing an auto-phosphorylation event of the 
receptor and upon activation PDGFR binds to Src homology 2 (SH2) domain 
containing proteins to participate in downstream signalling events50,56. Since PDGFR 
is not expressed in endothelial cells, it is likely that the inhibitor compounds used in 
the screen were targeting the structurally related endothelial expressed tyrosine 
kinase receptor VEGFR. Many commonly used therapeutic agents including 
sorafenib and sunitinib which are used primarily to target VEGFR to reduce vessel 
growth in vivo are known to additionally target PDGFR53,57-59. PDGF signalling is also 
often targeted therapeutically to prevent pathological angiogenesis since there is high 
expression of PDGFR in pericytes, therefore blocking this receptor tyrosine kinase 
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causes pericytes to detach from the vessels causing destabilisation of the 
vasculature45,60-62. 
The results of the kinase inhibitor screen identified six inhibitor compounds which 
targeted EGFR and significantly reduced endothelial migration in the scratch wound 
angiogenesis assay. Additionally, ten compounds reduced tube formation in the 
matrigel tube formation assay by targeting EGFR, whilst nine EGFR inhibitors 
reduced the total sprouting length of endothelial sprouts in the hanging drop spheroid 
assay. The identification of EGFR having an important role in endothelial migration, 
sprouting and tube formation was of interest since it has been reported that EGFR is 
not expressed in normal endothelial cells, even though there have been many reports 
that have stated that EGFR is highly expressed by tumour associated endothelial 
cells239. The overexpression of EGFR and its ligand EGF has been associated with 
many different types of cancers, therefore this type I receptor tyrosine kinase has 
been targeted by therapeutic agents known as EGFR tyrosine kinase inhibitors 
(TKIs), which prevents activation of the receptor and causes an  induced apoptosis of 
cancer cells240-244. Cancer cells secrete the EGFR ligand EGF in response to hypoxic 
conditions, subsequent binding of EGF to EGFR causes receptor dimerization 
followed by auto-phosphorylation and the recruitment of additional signalling and 
adaptor proteins which affect cellular migration, proliferation and differentiation as 
well as promote anti-apoptosis64,65,245. The results in this study suggest that EGFR 
could also be expressed by normal endothelial cells and acts through EGF signalling 
to regulate endothelial migration, sprouting and tube formation which are critical 
steps within the angiogenic pathway. 
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Inhibiting PKC using the inhibitors H-7.2HCl and PKC-412 also impaired cell 
migration, endothelial sprouting and tube formation. The different isoforms of PKC 
become activated through signalling of intracellular calcium ions, diacylglycerol 
(DAG) and phospholipids such as phosphatidylserine, this activation event causes 
PKC to modulate transcriptional events67. Additionally, GW 5074 reduced 
angiogenesis by targeting cRAF which is known to play a critical role in determining 
cell fate through association and regulation of the MAPK and ERK pathway246.  
Interestingly, treatment of staurosporine in the hanging drop spheroid assay caused 
an enhancement of the numbers of endothelial segments, junctions and end points 
formed by the spheroids but caused defective cell migration and tube formation. 
Staurosporine is a pan-kinase specific inhibitor which is a widely used apoptotic 
agent for numerous cell lines247. Kabir et al. showed that staurosporine acts to induce 
cell death in endothelial cells through dephosphorylation of FAK causing disassembly 
of focal adhesion complexes248. It is therefore possible that staurosporine caused 
defective cell migration due to the high dependency of the formation of focal 
adhesion complexes for cell motility.  
In conclusion, the kinase inhibitor screen was able to generate a range of endothelial 
sprouting phenotypes which proved useful for testing and evaluating the capabilities 
and outputs generated by the designed ImageJ Spheroid Analysis plugin. The 
ImageJ plugin can be applied to different morphological images of endothelial 
sprouting from fluorescently labelled spheroids generated using the in vitro hanging 
drop spheroid angiogenesis assay. As outlined in this chapter, the Spheroid Analysis 
plugin can rapidly and effectively generate quantitative results on many different 
sprouting parameters and is therefore suitable for large scale screening procedures 
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to identify compounds which affect the process of endothelial sprouting. Furthermore, 
the results in this chapter outlined the broad spectrum of activity exhibited by small 
molecule kinase inhibitors and that protein kinases particularly receptor tyrosine 
kinase activity was indispensable for effective endothelial migration, proliferation and 
tube formation. 
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Chapter Five 
Developing, testing and 
evaluating computer based 
analysis methods for quantifying 
the zebrafish vasculature 
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5.1. Chapter summary 
The aim of this chapter was to generate a computer based analysis method to 
quantify the development of the intersegmental blood vessels (ISVs) in embryonic 
fli1-GFP zebrafish. Two computer based analysis methods were developed using 
IMARIS and ImageJ software to provide quantification of the vasculature by 
specifically targeting the ISVs and their connectivity to the dorsal longitudinal 
anastomotic vessel (DLAV). The ImageJ analysis method was tested using normal 
and abnormal zebrafish vasculature images and compared to a frequently used 
manual analysis method. The advantages and disadvantages for both computer 
based analysis methods were considered and discussed and the results and findings 
of these methods are presented in this chapter.  
The structure for this chapter is as follows: section 5.2 chapter introduction, section 
5.3 presents the computer based analysis methods for analysing the zebrafish 
vasculature, section 5.4 imaging the effects of silencing vascular related genes, 
section 5.5 analysing and evaluating the effects of silencing vascular related genes, 
section 5.6 analysing the effects of inhibitor treatment on vascular development, 
section 5.7 evaluating the computer based analysis method, section 5.8 chapter 
discussion.  
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5.2. Chapter introduction 
The zebrafish (Danio rerio) is a widely used in vivo vertebrate model used to study 
blood vessel formation. Imaging the cardiovascular development in this organism 
allows the effects of silencing genes through morpholino oligonucleotide (MO) 
injection to be determined and novel compounds which act on the angiogenic 
pathway to be identified. However, at present there are limited computer based 
analysis tools which are easy to use and widely available that can be applied 
specifically to zebrafish images to provide rapid quantification of the growth and 
connectivity of the developed vasculature. 
Vascular analysis data presented in the literature frequently targets the development 
of the ISVs as these are the first angiogenic vessels to form in the zebrafish at 24 
hpf145. The extent of ISV disruption in response to anti-angiogenic factors such as 
inhibitor compounds or knocking down genes is frequently reported by manually 
classifying the appearance of the vasculature into categories such as ‘mild’, 
‘intermediate’ or ‘severe’ disruption164-167 or represented by a single calculation of the 
number of ISVs that have connected or remain disconnected to the DLAV in the trunk 
and tail regions of the zebrafish embryos168-176. These analysis methods may be 
performed manually or assisted using imaging or microscopy software, these 
methods give a global view and understanding of the developed vasculature, 
however apart from being labour intensive, they do not provide information on the 
lengths of the ISVs and in the case of the manual classification system it also does 
not specify vascular connectivity. In this chapter, two computer based analysis 
methods that were developed to quantify ISV growth and development will be 
presented, along with the findings of testing and evaluating the analysis methods. 
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5.3. Computer based analysis methods for analysing the zebrafish 
vasculature 
The ISVs are fully formed and connected to the DLAV at 48 hpf therefore the 
zebrafish vasculature is often imaged at this time point, when the effects of a gene 
knock down or the treatment with angiogenic compounds can be clearly visualised by 
studying the growth of the ISVs145. The aim of this study was to develop computer 
assisted approaches to enable easy and rapid quantification of these blood vessels. 
To achieve accurate analysis, there was a requirement for the vascular images to 
have a high fluorescence intensity particularly from the ISVs and DLAV in order to 
assess ISV connectivity; this was achieved by compressing confocal optical sections 
to produce a highly fluorescent vascular image. 
The first computer based approach was generated using ImageJ software, which is 
an open platform designed to analyse scientific images. The ImageJ analysis method 
consisted of a series of steps as outlined in figure 5.1. Firstly, the compressed 
vascular image was loaded into ImageJ, where the polygon selection tool was used 
to outline the DA at the positions where the ISVs sprout from during development. 
The line generated by the polygon selection tool was joined up around the base of 
the image to form a fully connected shape containing all of the vessels that were not 
required for the analysis process such as the DA and the PCV, shown in step 2 of 
figure 5.1. By clicking on the selected area with the black fill tool, these vessels were 
merged into the image background leaving the remaining vessels of the ISVs and 
DLAV within the image to be analysed. The vascular image was then binarised in 
step 4 to produce an 8-bit black and white image. The fill holes function shown in 
step 5 was used to remove loops formed by the DLAV as only the connectivity of the 
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ISVs was required for analysis. The despeckle function shown in step 6 was used to 
remove noise pixels which were acquired during the image acquisition process. The 
image was then skeletonised using the inbuilt Skeletonize 3D plugin, which eroded 
the vascular objects within the image iteratively until the vessels were visualised as a 
network structure 1 pixel in diameter, as shown in step 7. The skeletonised image 
was then analysed and quantified using the inbuilt ImageJ Analyze Skeleton (2D/3D) 
plugin. Each pixel from the skeletonised network was assessed according to its 
neighbouring pixels and assigned either as a segment, junction or end point pixel. A 
segment pixel was assigned if the pixel had exactly two neighbouring pixels in the 
skeleton, a junctional pixel was assigned if it had more than two neighbouring pixels 
and an end point pixel was assigned if it had zero or one neighbouring pixel. The 
vascular segments within the images were defined as a series of connected segment 
pixels which were separated either by two end point pixels, two junctional pixels or 
one end point and one junctional pixel, see figure 7.7 in section 7.3 of the appendix 
for further information on these parameters. The analysed image in step 8 of figure 
5.1 shows the analysed skeleton that was generated by the ImageJ analysis method, 
where orange pixels represented the outline of the vessels, pink pixels indicated the 
presence of vascular junctions and blue pixels showed the vascular end points. The 
area highlighted in the red box was enlarged to show the identification of individual 
pixels using this approach and an overlaid image of the original zebrafish vascular 
image and the skeletonised vascular network was generated to determine the 
accuracy of the analysis procedure, as shown in step 10 of figure 5.1. The steps of 
the ImageJ analysis method shown in figure 5.1 from binarisation through to 
generating the outputs of the analysed vascular skeleton (steps 4 - 8) were recorded 
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Figure 5.1 Steps of the ImageJ based approach to analyse vascular images of 
fli1-GFP zebrafish 
The ISVs and DLAV were analysed by 1) loading in the vascular image, 2) removing 
the PCV and DA using the polygon selection tool, 3) leaving the ISVs and DLAV, 4) 
binarisation created a black and white image, 5) the fill holes function removed small 
holes in the DLAV, 6) the despeckle function removed noise pixels, 7) the 
vasculature was skeletonised, 8) analysis of the skeletonised vasculature, 9) the 
region highlighted in the red box was enlarged to show the identification of individual 
pixels, 10) an overlaid image of a region of the original and skeletonised images to 
show the accuracy of the procedure, arrows show an end point and junctional pixel. 
Load in zebrafish vasculature image Use the polygon selection tool 
The ISVs and DLAV Binarised image 
Fill holes function Despeckled image 
Skeletonised image Analysed vasculature 
Highlighted skeletonised region Overlaid image 
1. 
3. 
5. 
4. 
6. 
7. 8. 
2. 
9. 10. 
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into an ImageJ macro known as the zebrafish vasculature analysis macro this 
enabled semi-automated analysis of the zebrafish vascular images and reduced the 
processing time. See section 7.4 in the appendix for the code of the recorded 
zebrafish vasculature analysis macro. One limitation of this analysis method was the 
requirement to transfer the image data files from ImageJ to Microsoft Excel to further 
process the data and select the desired parameters. For this study the total and 
average vessel lengths were calculated in Excel as well as the total numbers of 
vascular junctions and end points. The semi-automated ImageJ method of analysis 
relied on the inbuilt plugins Skeletonize 3D and Analyze Skeleton (2D/3D) but the 
method was able to rapidly analyse the vascular images and the outputs of the 
analysed skeleton data from a single image were produced within 35 seconds.   
The second analysis method was produced using the Filament Tracer module in 
IMARIS. In a similar way to the ImageJ method, a series of steps were produced to 
analyse the growth and connectivity of the ISVs, the series of steps has been shown 
in figure 5.2. Firstly the compressed zebrafish vascular image was loaded into 
IMARIS, where a three dimensional mask of the vasculature was generated using the 
surface function and selecting a threshold value shown in grey in step 2 of figure 5.2. 
The original vascular mask was created to provide a filtered version of the original 
image containing all of the vessels within the image; since the mask was used for all 
subsequent measurements of the vessels, therefore the mask must accurately 
represent the original vasculature. Once the mask had been created, it was possible 
to adapt the mask using the cutting tool by selecting the base of each ISV along the 
DA, in this way each ISV was disconnected from the DA, the red lines in step 4 
shows where the cutting tool was positioned. 
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Figure 5.2 Steps of the IMARIS approach to analyse fli1-GFP zebrafish vascular 
images 
The ISVs and DLAV were analysed by 1) loading in the vascular image, 2) a 3D 
mask of the vasculature was created in one vascular region, 3) the 3D mask was 
expanded to include all the vessels in the image and was rotated to allow clear 
visualisation and connectivity of the blood vessels, 4) the cutting tool was used to 
remove individual blood vessels from the image, 5) the PCV and DA was highlighted 
and removed, 6) leaving the ISVs and DLAV for analysis, 7) the remaining 
vasculature was skeletonised and analysed for a range of parameters including 
lengths, connectivity and end points, 8) the analysed skeleton was overlaid onto the 
original image to check the accuracy of the analysis procedure. 
Load in zebrafish vasculature image Create surface mask 
3D mask of vasculature 
Select unwanted vasculature ISVs and DLAV 
Cut vasculature mask 
Skeletonised image Overlaid image 
1. 2. 
3. 4. 
5. 6. 
7. 8. 
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The DA and PCV were then selected and removed from the mask, leaving a mask 
containing the ISVs and DLAV for analysis. One limitation of this method was the 
requirement to rotate the image between each cut that was applied to the mask to 
enable the cutting tool to work; this image manipulation procedure was time 
consuming as approximately 24 cuts were required per image. The mask of the ISVs 
and DLAV was skeletonised, which reduced the vessels to a 1 pixel diameter 
network which was then subsequently analysed. The analysis procedure for a single 
image took approximately 5 minutes for images with around 24 ISVs, the time was 
dependent on the number of vessels within the image and the user’s experience of 
the software. The IMARIS software presented the analysis data from the vascular 
skeleton as a table in the software window; this data table was exported to Microsoft 
Excel to calculate the total number of vessels, vascular junctions, end points and 
average and total vessel length. The skeletonised image was easily overlaid onto the 
original image to determine the accuracy of the skeletonisation step, shown in the 
final image of figure 5.2.  
To compare the zebrafish vasculature analysis data generated by the two computer 
based analysis methods using ImageJ and IMARIS, images of normal zebrafish 
vascular development were produced by carrying out time-course imaging of fli1-GFP 
zebrafish embryos from 24 – 72 hpf. Optical image sections were compressed to 
produce high resolution images of the blood vessels in the trunk and tail regions of 
the zebrafish and the images in figure 5.3 showed the rapid growth of the ISVs.  
At 24 hpf the endothelial cells of the ISVs were seen to sprout bilaterally from the DA 
with filopodia extending from the tip cells of the developing ISVs to direct vessel 
growth. From 26 hpf to 28 hpf the ISVs elongated and produced increasing numbers  
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Figure 5.3 Developmental time course images of the zebrafish vasculature 
Confocal microscopy images showing the development and connectivity of the ISVs 
with the DLAV in transgenic fli1-GFP zebrafish embryos from 24 hpf to 72 hpf. The 
ISVs sprout from the DA and fully connect with the DLAV at 48 hpf. Scale: 500 µm. 
24 hpf 
28 hpf 
30 hpf 
36 hpf 
72 hpf 
26 hpf 48 hpf 
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of filopodia as they extended and began to reach the neural tube. As the vessels 
approached the neural tube, they separated into rostral and caudal branches which 
interconnected to form the DLAV157. At 30 hpf and 36 hpf, the paired ISVs were 
clearly visible and the DLAV had almost fully formed. At 48 hpf, all of the ISVs were 
joined to the DLAV and the primary vessel network within the organism had been 
established. By 72 hpf, the entire zebrafish vascular network had fully formed to 
provide a functional circulatory system within the embryo that coincided with the 
straightening out of the tail157. 
The ImageJ and IMARIS methods were used to analyse the zebrafish vascular 
images at the following developmental time points: 24, 26, 28, 30, 36, 48 and 72 hpf; 
the number of blood vessel segments, vascular junctions, end points, total and 
average vessel lengths were measured in the images. The average values for each 
parameter and the standard error of the mean (SEM) at each time point were plotted 
and is shown in figure 5.4.  
Both the ImageJ and IMARIS analysis methods provided quantification of the 
vasculature, studying the parameters measured in the images showed that there was 
a general trend in the results which indicated the rapid development and formation of 
the vascular system between 24 hpf and 30 hpf. The line graphs in figure 5.4 showed 
a rapid increase in the numbers of vessel segments, junctions, end points and total 
vessel length between these time points. This result correlated accordingly with the 
overall development of the embryo which occurs most rapidly in the first few days 
after fertilisation. Generally, the rate of vascular growth decreased after 30 hpf which 
reflected the slower rate of development in the organism.  
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Figure 5.4 Line graphs of vascular analysis comparing the data generated by 
the ImageJ and IMARIS methods of analysis 
The developmental time-course images of the zebrafish vascular system were 
analysed using the ImageJ and IMARIS analysis methods, the parameters of the 
total and average vessel lengths, numbers of vessel segments, junctions and end 
points at each time point were plotted, n=10-14 images. Error bars represent the 
standard error of the mean (SEM). 
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The graphs for the number of vessel segments and the total and average vessel 
lengths showed that similar results were obtained using the two analysis methods; 
the average vessel length remained relatively constant over the course of 
development, between 30-40 µm. The average vessel length was derived from the 
parameters of total vessel length and the number of vessel segments and since both 
of the analysis methods calculated an increase in total vessel length and the number 
of segments over time, it was expected that the average vessel length would remain 
relatively constant. The IMARIS method measured slightly higher numbers of 
segments at 72 hpf compared to the ImageJ method, but at this time point the total 
vessel length measured from both methods was the same, therefore a slight 
reduction in the average vessel length was calculated for the IMARIS method at this 
time point.  
Similar numbers of vascular junctions were measured using the two analysis 
methods from 24 hpf to 36 hpf, however after 36 hpf the IMARIS analysis method 
continued to record increasing numbers of junctions, with a mean of 132 junctions 
calculated at 72 hpf compared with 74 junctions measured by the ImageJ method. 
The two analysis methods have different morphological post-processing steps which 
explain this difference; the ImageJ method used a fill holes function which is a 
closing operation to remove unwanted vessel loops formed in the DLAV and thereby 
reduced the numbers of junctions measured within the images after 36 hpf when 
these loops developed. The aim of the study was to specifically target the ISVs for 
analysis and measure the length of the ISVs and their connectivity to the DLAV; 
thereby the fill holes function removed the additional junctions formed by the DLAV 
which did not involve connectivity to the ISVs. The fill holes function could be omitted 
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from the analysis process if the DLAV complexity is of interest. The ImageJ method 
therefore continued to measure relatively constant numbers of junctions after 36 hpf, 
even though the complexity and connectivity of the DLAV became more elaborate. In 
the IMARIS method, the additional junctions and loops in the DLAV were included in 
the analysis as this software does not provide a function that performs this closing 
operation. Therefore, as the DLAV increased in complexity over time, an increased 
number of junctions within the vascular images was detected using the IMARIS 
method and this was reflected in the graph in figure 5.4. 
The results for the number of end-points measured using the two analysis methods 
differed although a similar pattern over time was observed. The ImageJ analysis 
method calculated higher numbers of end points at every time point with larger error 
bars, compared to the results of the IMARIS analysis method which detected smaller 
numbers with smaller error bars. An explanation for this difference was again due to 
the differences in the morphological post-processing steps of the two methods. The 
ImageJ method uses the despeckle function to remove any unwanted noise in the 
image, noise are errors in the image file acquired through image acquisition and 
these noise pixels must be removed to improve the accuracy of analysis. The 
despeckle function in ImageJ used a median filter to compare each pixel to its 
neighbouring nine pixels and reassigned noise pixels to the image background to 
excluded these pixels from the analysis procedure, however if any noise pixels, 
image artefacts or background fluorescence remained in the image they will be 
identified in this analysis method as end points. Furthermore, this process could have 
inadvertently eroded or replaced pixels in the vascular object in the image; therefore 
causing minor fragmentation of the vessels upon skeletonisation, introducing higher 
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numbers of end points upon analysis. The IMARIS analysis method relied on the 
formation of a vascular mask created from the connected vascular regions within the 
image, the subsequent measurements and quantification were performed using only 
the mask rather than the original image file, thereby bypassing the requirement to 
remove noise or artefacts from the image.   
To compare the outputs generated by the two analysis methods and determine if 
there was a linear relationship between the results generated by these methods, the 
measurements from each zebrafish image from the developmental time-course study 
were plotted on correlation graphs, shown in figure 5.5. The coefficient of 
determination values (r2 values) for the parameters of total vessel length, number of 
vessel segments, junctions and end points were also calculated to determine if there 
was a linear relationship between the data generated by the ImageJ and IMARIS 
analysis methods. The plot for the average vessel length was not included as this 
parameter was dependent on the total vessel length and the number of segments. An 
r2 value of 1.0 indicated an entirely linear relationship between the x and y co-
ordinates, whereas an r2 value of 0.0 indicated no linear relationship.  
The highest r2 value of 0.841 was calculated for the data generated on the parameter 
of total vessel length, this proved that similar and comparable results were obtained 
throughout zebrafish development using the two analysis methods. Measuring the 
number of vascular junctions within the images using the analysis methods 
generated an r2 value of 0.665, the graph in figure 5.5 showed a linear relationship for 
the smaller numbers of junctions measured however due to IMARIS measuring the 
additional junctions formed in the DLAV at time points after 36 hpf, this initial linear  
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Figure 5.5 Studying linear relationships between the outputs generated from 
the ImageJ and IMARIS analysis methods 
The measurements generated from the two analysis methods using ImageJ and 
IMARIS from each zebrafish vascular image from the developmental time course 
study were compared to identify linear relationships between the data sets. The 
outputs of the parameters for the total vessel length and the number of vessel 
segments, junctions and end points were studied. The r2 values were calculated to 
give an indication of the linear relationship between the two methods and the line of 
best fit was plotted. 
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relationship was lost and the graph showed that ImageJ did not measure more than 
90 junctions within the images, compared with 159 for IMARIS. An r2 value of 0.555 
was calculated for the number of vessel segments, with larger variations measured 
for the higher numbers of vessel segments within the images. The smallest r2 value of 
0.197 was calculated for the number of end points, proving that there was not a linear 
relationship between the data generated on this parameter using the two analysis 
methods, which was expected due to the previous results shown in figure 5.4. As 
previously discussed, ImageJ detected more end points within the vascular images at 
each time point compared with the IMARIS method and the graph in figure 5.5 
showed that the highest number of end points calculated by IMARIS was 209 and for 
ImageJ was 353. The differences in the number of end points calculated by the 
ImageJ and IMARIS methods were due to the differences in the morphological post-
processing operations of the two computer based analysis methods. 
The ImageJ analysis method would be freely and widely available to the scientific 
community as the ImageJ software is in the public domain and the macro would be 
easy to implement and use. Additionally, this computer based analysis approach was 
able to rapidly and effectively analyse the zebrafish vasculature, for these reasons 
this analysis method was chosen for subsequent testing and evaluation by 
quantifying abnormal vascular development.  
5.4. Imaging the effects of silencing vascular related genes 
To assess the capabilities of the ImageJ analysis method to quantify abnormal vessel 
development, images of abnormal vasculature development were obtained by 
knocking down known vascular related genes using antisense morpholino 
oligonucleotide (MO) injections at the one cell stage of development in fli1-GFP 
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embryos. Subsequent vessel formation was imaged at either 30 hpf or 48 hpf 
depending on the phenotype resulting from the morpholino knock down and the 
ImageJ analysis method was used to analyse the growth and connectivity of the ISVs 
to the DLAV. 
The vascular images of zebrafish embryos which had been injected with the gene 
targeting morpholino were compared with images obtained using a negative control 
mismatch morpholino. The control mismatch morpholino injected embryos showed 
normal vascular development, with most ISVs fully formed and connected to the 
DLAV at 30 hpf and all ISVs had fully connected to the DLAV at 48 hpf. 
The C-type lectin CLEC14A was knocked down and the development of the zebrafish 
vasculature was imaged at 30 hpf and 48 hpf using confocal microscopy, the images 
are shown in figure 5.6A. Upon CLEC14A knock down, abnormal vessel growth was 
observed with stunted ISV growth and no formation of the DLAV at 30 hpf, however 
observing vascular development at 48 hpf revealed normal vessel development with 
the ISVs fully formed and connected with the DLAV.  
Use of the ECSCR 5’ UTR and splice targeting morpholinos caused defective and 
truncated ISV growth and no DLAV formation at 30 hpf when this glycosylated 
transmembrane protein was knocked down, shown in figure 5.6B. The mismatch 
control morpholinos showed normal development of the vasculature with complete 
formation of the ISVs with connections to the DLAV.    
The knock down of the orphan adhesion G-protein coupled receptor ELTD1 shown in 
figure 5.7A and the predominant roundabout receptor that is expressed in the 
zebrafish vasculature ROBO4 caused defective growth of the ISVs when imaged at  
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Figure 5.6 Silencing CLEC14A and ECSCR caused defective ISV development 
at 30 hpf in fli1-GFP zebrafish 
Oligonucleotide morpholino injection performed at the one-cell stage of development 
in fli1-GFP zebrafish embryos silenced A) C-type lectin domain family 14 member a 
(CLEC14A) and the vasculature was imaged at 30 hpf and 48 hpf, B) Endothelial 
Cell-Specific Chemotaxis Regulator (ECSCR) using the translation-blocking (5’ UTR 
targeting) or splice-blocking morpholino and the vasculature was imaged at 30 hpf,  
scale: 500 µm. 
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48 hpf as shown in figure 5.7B. The ISVs had misdirected growth and were 
truncated; the DLAV remained underdeveloped and disconnected.  
VEGFA is a known potent regulator of angiogenesis and the different isoforms 
generated by alternative splicing regulates blood vessel development. The knock 
down of VEGFA in zebrafish embryos caused severe vascular defects, as shown in 
figure 5.7C. Upon silencing VEGFA, defective ISV sprouting from the DA was 
observed causing absent or severely truncated vessels with only the full length ISVs 
initiating the formation of the DLAV.  
It was also identified in this study that RCAN1.4, which is a variant of regulator of 
calcineurin 1 (RCAN) and upregulated in response to VEGF signalling196, was 
responsible for co-ordinating ISV formation in zebrafish embryos, as well as playing a 
global and essential role in the overall development of the organism. Silencing 
RCAN1.4 through morpholino injection caused disrupted vascular growth and the 
images in figure 5.7D showed that the RCAN1.4 targeted morpholino injected 
embryos remained curved around the yolk sac for a longer period of time before the 
straightening of the tail occurred in comparison to the control treated embryos. 
RCAN1.4 has been shown to be important in regulating endothelial migration and 
tube formation197, and this result revealed an additional role for RCAN1.4 in 
establishing normal vascular morphology during embryonic development of 
zebrafish.  
Members of the ETS-domain family of transcription factors play vital roles during the 
embryonic development of zebrafish, driving differentiation of angioblasts and 
enabling efficient vasculogenesis and angiogenesis249. Two of the transcription family  
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Figure 5.7 Knocking down ELTD1, ROBO4, VEGFA and RCAN disrupted ISV 
and DLAV growth in fli1-GFP zebrafish 
Morpholino injection at the one-cell stage of embryonic development in fli1-GFP 
zebrafish was performed to silence A) EGF, Latrophilin and Seven Transmembrane 
Domain containing 1 (ELTD1), B)  Roundabout 4 (ROBO4), C) Vascular Endothelial 
Growth Factor A (VEGFA), D) Regulator of calcineurin (RCAN), vascular imaging 
was performed at 48 hpf, scale: 500 µm.  
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Figure 5.8 Silencing the ETS transcription factor family member ETSRP caused 
defective and absent ISV growth in fli1-GFP zebrafish 
Fli1-GFP zebrafish embryos were injected at the one cell stage of development with 
oligonucleotide morpholino to knock down A) ETS Related Gene (ERG), B) ETS-1 
Related Protein (ETSRP), C) ERG and ETSRP, the vasculature was imaged at 48 
hpf, scale: 500 µm. 
ETSRP Morpholino ETSRP Mismatch  
ERG Morpholino ERG Mismatch  
ETSRP and ERG Mismatch  ETSRP and ERG Morpholino C 
B 
A 
189 
 
members ERG and ETSRP were silenced and the embryos were imaged at 48 hpf. 
Upon ERG knock down, the vasculature developed normally as shown in figure 5.8A, 
the ISVs grew bilaterally and connected to the DLAV. Upon silencing ETSRP as 
shown in figure 5.8B there was defective ISV growth with some vessels completely 
absent and the DLAV failed to fully develop. Ellett et al. reported a synergic functional 
interaction between ERG and ETSRP, and therefore a double knock down to silence 
both transcription factors in zebrafish should have further reduced ISV growth 
compared to silencing ETSRP alone168.  However, no further vascular disruption was 
observed within the embryos upon knocking down both ERG and ETSRP as shown 
in figure 5.8C.    
5.5. Analysing and evaluating the effects of silencing vascular related 
genes 
The vascular related genes of CLEC14, VEGFA, RCAN, ROBO4, ELTD1, ECSCR, 
ERG and ETSRP were knocked down in zebrafish embryos to cause a range of 
vascular abnormalities. To test the capabilities of the ImageJ analysis method to 
analyse a range of vascular morphologies, the vascular images from each gene 
silenced were analysed using the ImageJ analysis approach.  Quantitative data was 
collected on the vascular parameters of the number of vessel segments, junctions, 
end points and the average and total vessel lengths and statistical differences 
between the mismatch and morpholino injected embryo images were determined 
using the Mann-Whitney statistical test. The data generated from images captured at 
30 hpf are represented in bar charts shown in figure 5.9 and at 48 hpf in figures 5.10 
and 5.11. 
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Figure 5.9 Quantitative ImageJ analysis of vascular images studying the knock 
down of CLEC14A and ECSCR in fli1-GFP zebrafish at 30 hpf 
The vascular images of the mismatch (grey) and morpholino (black) injected fli1-GFP 
zebrafish targeting CLEC14A and ECSCR were analysed using the ImageJ analysis 
method and the data represented in bar charts. Significant differences were 
determined using a Mann-Whitney test, n=5-15, and error bars represent the SEM. 
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Figure 5.10 Quantitative ImageJ analysis of vascular images studying the effect 
of silencing vascular related genes on the number of vessel segments, 
junctions and end points at 48 hpf 
The vascular images of the mismatch (grey) and morpholino (black) injected fli1-GFP 
zebrafish targeting VEGFA, RCAN, ROBO4, ELTD1, ETSRP, ERG, ETSRP and 
ERG and CLEC14A were analysed using the ImageJ analysis method and the data 
represented in bar charts. Significant differences were determined using a Mann-
Whitney test, n=5-15, and error bars represent SEM. 
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Figure 5.11 Quantitative ImageJ analysis of vascular images studying the effect 
of silencing vascular related genes on the average and total vessel length at 48 
hpf 
The vascular images of the mismatch (grey) and morpholino (black) injected fli1-GFP 
zebrafish targeting VEGFA, RCAN, ROBO4, ELTD1, ETSRP, ERG, ETSRP and 
ERG and CLEC14A were analysed using the ImageJ analysis method and the data 
represented in bar charts. Significant differences were determined using a Mann-
Whitney test, n=5-15, and error bars represent the SEM. 
**** *** *** ** ** * *** 
**** **** *** ** * 
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The parameters measured in the vascular images using the ImageJ analysis 
approach were used to draw conclusions on the connectivity and the complexity of 
the vasculature formed. The bar charts in figure 5.9 showed that knocking down 
CLEC14 and ECSCR significantly reduced the connectivity of the vasculature and 
caused defective ISV growth compared to the mismatch control injected embryos at 
30 hpf. The data generated from the ImageJ method revealed that using either the 
splice or the translation blocking morpholino to silence ECSCR caused abnormal 
vessel growth to similar effect. Upon studying the knock down of VEGFA, RCAN, 
ROBO4, ELTD1, ETSRP, ERG, ETSRP and ERG and CLEC14, a range of vascular 
defects and abnormalities were imaged at 48 hpf. Quantitative analysis of the 
vasculature revealed that there were significant reductions in the average and total 
lengths of the vessels when the majority of the vascular related genes were knocked 
down, apart from when CLEC14 and ERG were silenced, which resulted in similar 
vessel lengths compared to their corresponding mismatch controls. The parameters 
that revealed the largest differences between the mismatch and morpholino images 
at 48 hpf were the number of junctions, average and total vessel lengths. The 
number of end points between the mismatch and morpholino images remained 
relatively constant at 48 hpf, possibly due to the morphological post-processing steps 
that lead to the fragmentation of the vessels and inclusion of noise or artefact pixels, 
however a significant reduction in the number of end points was measured when 
VEGFA was silenced as shown in figure 5.10. This result suggested that measuring 
the numbers of end points within vascular images using this method may only be 
informative when there is severe vascular disruption leading to the considerable 
absence of ISV formation.  
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Figure 5.12 Bar charts showing the severity of vascular disruption caused by 
silencing vascular related genes  
The parameters of the number of vessel segments, junctions and total vessel length 
were quantified by the ImageJ zebrafish vasculature analysis method. Fli1-GFP 
zebrafish embryos were injected with morpholino oligonucleotides to silence each 
vascular related gene and the developed vasculature was imaged at 48 hpf. The data 
generated for each gene was normalised to their corresponding control data sets to 
allow the severity of vascular disruption to be compared between the different 
silenced genes. Each bar is represented as a percentage of the control. 
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Figure 5.13 Similar patterns of results were obtained using the ImageJ and 
manual analysis methods 
Fli1-GFP zebrafish embryos were injected with morpholino oligonucleotides to 
silence each vascular related gene and the developed vasculature was imaged at 48 
hpf. The percentage of ISVs that connected to the DLAV in the vascular images of 
both the mismatch (grey) and morpholino (black) injected zebrafish were manually 
analysed and statistical differences were determined using a Mann-Whitney test, 
n=5-15, error bars represent the SEM. 
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The quantitative analysis of the vascular images also enabled a comparative study 
between the severities of vascular disruption caused by silencing the different genes; 
by normalising the data for each gene that was silenced and imaged at 48 hpf to their 
corresponding mismatch control data, the severity of the vascular disruption could be 
easily compared as shown in figure 5.12. The parameters that have been shown in 
figure 5.12 include the number of vessel segments and junctions as well as the total 
vessel lengths since these parameters were able to give a detailed understanding of 
the developed vascular morphology in the organisms, specifically identifying how 
many vessels developed, their connectivity and the extent of global vascular 
formation in the organism. The normalised graphs in figure 5.12 revealed that 
knocking down VEGFA caused the most severe disruption, followed by ROBO4 and 
ELTD1.  Knocking down ERG and CLEC14 at 48 hpf caused the vessels to develop 
with a similar morphology to their corresponding mismatch control embryos. 
To compare the results of the ImageJ analysis method against the frequently used 
analysis approach of manually counting the number of ISVs which connected to the 
DLAV, the vascular images were manually assessed for connectivity and the 
percentage of fully connected ISVs has been shown in figure 5.13. Comparing the 
severity of the vascular disruption between the different silenced genes using the 
manual analysis method revealed a similar pattern of results to the ImageJ analysis 
method, as shown by the bar charts in figures 5.12 and 5.13. The pattern of vascular 
disruption was studied as the total number of junctions measured by the ImageJ 
method was different to the number of connections counted manually. The ImageJ 
method measured an increased number of junctions in comparison to the manual 
method, as ISV outgrowths which formed in the mid region of the vessels during 
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vessel growth were automatically detected using ImageJ. The manual analysis 
method measured only the number of ISVs which formed connections with the DLAV.  
The manual analysis method revealed that knocking down VEGFA, RCAN, ROBO4, 
ELTD1, ETSRP, ETSRP & ERG and imaging at 48 hpf caused significant reductions 
in the number of ISVs which grew from the DA and connected to the DLAV. A 
comparable result was obtained in figure 5.10 which identified that significant 
reductions in the numbers of junctions were measured in the vascular images using 
the ImageJ analysis method, with the addition of CLEC14 which was also identified 
by this method as causing a reduction in junction formation.  
Both methods of analysis revealed that the three genes that caused severe vascular 
disruption when silenced were VEGFA, ROBO4 and ELTD1, with the ImageJ method 
identifying that silencing VEGFA caused the most severe disruption, whereas the 
manual method identified ROBO4. This difference was due to the different vascular 
phenotypes formed by knocking down these genes, silencing VEGFA lead to 
complete absence of ISV growth in some areas along the DA, however where the 
ISVs formed, they often connected to the DLAV. Whereas, in ROBO4 silenced 
embryos the ISVs developed through endothelial sprouting but failed to connect or 
form the DLAV, leading to reduced connectivity using the manual analysis method. 
The ImageJ and manual analysis methods also identified that the two genes that had 
comparable vascular phenotypes to their corresponding control treated embryos 
were ERG and CLEC14 upon imaging at 48 hpf.  
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5.6. Analysing the effects of inhibitor treatment on vascular 
development 
The ImageJ analysis method proved to be a useful tool for assessing the severity of 
vascular disruption in zebrafish when genes were silenced through MO injection; 
therefore the computerised approach was used to determine the effect of inhibitor 
concentrations on vascular development.  
Inhibitor compounds are commonly added to media surrounding zebrafish embryos 
during development to determine the effect of the compound on vasculature 
formation. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor which acts 
on many kinases including VEGFR1-3 and PDGFRα and β thereby inhibiting 
angiogenesis58,250,251. To study the effect of sunitinib on zebrafish vasculature 
development, 0.1 µM and 1.0 µM sunitinib treatment was given to developing 
zebrafish embryos at the one-cell stage. The images in figure 5.14A showed that 0.1 
µM sunitinib treatment caused no apparent vascular abnormalities compared with 
DMSO control treated embryos. However, severe vascular defects were observed 
upon 1.0 µM sunitinib treatment, the ISVs either failed to form or remained 
disconnected from the DLAV.  
The ImageJ analysis method was subsequently used to quantify vasculature 
development of sunitinib treated zebrafish embryos and revealed that the numbers of 
vessel segments, junctions, end points, average and total vessel lengths were all 
significantly reduced upon treatment with 1.0 µM sunitinib. The total vessel length 
formed by embryos treated with 0.1 µM sunitinib was also significantly reduced;  
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Figure 5.14 Sunitinib treatment disrupted ISV growth and DLAV connectivity 
Fli1-GFP zebrafish were treated with 0.1 µM, 1.0 µM sunitinib treatment or DMSO in 
E3 media and imaged at 48 hpf. A) Vascular images of the DMSO or sunitinib treated 
embryos, scale: 500 µm, B) ImageJ analysis of the vascular images, statistical 
differences were determined using a Mann-Whitney test, n=10. The error bars 
represent the SEM.  
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Figure 5.15 Ibrutinib treatment inhibited ISV formation in fli1-GFP zebrafish 
Fli1-GFP embryos at the one cell stage of development were treated with 10 nM, 100 
nM, 5 µM, 10 µM , 12.5 µM or 15 µM ibrutinib or 15 µM DMSO in E3 media,  the 
developing vasculature was imaged at 48 hpf, scale: 500 µm.  
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Figure 5.16 Ibrutinib treatment significantly reduced vessel growth and 
connectivity in fli1-GFP zebrafish embryos 
Vascular images of embryos treated with 10 nM, 100 nM, 5 µM, 10 µM , 12.5 µM or 
15 µM ibrutinib or 15 µM DMSO in E3 media were analysed using the analysis 
method and statistical differences were found using a Student’s t test, n=3-4. Error 
bars represent the SEM. 
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however the numbers of vessel segments, junctions, end points and average vessel 
length remained comparable to the control treated embryos.  
Another inhibitor that was used was ibrutinib which inhibits both BTK and BMX, to 
determine the ibrutinib concentration that affects vascular development in zebrafish, 
embryos were treated with a range of ibrutinib concentrations from 10 nM to 15 µM 
and the vasculature was imaged at 48 hpf as shown in figure 5.15. Vascular 
abnormalities were observed in zebrafish embryos treated with concentrations above 
5 µM ibrutinib, these concentrations caused stunted and absent ISV sprouting as 
shown in figure 5.15. The DLAV failed to develop in embryos treated with 12.5 µM 
and 15 µM ibrutinib, the quantitative analysis of the vascular images using the 
ImageJ analysis method confirmed that embryos treated with 12.5 µM and 15 µM 
ibrutinib caused significant vascular defects shown in figure 5.16. A significant 
reduction in the number of vessel segments, junctions and total vessel length was 
calculated at these concentrations of ibrutinib treatment. The ImageJ analysis 
method enabled a comparative study between the different inhibitor treatments and 
provided quantitative analysis on the effects of using different concentrations of 
inhibitor compounds on vascular development. 
5.7. Evaluating the computer based analysis method 
The vascular images from the developmental time-course, gene knock down and 
inhibitor studies were analysed using the ImageJ analysis method, the average 
values for each developmental time point, gene silenced and each inhibitor 
concentration were determined. Using the combined data sets, the Pearson product 
moment correlation coefficient (R) and p values from a Student’s t-test were 
calculated to study correlations between the parameters measured from the vascular  
DMSO Control  
1 uM Sunitinib 
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Table 5.1. Significant correlations were identified between the different 
parameters measured using the ImageJ analysis method.  
The Pearson product moment correlation coefficient (R) values and p values from a 
Student’s t-test were calculated to determine correlations between the parameters of 
the number of segments, number of junctions, number of end points, total and 
average vessel lengths measured using the ImageJ analysis method. The correlation 
values were calculated using the combined mean data sets from the time course 
developmental data, the inhibitor data and the gene knock down data.  
 
 R values 
 
 
P values 
Number 
of 
Segments 
Number 
of 
Junctions 
Number 
of End 
Points 
Total 
Vessel 
Length 
(pixels) 
Average 
Vessel 
Length 
(pixels) 
Number of 
Segments 
 
0.899 0.726 0.879 0.533 
Number of 
Junctions 4.475 x 10-10 
 
0.552 0.970 0.716 
Number of End 
Points 2.739 x 10-5 0.003 
 
0.570 0.089 
Total Vessel 
Length (pixels) 3.436 x 10-6 3.268 x 10-16 0.002 
 
0.807 
Average Vessel 
Length (pixels) 0.005 3.891 x 10-5 0.664 6.178 x 10-7 
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images which included the number of vessel segments, junctions, end points, 
average and total vessel lengths. 
The R and p values are shown in table 5.1; the highest correlation was calculated 
between the total vessel length and the number of junctions, as indicated by the 
smallest p value of 3.268 x 10-16 and an R value close to 1.0 of 0.970. Strong 
correlations were also calculated between the number of segments and the number 
of junctions with a p value of 4.475 x 10-10 and an R value of 0.899, as well as 
between the total vessel length and the number of segments with a p value of 3.436 
x 10-6 and R value of 0.879. These strong correlations suggested accordingly that as 
the zebrafish vasculature developed, the length and the number of junctions formed 
by the vessels increased which reflected the complexity and connectivity of the 
vessels. The smallest correlations were calculated between the number of end points 
measured in the images and the other parameters, the highest p value of 0.664 and 
the lowest R value of 0.089 was calculated between the number of end points and 
the average vessel length. Considering the previous results in section 5.5 which 
outlined that the number of end points measured in the vascular images were 
comparatively similar between the mismatch and morpholino images for different 
genes that were silenced; this correlation result was unsurprising and suggested that 
measuring the number of end points within vascular images did not provide useful 
morphological information on the developed vascular network.   
Correlation graphs were plotted using the data generated by the ImageJ analysis 
method for the developmental time course, gene knock down and inhibitor images to 
give a visual representation of the correlation between the different vascular 
parameters measured within the images, as shown in figures 5.17 and 5.18. Each  
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Figure 5.17 The strongest correlation was identified between the parameters of 
total vessel length and the number of junctions 
Correlation graphs were plotted using the combined mean data sets from the ImageJ 
based analysis using the time course developmental data, the morpholino and 
inhibitor data and the inhibitor data. The Pearson Product Moment Correlation 
Coefficient (R) values and p values from a two tailed t-test were calculated and 
statistical differences have been shown **** indicates p ≤ 0.0001.  
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Figure 5.18 Measuring the number of end points revealed a high degree of 
variation in the vascular images 
Correlation graphs were plotted using the combined mean data sets from the ImageJ 
based analysis using the time course developmental data, the morpholino and 
inhibitor data and the inhibitor data. The Pearson product moment correlation 
coefficient (R) values and p values from a two tailed t-test were calculated and 
statistical differences have been shown ** indicates p ≤ 0.01, * p ≤ 0.05, ns p > 0.05. 
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parameter was studied individually against the other parameters and the line of best 
fit was plotted to give an indication of the degree of correlation between the two 
parameters.  
The plots in figure 5.17 showed extremely significant correlations between the 
parameters with p values less than 0.0001. The graphs confirmed that as the 
vasculature developed in complexity and connectivity, an increased number of 
vessels and junctions were detected along with measuring longer vessel lengths 
confirming that the analysis results reflected accordingly with the development of the 
organism. The strong correlation results identified that these parameters of the total 
vessel length, the number of vascular junctions and the number of vessel segments 
would be informative when assessing zebrafish vascular morphology. The average 
vessel length could also be considered for use in morphological studies however due 
to this parameter being calculated through the dependence of the total vessel length 
and the number of segments, the trend for this parameter would be observed through 
the existing results.   
The plots in figure 5.18 showed there were large variations in the number of end 
points measured in the vascular images. No statistical significance was found 
between the number of end points and the average vessel lengths. These results 
suggested that measuring the number of end points should not be used to draw 
conclusions on the vessel morphology as measuring this parameter did not give a 
valid indication of the complexity of the developed vasculature.  
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5.8. Chapter discussion 
The aim of this chapter was to develop and evaluate an alternative computer based 
method that could be applied to fluorescent zebrafish images to generate 
quantification and analysis of vascular development. This aim was achieved by 
generating two analysis methods using ImageJ and IMARIS software which targeted 
the ISVs for quantitative analysis of their numbers, lengths and connectivity to the 
DLAV. The ISVs were specifically targeted since they are the first angiogenic vessels 
to form in the zebrafish145. Both analysis methods can be used and applied to 
fluorescent vascular images to provide useful information on vessel morphology of 
both normal and abnormal vessel development in response to silencing vascular 
related genes or assessing the effect of angiogenic agents.  
The computer based analysis methods were able to quantify the developing 
zebrafish vasculature by measuring the parameters of the total and average vessel 
lengths, the number of vessel segments, vascular junctions and end points formed 
within fluorescent zebrafish images. The two methods of analysis used different 
morphological post-processing steps and therefore each method offered unique 
advantages when compared.  
The IMARIS analysis method required the production of a three dimensional vascular 
mask which allowed the vessels to be viewed at 360o, therefore this approach gave 
an excellent visual understanding of vessel connectivity. The creation of this mask by 
manually defining a threshold value must accurately represent the imaged 
vasculature as the original image file has to be discarded for analysis; however the 
mask production had the advantage of being able to exclude noise pixels or image 
artefacts. An additional limitation of this analysis method was the requirement to 
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detach each ISV which sprouted from the DA from the mask using the cutting tool, 
which only worked in a single orientation, therefore it was necessary to rotate and 
manipulate the position of the vascular mask in the viewer window to remove 
unwanted vessels from the analysis procedure. The process of cutting the individual 
vessels was time consuming, leading to an analysis time of approximately 5 minutes 
per image, dependent on the number of ISVs within the image and the user’s 
experience of the software. The IMARIS software must be purchased from bitplane 
which can be expensive therefore this approach for analysing zebrafish vascular 
images may not be widely available to the scientific community. However, the 
IMARIS software has been specifically created for three dimensional rendering of two 
dimensional optical image sections and provides an interactive user space which 
enables the user to create, visualise, edit and analyse data sets within a single 
window within the software. The Filament Tracer module in IMARIS has been 
optimised to automate tracking and classification of filamentous structures such as 
spines and dendrites of neurons, consequently it is able to detect and analyse small 
vessels such as the ISVs accurately. However, the package is not specifically 
designed for this application; therefore the inclusion of the number of junctions 
formed in the DLAV after 36 hpf in the developmental time-course study caused the 
quantification for this parameter to increase steadily as the organism developed. The 
IMARIS software did not include a function which would allow for the automatic 
exclusion of the junctions in the DLAV such as the fill holes function used in the 
ImageJ analysis method. For this reason, the IMARIS analysis method would be 
more suitable for global vasculature analysis rather than specifically targeting the 
ISVs for analysis. Due to the considerable time restraints using this analysis method, 
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this method would be best suited for use in studies with small numbers of images, 
where vascular defects could be studied in detail using the 360o viewer.  
In contrast, the ImageJ analysis method was not reliant on the generation of a mask 
thus the parameters were measured directly from the original image file. However, 
this revealed that the method was prone to the inclusion of noise or artefact pixels 
within the image and extra fragmentation of the vascular skeleton which enhanced 
the numbers of end points detected. The creation of the ImageJ zebrafish 
vasculature macro offered the significant advantage of rapid quantification of the 
vasculature as the image outputs were generated within 35 seconds, which was 8.6 
times faster than the IMARIS analysis method. Furthermore, the fill holes function 
which was utilised in this method enabled the analysis method to target the ISVs 
specifically by removing the additional connections formed in the DLAV after 36 hpf. 
The ImageJ software is available free of charge and in the public domain; therefore 
using the macro for analysis would be easy to use and widely available. Since this 
analysis method was able to analyse both major and minor vascular defects in a time 
dependent manner, it would be suitable for analysing larger sets of zebrafish 
vascular images.      
Both of the computer based analysis methods were able to quantify vascular images 
and therefore either method can be used to assess normal and abnormal vascular 
development. The ImageJ method was chosen in this study to analyse the vascular 
images from the studies of silencing genes and using inhibitor compounds since it 
provided rapid analysis and was therefore less time consuming. In this chapter, the 
studies revealed that the ImageJ analysis method can be used to quantify a range of 
vascular phenotypes within zebrafish embryos, therefore this analysis method could 
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be used as a useful tool to assess vascular development in response to knocking 
down genes as well as determining the effect of inhibitor compounds on vascular 
formation.  
Significant correlations were observed between some of the parameters measured 
by the ImageJ analysis method; as the vascular network expanded and became 
more elaborate, increased numbers of vessel segments, lengths and vascular 
junctions were detected in the images, this result reflected accordingly with the 
development of the zebrafish. Measuring the parameters of the total vessel length, 
the number of vascular junctions and the number of vessel segments within a 
zebrafish image would provide an excellent overview of the vascular morphology 
which had developed within the organism. Measuring the total vessel length would 
give a global understanding of the extent of vessel formation, whereas measuring the 
number of junctions would be informative on the vessel connectivity. Measuring the 
number of vessel segments formed within the organism would suggest if endothelial 
sprouting had been affected. Measuring the total vessel length and the number of 
vessel segments would also enable a further calculation of the average vessel 
length, if required. Measuring the numbers of end points showed limited correlations 
to the other parameters and did not provide useful information on vascular 
morphology in this study, measuring this parameter would only be beneficial if there 
was severe absence of ISVs or extensive hyper-sprouting of the vasculature.  
Confocal image sections can be compressed to improve image resolution and the 
application of post-processing image operations such as image registration, 
binarisation and image segmentation can be applied to fluorescent zebrafish images 
to aid vascular analysis; however at present there is no gold standard computer 
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based method that is widely used for the quantification of the zebrafish vasculature. 
Many of the analysis frameworks which have been reported often give excellent 
visual representations of the analysis but use software which is not widely available 
or in practice hard to implement or modify such as Visual C++ Language183. Other 
methods used to analyse vascular growth include analysing ISV sprouting from the 
DA using primarily the process of image registration to measure increases in vessel 
lengths at different time points, however this method does not generate data on 
vessel junctions and therefore no knowledge of vessel connectivity is obtained181,182.  
Additional analysis methods targeting the ISVs have used microscopy software such 
as the Nikon Imaging Software (NIS) Elements to measure the lengths of ISVs which 
is neither automated nor applicable for large numbers of images178. Due to the 
difficulties associated with implementing computer based analysis methods, many 
researchers continue to manually analyse the vascular disruption using scoring 
systems and classifying the vascular phenotypes into categories such as ‘mild’, 
‘intermediate’ or ‘severe’ ISV disruption164-167. An alternative and frequently used 
approach to analyse the ISVs is to manually count the number of ISVs which connect 
or remain disconnected from the DLAV, this is also often represented as a 
percentage of the total number of ISVs168-170,172-177. Both of these manual approaches 
to analysis are able to give a global understanding of how the vascular network has 
developed in the organism. The method of evaluating if the ISVs have connected to 
the DLAV, gives a greater understanding of ISV connectivity compared to the 
classification system of analysis, however the extent of ISV growth is not assessed, 
therefore the resulting analysis data does not provide information on whether the 
ISVs failed to sprout or whether they developed but were unable to form vessel 
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connections. The ImageJ analysis method generated in this chapter was able to 
provide rapid results and an understanding of the vascular morphology similar to the 
manual analysis methods that are currently used to assess vascular development. 
The ImageJ analysis method assessed vessel connectivity by calculating the number 
of vascular junctions within the images and additionally was able to generate 
informative data on vessel lengths and the number of vessels formed.  
As shown in this chapter, similar results were obtained using the ImageJ analysis 
method compared to the results obtained using the manual method of calculating the 
percentage of connected ISVs in the zebrafish gene knock down study. Both 
methods revealed that the three genes that caused severe vascular disruption when 
silenced were VEGFA, ROBO4 and ELTD1 and the two genes that had comparable 
vascular phenotypes to their corresponding control treated embryos were ERG and 
CLEC14 upon imaging at 48 hpf. The manual analysis method identified that 
silencing ROBO4 caused fewer numbers of ISVs to connect to the DLAV in 
comparison to VEGFA which was identified as having the most vascular disruption 
using the ImageJ analysis method. Silencing VEGFA caused severe absence of ISV 
growth from the DA, however the ISVs that did form often connected to the DLAV. 
Whereas in ROBO4 knocked down embryos, widespread endothelial sprouting 
occurred during the formation of the ISVs however the DLAV failed to form. The 
ImageJ analysis method revealed that the ROBO4 silenced embryos formed twice as 
many vessels as VEGFA silenced embryos and also exhibited longer average and 
total vessel lengths. Studying a number of different parameters is useful for 
determining the vascular morphology which has developed in the organism.    
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To achieve accurate data analysis it was important to initially acquire and load a 
highly fluorescent vascular image particularly from the vessels of interest into the 
computer software. At present, both analysis methods worked most effectively when 
the generated analysis data was exported from ImageJ or IMARIS into Microsoft 
Excel, where the final calculations to obtain totalled or averaged values could be 
obtained. Future work, particularly on the ImageJ analysis method would be to create 
an extra step in the analysis process to include automation of the final calculations, 
eliminating the need to export the data.  
In summary, two objective computerised methods using ImageJ and IMARIS 
software were developed which were able to quantify vascular development in 
zebrafish. Both computer based approaches enabled accurate analysis of the 
number of vessel segments, junctions, total and average vessel lengths which were 
unbiased and offered the potential to be used as useful analysis tools for determining 
the function of genes and the action of novel compounds on the angiogenic pathway.  
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Chapter Six 
General Discussion 
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6.1. Overall project findings 
The aim of this PhD project was to monitor, manipulate and analyse in detail the 
process of angiogenesis through the development of high resolution fluorescence 
imaging techniques and the generation of useful analysis tools to allow angiogenic 
images to be rapidly and effectively quantified. The quantification of images enables 
the comparison of the effects gene silencing or treatment with compounds which 
affect the angiogenic process to be effectively studied. The aims of this project were 
achieved by utilising the ability to fluorescently label endothelial cells and proteins 
prior to their use in the in vitro co-culture tube formation assay and the hanging drop 
spheroid angiogenesis assay and using transgenic fli1-GFP zebrafish embryos. High 
fluorescence emission from endothelial cells in vitro and in vivo was required to 
permit high resolution confocal imaging, which enabled the generation of useful 
computer based tools for analysing such images. 
6.1.1 Summary of findings from investigating lumen formation within 
endothelial tubules 
To investigate lumen formation in the co-culture tube formation assay various 
fluorescent labelling approaches were used, a new two coloured fluorescence 
labelling technique was established using the cytoplasmic dyes, CFSE and 
CellTracker orange, as well as F-actin labelling using lifeact-GFP and lifeact-RFP. 
The two coloured labelling approach allowed a detailed investigation into the 
lumenogenesis mechanisms in comparison to visualising greyscale images. 
Additionally, a novel technique for visualising the formation of endothelial lumens in 
live tubules was presented using cells which expressed the lifeact peptide conjugated 
to fluorescent proteins. This study revealed that F-actin fibres clearly outline lumenal 
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boundaries and also proved useful for studying filopodia formation. Overall, the 
endothelial cell rearrangement mechanism was the predominant mechanism 
observed in the assay, the vacuole fusion mechanism was also visualised using the 
F-actin labelling technique although less frequently than the endothelial cell 
rearrangement mechanism.  
6.1.2 Summary of findings from designing, testing and evaluating a 
computer based method to analyse endothelial sprouting for 
screening purposes 
A new computer based analysis tool was designed which was able to rapidly and 
effectively quantify endothelial sprouting by measuring various sprouting parameters 
from fluorescent spheroid images generated from the hanging drop spheroid assay. 
The Spheroid Analysis plugin was able to automatically analyse a wide range of 
sprouting phenotypes. Upon evaluation it was determined that the analysis tool was 
able to generate comparable results to the frequently used manual analysis method 
of calculating the total sprouting length but in a time that was approximately seven 
times faster than the manual approach. The results from this study confirmed that the 
new ImageJ plugin is a useful analysis tool for screening compounds which affect the 
process of endothelial sprouting. The Spheroid Analysis plugin will be published 
online and will be freely available and widely accessible for the scientific community 
to use.  
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6.1.3 Summary of findings from developing, testing and evaluating 
computer based analysis methods for quantifying the zebrafish 
vasculature  
Two computer based analysis methods were developed using IMARIS and ImageJ 
software, both can be used to assess and quantify the development of the zebrafish 
vasculature. The two analysis methods used different post-processing steps and 
therefore each method offered unique advantages when compared. The IMARIS 
analysis method enabled a detailed investigation into the developed vasculature 
through the use of an interactive window, whereas the ImageJ Zebrafish Analysis 
Vasculature Macro enabled rapid and specific analysis of ISV growth and 
connectivity to the DLAV. The ImageJ analysis method using established ImageJ 
functions will be freely available, widely accessible and produced comparable results 
to the frequently used manual analysis method of determining the number of 
connected ISVs.  
6.2. Use of fluorescently labelled endothelial cells 
The aims of this PhD project were achieved by utilising the ability to fluorescently 
label and image endothelial cells and proteins, which enabled a detailed study into 
the angiogenic processes of endothelial tubulogenesis and lumenogenesis in the co-
culture tube formation assay, endothelial sprouting in the hanging drop spheroid 
assay and ISV growth and connectivity in zebrafish.   
It proved essential to fluorescently label endothelial cells with highly emissive dyes 
prior to use in both of the in vitro assays of the co-culture tube formation assay and 
the hanging drop spheroid angiogenesis assay. It was of importance in the co-culture 
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tube formation assay as highly emissive fluorescence dyes and proteins proved to be 
critical for monitoring tubular growth and enabled the endothelial cells to be 
distinguished from the fibroblasts. By fluorescently labelling endothelial cells with 
different coloured dyes an investigation into the mechanisms of lumenogenesis was 
achieved.  
In the hanging drop spheroid assay, the use of the highly emissive fluorescence dye 
CFSE proved critical for capturing high contrast images of the endothelial sprouts. 
The confocal image sections were compressed to produce high resolution images 
which showed clear endothelial cell boundaries against the collagen background, 
which made it possible to design and develop computer based analysis tools for the 
assessment and quantification of endothelial sprouting. Using confocal imaging 
avoided the problems of incomplete object boundaries which are often associated 
with non-fluorescent optical imaging techniques. The use of brightfield or phase 
contrast images would have been more challenging to analyse.  
Similarly, imaging and studying in vivo blood vessel formation was possible due to 
the use of transgenic fli1-GFP zebrafish embryos which stably expressed GFP 
throughout their vascular endothelium. In a similar way to the spheroid images, the 
optical image sections were compressed to produce a high contrast image of the 
blood vessels against the background of the organism. These high resolution images 
showed clearly the growth and connectivity of the ISVs during development, which 
was essential for being able to generate computer based analysis tools for accurately 
quantifying blood vessel formation.  
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6.3. Comparing the computer based analysis methods 
In this PhD project, three computer based analysis tools were tested and evaluated 
for their use of rapidly and effectively quantifying images of endothelial sprouting and 
blood vessel formation, these included the Spheroid Analysis plugin to analyse 
endothelial sprouting and the ImageJ and IMARIS analysis methods for analysing the 
development of the zebrafish vasculature. All three computer based analysis 
approaches initially required the loading of a fluorescent image with high contrast 
between the object of interest and the image background.  
The analysis procedures used different post processing steps which were specific to 
the application that they were designed for; however some of the steps in the 
processing stages were highly similar ensuring that each pixel within the acquired 
image was accurately assessed. All three computer based analysis tools made use 
of the skeletonisation function; this is a morphological thinning function which uses 
an algorithm to successively erode the object in the image until a network of single 
pixels remains. The skeletonisation process was able to create a simple 
representation of the original image object. This function is performed on a binary 
image; binarisation was used to clearly identify the object in the image from the 
image background. The product of the skeletonisation function was a simplified 
structure of pixels which was easily and quickly assessed for the presence of end-
points, junctional pixels, total number of pixels and segments. The skeletonised 
function worked effectively in all three analysis methods that were tested and this 
was shown by the overlaid images of the skeletonised and original images.  
Another important process in all three analysis methods was the requirement to 
remove noise pixels which were acquired during image acquisition to enhance the 
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accuracy of the analysis procedure. Two different processes were employed to 
remove noise, these included the despeckle function in ImageJ and thresholding 
during the creation of the mask in IMARIS. The despeckle function is a highly 
sensitive median filtering operation; each pixel was accessed and given a reassigned 
intensity value based on the values of the neighbouring nine pixels. Noise was 
removed in the IMARIS method by selecting a threshold value during the creation of 
the three dimensional mask which excluded all noise pixels from the subsequent 
analysis steps. Both methods successfully excluded noise from the analysis process, 
however the despeckle function had the advantage of being an automated function, 
whereas manually selecting a thresholding value can cause variability between 
images.  
It would have been useful for the IMARIS software to have an equivalent despeckle 
function to automate the process of noise removal as well as having an equivalent fill 
holes function which was used in ImageJ to remove additional vascular connections 
formed in the DLAV. This would have enabled the ISVs to be more specifically 
targeted for analysis. However, unfortunately it was not possible to alter the IMARIS 
platform due to the software being protected and commercially available. The ImageJ 
methods had the additional advantages of being freely available, widely accessible, 
easy to use and generated the quantitative outputs faster than the IMARIS and 
manual analysis methods.  
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6.4. Future work 
6.4.1 Future work for investigating lumen formation within endothelial 
tubules 
Using endothelial cells which expressed the lifeact peptide conjugated to fluorescent 
proteins proved to be a highly useful method for visualising the presence of lumen 
formation within endothelial tubules, however there were concerns as to whether the 
lifeact peptide was modifying the mechanism of lumen formation. To investigate 
whether the binding of the lifeact peptide to the actin fibres within the endothelial cells 
caused disruption to the dynamic functioning of the cytoskeleton, endothelial cells 
with and without lifeact expression should be used in the co-culture tube formation 
assay. The endothelial tubules without lifeact expression would be stained using 
fluorescently labelled phalloidin to compare the actin organisation in tubules formed 
in both co-cultures, this experiment would determine whether using lifeact expression 
caused any adverse effects to tubular growth or caused the formation of vacuoles. 
A particular limitation in this project was that endothelial processes were imaged 
using confocal microscopy at single time points. In the study of investigating the 
formation of lumens this meant that different endothelial tubules were studied during 
the duration of the assay. Using live-cell time lapse confocal microscopy alongside 
the fluorescent imaging techniques established in this project would have enabled 
the same endothelial cells to be imaged throughout the tubulogenesis and 
lumenogenesis processes. Future work would involve ensuring access to a 
fluorescence microscope that was able to perform time lapse imaging, to provide 
valuable insights into these processes. Unfortunately, it was not possible to perform 
time-lapse imaging during this project due to not having access to such microscope. 
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Performing time lapse imaging of the co-culture assay could posse challenges due to 
the long duration of imaging time required as the tubules develop over a period of 
several weeks. Stable conditions of 37 oC in an atmosphere of 5% carbon dioxide 
would be required with media refreshed every other day. The microscopy system 
would also have to have minimal drift to enable the same field of view to be imaged 
during the time course, which is often a challenge associated with time lapse 
imaging.  
6.4.2 Future work for designing, testing and evaluating a computer 
based method to analyse endothelial sprouting for screening 
purposes 
The Spheroid Analysis plugin relied on a highly fluorescent spheroid image to be 
loaded into the analysis tool to accurately analyse endothelial sprouting, this was 
achieved by labelling the endothelial cells with 5 μM CFSE. The plugin also required 
only a single spheroid per image to be loaded into the software, if more than one 
spheroid was present in the image, post-processing by the user was required to 
remove additional spheroids from the image. Future work in the development of the 
plugin would enable automatic analysis of several spheroids per image, thereby 
reducing image acquisition time. Additionally, the ability of the plugin to be able to 
automatically analyse batches of images would be highly valuable as this would 
substantially reduce the time required to process the data generated by the plugin.  
It would be interesting to further advance this analysis tool to enable processing and 
analysis of two coloured fluorescence images, this would enable tip and stalk cell 
dynamics could be studied in detail. A population of endothelial cells could be treated 
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and labelled with a particular fluorescence dye, and untreated cells could be labelled 
with a different coloured dye. The cells could be mixed and used in the hanging drop 
spheroid assay and the plugin could be used to assess whether the treated cells 
preferentially located to the tip or stalk positions of the endothelial sprouts. Another 
highly useful advancement of the ImageJ plugin would be to enhance the design so 
that it would be capable of analysing three dimensional reconstructional images of 
the spheroids. It would be possible to generate three dimensional reconstructional 
images of the spheroids using the confocal image sections and if the plugin was able 
to analyse these sprouting images it would provide greater knowledge on the 
arrangement and development of the endothelial sprouts.   
6.4.3 Future work for developing, testing and evaluating computer based 
analysis methods for quantifying the zebrafish vasculature 
Similarly to the study of investigating lumen formation, a limitation in the study of 
visualising ISV growth in zebrafish was that single time points of development were 
imaged using confocal microscopy. To further the work presented in this chapter and 
to gain an in depth understanding of the effects of silencing vascular related genes 
and the treatment with inhibitor compounds, time lapse confocal imaging would be 
used to study the development of the organism and vascular system from the one 
cell stage through to 48 hpf. Unfortunately as previously mentioned it was not 
possible to perform time lapse imaging during this study due to not having access to 
such microscope.  
To achieve accurate data analysis it was important to initially acquire and load a 
highly fluorescent vascular image particularly from the vessels of interest into both 
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the IMARIS and ImageJ analysis methods. It was not possible to alter the IMARIS 
platform therefore the future work would involve improving the ImageJ Zebrafish 
Analysis Vasculature Macro. At present, the analysis method worked most effectively 
when the generated analysis data was exported from ImageJ into Microsoft Excel, 
where the final calculations to obtain totalled or averaged values could be obtained. 
By converting the ImageJ macro into an ImageJ plugin it would be possible to create 
an extra step in the analysis process to include automation of the final calculations. 
The addition of this step would eliminate the need to export the data from each image 
individually and reduce the data processing time substantially. At present, this 
computer based analysis method to specifically target the ISVs and DLAV for 
analysis is semi-automated as the PCV and DA are manually selected for removal 
from the analysis process, this offers a useful manipulation step whereby the user 
can determine which vessels to analyse. However, it may be possible to introduce a 
step that automatically removes the PCV and DA using shape recognition algorithms, 
thereby reducing the analysis time whilst specifically targeting the ISVs for analysis. 
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7.1 Identification of the different parameters measured by the ImageJ 
Spheroid Analysis plugin for spheroid quantification 
The ImageJ Spheroid Analysis plugin was used to quantify endothelial sprouting from 
fluorescently labelled spheroid images generated using the in vitro hanging drop 
spheroid angiogenesis assay. As shown by figure 7.1A, the Spheroid Analysis 
ImageJ plugin was able to process the spheroid images by skeletonising the network 
of endothelial cells surrounding the spheroid mass. After the skeletonisation process, 
the endothelial sprouts appeared as a network of single pixels within the image, each 
pixel was assessed according to its neighbouring eight pixel values and subsequently 
categorised as either an end point, junction or segment pixel.   
A segment pixel was assigned if the pixel being assessed had exactly two 
neighbouring pixels that were also part of the skeletonised network, whereas an end 
point pixel was assigned if there was only one or zero neighbouring pixels. A 
junctional pixel was assigned if the pixel being assessed had more than two 
neighbouring pixels. In this way, all pixels within the skeletonised network were 
analysed and each pixel was colour coded accordingly. All end point pixels were 
identified in red and junctional pixels in dark blue as shown in figures 7.1B and 7.1C. 
Endothelial segments within the spheroid images were therefore separated by either 
two end point pixels, two junctional pixels or one end point and one junctional pixel, 
and all segmental pixels were identified in light blue, as shown in figure 7.1D. 
Following the pixel analysis, the ImageJ plugin automatically calculated the total 
segment length by summing the number of pixels assigned as a segment pixel and 
the average segment length was calculated by dividing the total segment length by 
the number of endothelial segments from within an image. 
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Figure 7.1 Identification of the parameters measured by the Spheroid Analysis 
plugin for the quantification of endothelial sprouting 
The ImageJ Spheroid Analysis plugin was used to analyse fluorescent spheroid 
images generated using the hanging drop spheroid angiogenesis assay. A) An image 
of the analysed network of endothelial sprouts produced by the ImageJ plugin from a 
fluorescently labelled spheroid image. The sprouting segments are shown in light 
blue, the endothelial junctions in dark blue and the end points in red. The red box 
highlights a selected region which was magnified to show in detail the identification of 
the different parameters that were measured by the plugin. B) A magnified image of 
an endothelial sprout analysed by the Spheroid Analysis ImageJ plugin, the arrows 
show the identification of five end points, shown in red, scale: 100 μm. C) The arrows 
show the identification of two endothelial junctions shown in dark blue. D) The 
endothelial segments are shown in light blue, an endothelial segment was defined as 
a region of connected segmental pixels separated either by two end points, two 
junctional points or one junction and one end point, an example of each of these has 
been shown and identified with arrows in the image, scale: 100 μm. 
A Analysed spheroid image B End points 
C Junctions 
D Segments 
1 end point  
and 1 junction 
2 junctions 
2 end points 
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7.2 Screening kinases to identify those with roles in endothelial 
sprouting 
A library of 80 small molecule kinase inhibitor compounds were added into the in vitro 
hanging drop spheroid angiogenesis assay to identify the effects the kinase inhibitors 
had on the processes on endothelial sprouting. In this way, a wide range of spheroid 
images showing different sprouting morphologies were generated and used to test 
the capabilities of the Spheroid Analysis plugin as described in this thesis in section 
4.4.  
The ImageJ Spheroid Analysis plugin was used to analyse the effects of the kinase 
inhibitor compounds on endothelial sprouting by applying the plugin to images of 
fluorescently labelled spheroids which were treated in the hanging drop spheroid 
assay with the inhibitor compounds. Five spheroids were imaged and analysed per 
inhibitor condition and bar charts of the results generated on the parameters of total 
and average endothelial sprouting length and the numbers of endothelial segments, 
junctions and end points have been shown in figures 7.2 – 7.6. Statistical analysis 
was performed using the Mann-Whitney test.  
The sprouting results for this study as presented in figures 7.2 – 7.6 were normalised 
to their corresponding controls and converted to percentages and were represented 
in heat map tables, as shown in tables 11 and 12  in chapter four.  
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Figure 7.2 The effect on the total sprouting length when kinase inhibitors were 
added to the hanging drop spheroid assay 
The ImageJ Spheroid Analysis plugin was used to analyse the total sprouting length 
of fluorescently labelled spheroids generated using the hanging drop spheroid 
angiogenesis assay with confocal imaging 16 hrs after collagen embedding. 
Statistical analysis was performed using the Mann-Whitney test, n=5 images per 
condition, **** indicates p ≤ 0.0001, *** indicates p ≤ 0.001, ** indicates p ≤ 0.01 and * 
indicates p ≤ 0.05. The error bars are the SEM. 
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Figure 7.3 The effect on the average sprouting length when kinase inhibitors 
were added to the hanging drop spheroid assay 
The ImageJ Spheroid Analysis plugin was used to analyse the average sprouting 
length of fluorescently labelled spheroids generated using the hanging drop spheroid 
angiogenesis assay with confocal imaging 16 hrs after collagen embedding. 
Statistical analysis was performed using the Mann-Whitney test, n=5 images per 
condition, **** indicates p ≤ 0.0001, *** indicates p ≤ 0.001, ** indicates p ≤ 0.01 and * 
indicates p ≤ 0.05. The error bars are the SEM. 
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Figure 7.4 The effect on the number of segments when kinase inhibitors were 
added to the hanging drop spheroid assay 
The ImageJ Spheroid Analysis plugin was used to analyse the number of segments 
of fluorescently labelled spheroids generated using the hanging drop spheroid 
angiogenesis assay with confocal imaging 16 hrs after collagen embedding. 
Statistical analysis was performed using the Mann-Whitney test, n=5 images per 
condition, **** indicates p ≤ 0.0001, *** indicates p ≤ 0.001, ** indicates p ≤ 0.01 and * 
indicates p ≤ 0.05. The error bars are the SEM. 
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Figure 7.5 The effect on the number of junctions when kinase inhibitors were 
added to the hanging drop spheroid assay 
The ImageJ Spheroid Analysis plugin was used to analyse the number of junctions of 
fluorescently labelled spheroids generated using the hanging drop spheroid 
angiogenesis assay with confocal imaging 16 hrs after collagen embedding. 
Statistical analysis was performed using the Mann-Whitney test, n=5 images per 
condition, **** indicates p ≤ 0.0001, *** indicates p ≤ 0.001, ** indicates p ≤ 0.01 and * 
indicates p ≤ 0.05. The error bars are the SEM. 
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Figure 7.6 The effect on the number of end points when kinase inhibitors were 
added to the hanging drop spheroid assay 
The ImageJ Spheroid Analysis plugin was used to analyse the number of end points 
of fluorescently labelled spheroids generated using the hanging drop spheroid 
angiogenesis assay with confocal imaging 16 hrs after collagen embedding. 
Statistical analysis was performed using the Mann-Whitney test, n=5 images per 
condition, **** indicates p ≤ 0.0001, *** indicates p ≤ 0.001, ** indicates p ≤ 0.01 and * 
indicates p ≤ 0.05. The error bars are the SEM. 
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7.3 Identification of the different parameters measured by the computer 
analysis tools for quantifying intersegmental blood vessel growth 
and connectivity 
The ImageJ and IMARIS computer based analysis methods were developed to 
analyse and quantify the growth of the ISVs within zebrafish and the connectivity of 
these vessels to the DLAV. Both of the computer based methods used a 
skeletonisation function to simplify the vascular network to a series of single pixels, 
which were individually assessed according to their neighbouring pixel values. Each 
pixel within the vascular skeleton was categorised as an end point, junctional or 
segmental pixel and colour coded accordingly, as shown in figure 7.7A. 
A segment pixel was assigned if the pixel being assessed had exactly two 
neighbouring pixels, whereas an end point pixel was assigned if the pixel had zero or 
one neighbouring pixel. A junctional pixel was assigned if the pixel being assessed 
had more than two neighbouring pixels. All end point pixels were labelled blue in 
colour and junctional pixels were labelled in pink, as shown in figures 7.7B and 7.7C 
respectively. A vascular segment was defined as a connected region of segment 
pixels between two end point pixels, two junctional pixels or one end point and one 
junctional pixel. All vascular segment pixels were shown in orange within the 
analysed image, as shown in figure 7.7D. After the pixels within the vasculature 
image had been analysed, the calculations of the total and average vessel lengths 
were determined.  
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Figure 7.7 Identification of the parameters measured by the computer analysis 
methods for the quantification of intersegmental blood vessel growth and 
connectivity 
The computer analysis methods using ImageJ and IMARIS analysed the 
skeletonised zebrafish vascular network in a similar way to produce outputs on the 
numbers of end points, junctions and vessel segments. The images shown in this 
figure were generated using the ImageJ analysis method. A) An image of the 
analysed and skeletonised network of ISVs and DLAV, vessel segments are shown 
in orange, junctions in pink and end points in blue. The red box highlights a selected 
region which was enlarged to show the identification of the different parameters that 
were measured, scale: 500 μm. B) An enlarged image of a region of skeletonised 
vasculature, arrows show the identification of end points. C) The arrows show the 
identification of junctions. D) A vascular segment was defined as a connected region 
of segment pixels between two end points, two junctional points or between one 
junction and one end point, an example of each has been identified with arrows.  
B End Points 
C Junctions 
D Segments 
A Skeletonised and analysed vascular image 
2 end points 
1 junction and  
1 end point 
2 junctions 
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7.4 ImageJ zebrafish vasculature analysis macro 
The zebrafish vasculature analysis macro was generated as part of the ImageJ 
analysis method for the quantification of the intersegmental blood vessels (ISVs) and 
their connectivity to the dorsal longitudinal anastomotic vessel (DLAV) in fli1-GFP 
embryonic zebrafish. The ImageJ analysis method for quantifying fluorescent images 
of the zebrafish vasculature is presented in this thesis in section 5.3. The image 
processing steps of binarisation through to generating the outputs of the analysed 
vascular skeleton which correlate to steps four through to eight in the method were 
generated as a macro. The macro can be transferred and saved to ImageJ to allow 
for semi-automated analysis of zebrafish vasculature images. 
run("8-bit"); 
setOption("BlackBackground", true); 
run("Make Binary"); 
run("Fill Holes"); 
run("Despeckle"); 
run("Skeletonize (2D/3D)"); 
run("Analyze Skeleton (2D/3D)", "prune=none show"); 
 
 
 
 
 
 
 
 
Figure 7.8 ImageJ zebrafish vasculature analysis macro code 
The ImageJ macro was generated to allow for the semi-automated analysis of the 
ISVs in vascular images of fli1-GFP zebrafish embryos. The code for the macro can 
be transferred and saved to ImageJ. 
